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The purposes of this cross-sectional, descriptive, correlational study were to 
describe the characteristics of sleep disorders and HRQOL; to explore the relationships 
between individual characteristics (age, gender, education, living arrangement, marital 
status, financial status, employment status, and type of language), HF characteristics 
(body mass index, comorbidity, and perceived health), sleep disorders (nocturnal sleep 
quality, daytime sleepiness, and daytime napping), and HRQOL; and to identify 
predictors of HRQOL. A nonprobability sample of 125 participants with HF was 
recruited from the outpatient departments of a large medical center and an affiliated 
hospital located in southern Taiwan. All participants were individually interviewed by the 
principal investigator in either a private area within a clinic or in their homes, except for 
two participants who completed the questionnaires by themselves at locations of their 
choice. 
Overall, the study findings indicated that insomnia (difficulty initiating sleep, 
maintaining sleep, or both) may be common among the participants. Approximately 
72.8% of the participants reported poor nocturnal sleep quality, however, only 30 (24%) 
 viii
of them had excessive daytime sleepiness. Additionally, the majority (81.6%) of the 
participants reported they were prone to habitual daytime napping after lunch. Except for 
the significant relationship between daytime sleepiness and the component of daytime 
dysfunction, daytime sleepiness and daytime napping were not significantly correlated 
with the global and componential variables of nocturnal sleep quality. 
By using a hierarchical multiple regression model analysis, six predictors were 
identified from 14 predictor variables, and those six accounted for 58.5% (p<.001) of the 
variance in HRQOL. After controlling for age, education, financial status, comorbidity, 
perceived health, and NYHA Class, the analyses showed that sleep variables (subjective 
sleep quality, sleep disturbances, and sleep latency) accounted for 7% of the variance in 
HRQOL. The study found that the Taiwanese persons with HF who experienced better 
HRQOL were those who had higher level of education, lower NYHA Classes, and small 
numbers of comorbid conditions, and reported better subjective sleep quality, fewer sleep 
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Chapter 1: Introduction
Chronic heart failure (HF) is a common and major health condition that results in
a high rate of rehospitalization, morbidity, and mortality across the world (Heidenreich et
al., 2006; Levy et al., 2002; Podrid  & Myerburg, 2005; Sanderson & Tse, 2003) . HF is
characterized by several complex symptoms that are difficult to control , and require
long-term clinical management. As a result, p eople not only suffer from symptoms caused
by HF itself, but also from treatment-related side effects. For example, symptom side
effects caused by two common medications, beta-blockers and diuretics, include edema,
fatigue, hypotension, copious amounts of urine, and electrolyte imbalance . These can
affect the ability to carry out daily activities and tasks and also enjoyment of life (Bennett,
Cordes, Westmoreland, Castro, & Donnelly, 2000; Hunt et al., 2005; Todero,
LaFramboise, & Zimmerman, 2002). As a result, quality of life may be significantly
impaired even though they are receiving evidence -based HF treatments (Bennett, Baker,
& Huster, 1998; Clark, Tu, Weiner, & Murray, 2003; Ekman, Fagerberg, & Lundman,
2002; Jessup & Brozena, 2003; Westlake et al., 2002) . This is also true for Taiwanese
people with HF (Shang, 2002; Shih, Chiou, Tsai, Ou, & Jeng, 2 003; Wang, 2004; Yang,
2000).
Identifying and ameliorating potential negative factors that could impact patients ’
health-related quality of life (HRQOL) is imperative to create better long term health-care
outcomes for people living with HF. As a composite outcome variable, HRQOL can be
used to reflect one’s subjective perceptions of the physical and psychosocial functional
effects of an illness and consequent therapy on daily activities (Reddy & Dunn, 2000;
Wiklund, Lindvall, Swedberg, & Zupkis, 1987) . HRQOL has been viewed as the most
important clinical outcome to guide effective therapeutic interventions for HF (Hadorn,
Baker, Dracup, & Pitt, 1994). However, people with HF are at risk for worsening
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HRQOL because of the symptoms and gradual functional decline (Coelho et al., 2005; 
Masoudi et al., 2004). Research has suggested that HF not only impairs physical 
functioning, but it also increases psychological distress, including anxiety, feelings of 
powerlessness, and depression (Bennett et al., 1998; Bennett et al., 2003; Cacciatore et al., 
1998; Friedman, 2003; Jalowiec & Grady, 1994; Lackey, 2004; Zambroski, 2003; 
Zambroski, Moser, Bhat, & Ziegler, 2005).  
Sleep disorders have been reported as one of the most burdensome symptoms for 
people with HF (Jaarsma et al., 1999; Jalowiec & Grady, 1994; Todero et al., 2002; 
Zambroski et al., 2005). They are more likely to develop sleep problems compared to the 
general population (Ancoli-Israel et al., 2003; Brostrom, Stromberg, Dahlstrom, & 
Fridlund, 2004; Katz & McHorney, 2002). Approximately 10 to 70% of patients with HF 
experience sleep problems (Brostrom et al., 2004; Erickson, Westlake, Dracup, Woo, & 
Hage, 2003; Jahaveri et al., 1995; Mansfield et al., 2004; Sin et al., 2003; Skobel et al., 
2005; Trupp et al., 2004; Villa et al., 2003). However, sleep disorders are one of the least 
studied correlates of HRQOL in people with HF, and information is especially lacking in 
Taiwanese people. 
The relationship between sleep disorders, HF, and HRQOL needs investigation. 
Two major causes for sleep disorders in this population are sleep-related breathing 
disorders and insomnia (Brostrom & Johansson, 2005). Sleep-related breathing disorders 
represent a complex manifestation of sleep disorders, and a powerful determinant of poor 
prognosis in people with HF (Rao & Gray, 2005). Insomnia is associated with complaints 
regarding the quantity, quality or timing of sleep at least 3 times a week for at least one 
month (Holbrook, Crowther, Lotter, Cheng, & King, 2000), and independently associated 
with worsened HRQOL almost to the same extent as HF (Katz & McHorney, 2002). 
Likewise, excessive daytime sleepiness following insomnia has been linked to increased 
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morbidity and mortality in people with HF (Newman et al., 2000). The limited research 
that has been done found that sleep disorders reduced the HRQOL of HF patients and 
their overall functional performance, including daily activities, work productivity, social 
participation, cognitive and mathematic functions, and psychological well-being 
(Brostrom et al., 2004; Erickson et al., 2003; Manocchia, Keller, & Ware, 2001; Skobel et 
al., 2005). There are no studies describing sleep disorders and HRQOL among Taiwanese 
people with HF. Because HRQOL is rooted in an individual’s cultural background (Yu, 
Lee, & Woo, 2004), cultural differences limit the application of research findings from 
the Western population to Taiwanese patients with HF. Understanding this interaction 
between sleep disorders and HRQOL is needed to provide effective care for this 
population. 
Purpose 
The purpose of this study was to investigate the relationship between sleep 
disorders and HRQOL in people with HF in Taiwan. In particular, the study described 
sleep characteristics, and HRQOL, and explored the relationships between HF 
characteristics, sleep disorders, and HRQOL.  
Background and Significance 
HF is a lethal syndrome affecting approximately 5.2 million Americans with 
550,000 new cases each year (Hunt et al., 2005; Podrid & Myerburg, 2005; Rosamond et 
al., 2007). The estimated cost of HF treatment in the U.S. was $33.2 billion in 2007 
(Rosamond et al., 2007). According to AHA, people with HF are six to nine times more 
likely to experience sudden cardiac death than the healthy population (Rosamond et al., 
2007). The mortality rate rose 28% between 1994 to 2004, and approximately 20% of 
patients died within one year after being diagnosed with HF. Furthermore, 80% of men 
and 70% of women under age 65 who have HF will die within 8 years of diagnosis 
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(Rosamond et al., 2007). 
In Taiwan, HF is a major cause for rehospitalization, and in 2004 accounted for 
approximately 2% of the total death rate (Taiwan Department of Health, 2005). Precise 
statistical data for the incidence of HF among Taiwanese people is unknown. However, in 
a retrospective medical record review study (n=411), researchers reported an in-hospital 
mortality rate of 7.8%, a six-month post-discharge mortality rate of 7.2%, and a 
six-month readmission rate of 39.9% (Tseng, 2004).  
The incidence of HF in Taiwan is likely to continue rising (Chen, Chang, Cheng, 
Chen, & Chai, 2003) based on several factors. Numerous conditions are prevalent, such 
as diabetes, obesity, and smoking, which are known to influence HF development (Bell, 
2003; Hunt et al., 2005; Hussey & Hardin, 2003; Wilhelmsen, Rosengren, Eriksson, & 
Lappas, 2001). Diabetes is the fourth leading cause of death in Taiwanese people and may 
even be underestimated (Lu, Hsu, Anderson, & Huang, 2005; Taiwan Department of 
Health, 2006). According to the 1998 and 1999 claims data from the Bureau National 
Health Insurance program in Taiwan, HF was the most prevalent complication of diabetes 
(32.9% and 23.3%, respectively) (Lin, Chou, Tsai, Lee, & Tai, 2004). 
Second, several heart diseases can cause HF (Hunt et al., 2005; Leung & Bradley, 
2001; Lloyd-Jones et al., 2002; Naughton, 2003). In 2005, heart disease was ranked as the 
third leading cause of all deaths in Taiwan and accounted for 9.3% of the total death rate. 
Hypertension was the tenth cause leading to 1.4% of the total death rate (Taiwan 
Department of Health, 2006). In a chart review study, the primary cause of HF was 
ischemic heart disease, including coronary artery disease and myocardial infraction, 
affecting approximately half of 411 Taiwanese people with HF (Tseng, 2004). 
Additionally, aging is an important risk factor for the increasing incidence and mortality 
rates of HF in Chinese populations (Hung, Cheung, Ip, & Fung, 2000; Hunt et al., 2005; 
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Masoudi, Havranek, & Krumholz, 2002). The Taiwanese population over age 65 years 
reached 9.5% in 2005 and is expected to continue to increase in the future (Taiwan 
Department of Health, 2005).  
Symptom burden in HF causes devastating physical and psychosocial functioning 
and poor HRQOL (Heo, Moser, Riegel, Hall, & Christman, 2005; Johansson, Dahlstrom, 
& Brostrom, 2006; Kasper, 2003). Patients report lacking energy and facing marked 
restrictions on performing daily activities including working, social participation, 
self-care activities, and household chores (Bosworth et al., 2004; Carlson, Riegel, & 
Moser, 2001; Riegel & Carlson, 2002; Zambroski et al., 2005). Challenges include 
having to modify their environments, adhere to HF treatments, and adapt to new 
limitations (Riegel & Carlson, 2002; Scotto, 2005). Symptom burden can lead to 
significant psychosocial distress, including uncertainty, role loss, and depression 
(Bosworth et al., 2004; De Jong, Moser, & Chung, 2005; Friedman, 2003; Zambroski, 
2003; Zambroski et al., 2005).  
Advanced and aggressive HF treatments have improved mortality rates, however, 
people living with HF still bear a high level of uncertainty of prognosis, particularly those 
who live longer (Levy et al., 2002; Tendera, 2004). There has been increased attention to 
improving patients’ HRQOL while prolonging their length of life. Research studies have 
found that patients with symptomatic HF often chose HRQOL over prolonging their lives 
(Lewis et al., 2001; Stanek, Oates, McGhan, Denofrio, & Loh, 2000). Some patients 
agreed to take potentially life-threatening medications in an effort to improve their 
HRQOL (Rector et al., 1995). 
HRQOL has been viewed as an important predictor of disease severity, 
responsiveness to treatment, development of depressive symptoms, utilization of 
resources, cardiovascular risk, and deaths and hospitalizations for HF (Hauptman et al., 
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2004; Havranek, Spertus, Masoudi, Jones, & Rumsfeld, 2004; Masoudi et al., 2004; Shin 
et al., 2001; Soto, Jones, Weintraub, Krumholz, & Spertus, 2004; Stull, Clough, & Van 
Dussen, 2001). It is vital that researchers evaluate HRQOL when people are diagnosed 
with HF and throughout the trajectory of this chronic illness, and develop effective 
interventions to ameliorate symptoms, improve psychosocial functioning, and maximize 
functional capabilities (Jenkinson, 1994; Yu et al., 2004).  
Because HRQOL is such a complex concept comprising a wide range of needs 
within a physical, psychosocial, and cultural context (Fayers & Machin, 2000; Haas, 
1999; Johansson et al., 2006; Sredl, 2004; Steinhauser et al., 2002), more research to 
identify correlates of better HRQOL among people with HF is needed. In Taiwan, some 
studies have examined the relationships between HRQOL and factors including dyspnea, 
exercise tolerance, coping skills, social support, and self-care among people with HF 
(Cheng, 2004; Shang, 2002; Shih et al., 2003; Wang, 2005; Wang, 2004; Wang, 2003; 
Yang, 2000). However, information about sleep disorders and HRQOL is lacking.  
Recent studies have linked sleep to HRQOL in Western people with HF (Brostrom 
& Johansson, 2005; Johansson, Agnebrink, Dahlstrom, & Brostrom, 2004; Manocchia et 
al., 2001; Skobel et al., 2005). Most researchers describe patients’ sleep disorders in this 
population within the context of sleep-related breathing disorders (Brostrom & Johansson, 
2005; Cormican & Williams, 2005; Parker & Dunbar, 2002). There are two major types 
of sleep-related breathing disorders in people with HF: obstructive sleep apnea syndrome 
(OSA) and Cheyne-Stokes respiration with central sleep apnea (CSR-CSA) (Lanfranchi 
& Somers, 2003; Spieker & Motzer, 2003). When OSA occurs, the upper airway is 
repeatedly obstructed or partially obstructed during sleep (Trupp, 2004). Approximately 
10% to 36 % of people with HF have OSA (Caples, Gami, & Somers, 2005; Sin et al., 
2003). In contrast, CSR-CSA occurs as a result of an absence or a reduction of ventilatory 
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effort during non-rapid-eye movement sleep (American Academy of Sleep Medicine, 
1999; Trupp, 2004). The CSR-CSA condition is more likely to occur in HF patients with 
left ventricular ejection fractions (LVEF) less than 45% (systolic HF) (Jahaveri et al., 1995). 
Researchers reported that the prevalence of CSR-CSA in people with HF ranges from 
23% to 37% (Javaheri, 2006; Skobel et al., 2005). Some people developed a mixed type 
of sleep apnea with components of both OSA and CSR-CSA (Cormican & Williams, 
2005; Lanfranchi & Somers, 2003; Rao & Gray, 2005; Spieker & Motzer, 2003). 
Sleep-related breathing disorders may actually accelerate the deterioration of 
cardiac function. Generally, OSA is identified as a risk factor for developing HF, whereas 
CSR-CSA is recognized as a consequence of HF (Lanfranchi & Somers, 2003; Yamashiro 
& Kryger, 1993). Recently, however, there has been increasing interest in the role that HF 
might play in causing the development of OSA. Two possible mechanisms for this are: (1) 
HF-related periodic breathing could undermine the respiratory tract and contribute to its 
collapse; and (2) edema in the soft tissues of the neck and pharynx caused by fluid 
retention and HF-dependent edema could constrict the upper airway and exacerbate the 
collapse (Leung & Bradley, 2001; Ventura, Potluri, & Mehra, 2003).  
More research is needed to explore the nature of sleep in people with HF. 
Insomnia may be prevalent in people with HF but the research on this topic is limited. 
Insomnia indicates an inability or difficulty with sleeping, and is characterized by sleep 
complaints including difficulty initiating, maintaining sleep, or both (Holbrook et al., 
2000). Up to 70% of people with HF report sleep complaints (Brostrom et al., 2004; 
Erickson et al., 2003). They reported their sleep interruptions caused by several HF 
symptoms, including orthopnea, paroxysmal nocturnal dyspnea, cough, palpitations, and 
nocturia (Brostrom, Stromberg, Dahlstrom, & Fridlund, 2001). The most common 
nocturnal sleep complaints were inability to sleep flat, difficulties initiating and 
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maintaining sleep, and early awakening (Brostrom et al., 2004; Erickson et al., 2003; 
Lainscak & Keber, 2003). Excessive daytime sleepiness may follow insomnia (Brostrom 
et al., 2004) and further impair people’s general health, work activities, cognition, and 
memory (Asplund, 1996; Bixler et al., 2005). Daytime sleepiness is associated with 
increased morbidity and mortality of cardiovascular disease including myocardial 
infarction and HF (Newman et al., 2000). Likewise, nocturnal sleep greater than eight 
hours is related to increased mortality (Kripke, Garfinkel, Wingard, Klauber, & Marler, 
2002; Youngstedt & Kripke, 2004). Excessive sleep may not be helpful to the restoration 
of damaged myocardium.  
Recognition of sleep disorders in the HF population, thus, is extremely important 
in order to guide early diagnostic evaluations for any sleep disorders, including OSA and 
CSR-CSA, as well as treatment of the HF condition (Principe-Rodriguez, Strohl, 
Hadziefendic, & Pina, 2005). Improving sleep may also improve functional capacity and 
mental health in people with HF, and may help them to achieve a better HRQOL 
(Principe-Rodriguez et al., 2005; Redeker & Hilkert, 2005).  
Outcomes from this study will provide empirical data about sleep disorders in 
Taiwanese people with HF. Sleep has been overlooked in the Chinese society (Lee, 1995; 
Lee, 2006). In comparison with Korean and Japanese population, Taiwanese people have 
reported a higher prevalence of insomnia (Nomura, Yamaoka, Nakao, & Yano, 2005). 
Taiwanese people tend to attribute sleep problems to physical diseases caused by the 
imbalance of yin and yang and disharmony with nature (Lee, 1995), thus, not sleeping 
well may be considered reasonable and natural. As a result, they may engage in few 
actions to deal with their sleep problems (Wang, 2005). Based on the evidence that 
sleep-related breathing disorders may contribute to the development of HF, and HF can 
cause sleep disorders (American Academy of Sleep Medicine, 1999; Leung & Bradley, 
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2001), this Chinese belief may put people at the risk for developing HF.  
Information from this study may help nurses design effective patient teaching 
program and interventions to improve sleep condition and HRQOL in people with HF. 
Understanding correlates of HRQOL is important for nurses to help patients identify 
factors that can cause sleep disorders and worsen HROQL and to provide more effective 
care to meet their needs. By designing educational programs about HF, sleep disorders, 
and HRQOL, nurses can help patients and their families to cope better with their disease, 
sleep problems and thus to maintain a better HRQOL.  
This study will contribute to a better understanding of sleep disorders and 
HRQOL. Although several studies about sleep disorders and HRQOL in people with HF 
have been done, few studies reflect a nursing science perspective. Because research is 
lacking to describe sleep disorders and HRQOL in Taiwanese people living with HF, the 
study will enhance knowledge to guide effective interventions. 
Conceptual Model 
The conceptual framework for the study is based on the concept of health-related 
quality of life (HRQOL) (see Figure 1). The term “HRQOL” is derived from the concept 
of quality of life (QOL). Researchers contend that QOL is a broad concept that consists of 
all perspectives of life including health, jobs, recreation, finances, culture, rights, values, 
beliefs, and aspirations (Guyatt, Feeny, & Patrick, 1993; US Department of Health and 
Human Services, 2000). Although QOL is not a well-defined term, it has been widely 
used in different disciplines such as nursing, medicine, sociology, and economics 
(Farquhar, 1995). Investigators usually define QOL based on their unique purposes and 
situations, thus further confusing its meaning (Dijkers, 1999; Sartorius, 1987). Usually, 
QOL refers to an individual’s general perception of happiness and satisfaction with 
her/his life and environment (Calman, 1987; Ferrans, 1996; Meeberg, 1993; Oleson, 1990; 
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US Department of Health and Human Services, 2000). Three concept analyses of QOL 
identified it as a multidimensional concept that consists of both objective and subjective 
indicators (Haas, 1999; Kleinpell, 1991; Meeberg, 1993). Domains of QOL includes 
health, physical, psychological, social, family, economic, and spiritual domains (Ferrans, 
1996; Haas, 1999; Juarez, Ferrell, & Borneman, 1998). Although a general agreement on 
a definition is lacking, the consensus is that QOL has varied meaning in different cultures 
and populations (Calman, 1987; Fayers & Machin, 2000). 
Ware (1987) argued that QOL is a broader concept than health and disease. To 
address the direct impact of health and illness on QOL, HRQOL is considered a more 
specific indicator of QOL within the context of health (Aaronson, 1990; Berry & 
McMurray, 1999; Farquhar, 1995). HRQOL originated from the World Health 
Organization (WHO) Constitution's (1948) definition of health: “Health is a state of 
physical, mental, and social well-being and not merely the absence of disease or 
infirmity” (Power, 2003). The definition of health has been extended to include HRQOL 
(Barbette, Guillemin, Chau, & the Lorhandicap Group, 2001).  
HRQOL is conceptualized based on the social science paradigm concerned with 
individuals’ perceptions of daily functioning and overall well-being with attention to their 
behaviors and feelings (Wilson & Cleary, 1995). This is different from the traditional 
biomedical paradigm that primarily focuses on clinical markers to guide diagnosis and 
treatment of diseases. Researchers have suggested that HRQOL should be expanded from 
objective evidence of the effect of illness and treatment to include the individuals’ 
subjective perceptions and experiences (Montazeri, Gillis, & McEwen, 1996; Oleson, 
1990). Therefore, HRQOL can be used to reflect people’s perceptions of the degree of 
functioning in their daily lives (van der Steeg, De Vries, & Roukema, 2004). 
HRQOL is a broad, multidimensional, and dynamic concept. Not all researchers 
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agree on the domains of HRQOL. Whether or not an illness and consequent treatments 
restrict a person’s ability to perform a normal role in daily activities is a consideration. 
Researchers have suggested that several areas including symptoms, physical domain, 
psychosocial functioning, and functional status should be considered the domains of 
HRQOL (Aaronson, 1988; Bosworth et al., 2004; Green, Porter, Bresnahan, & Spertus, 
2000; Hawthorne & Hixon, 1994; Leidy, Rentz, & Zyczynski, 1999; Schipper, Clinch, & 
Olweny, 1996; Spilker, 1996; Wilson & Cleary, 1995). However, some researchers have 
argued that HRQOL should consider income, freedom, future expectation, personality, 
and quality of environment (Guyatt et al., 1993; Sredl, 2004), while others contended that 
opportunities, education, freedom, jobs, housing, economy, religion, and social security 
are indirectly affected by diseases and treatments (Schipper et al., 1996; Ware, 1987). 
Some characteristics, such as subjective well-being, spiritual, and life satisfaction, can be 
affected by several factors such as job satisfaction, socioeconomic status, thus, they 
should be considered as influencing factors rather than domains of HRQOL (Ormel, 
Lindenberg, Steverink, & Vonkorff, 1997; Wilson & Cleary, 1995). Similarly, perceived 
health can affect perception of HRQOL (Heo et al., 2005; Johnson & Wolinsky, 1993; 
Ware, 1987; Wilson & Cleary, 1995). 
Clear agreement about theoretical perspectives on HRQOL is somewhat 
problematic because the concept has multiple interpretations and definitions (Fayers & 
Machin, 2000; Ferrans, Zerwic, Wilbur, & Larson, 2005). There are four different 
perspectives of HRQOL: (1) HRQOL is a holistic concept with several domains including 
physical and psychosocial well-being, environment, and overall life satisfaction (Guyatt 
et al., 1993; Sredl, 2004); (2) HRQOL is an individual’s perception of the gap between 
the expectation of health and the actual experience of it (Carr, Gibson, & Robinson, 2001; 
Spertus et al., 2005; Steinhauser et al., 2002); (3) HRQOL is an individual’s perceptions 
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of his/her limitations on daily functioning affected by diseases, impairments, and 
treatments (Bowling, 2003; Cooley, 1998; Patrick & Chiang, 2000; Reddy & Dunn, 2000; 
Schipper et al., 1996; Sredl, 2004); and (4) HRQOL is the improvement of symptoms, 
well-being, and daily functioning (Wiklund et al., 1987).  
Johansson and colleagues (2006) reviewed 58 quantitative HRQOL studies in 
people with HF and concluded that HRQOL was negatively influenced by HF symptoms 
and functional capability. Several factors, particularly individual characteristics, such as 
age, gender, and personality, have to be taken into consideration because different 
perspectives might exist regarding the components of a good HRQOL. Decreases in the 
physical and social domains of HRQOL may result in feelings of loss of control and 
further cause emotional responses, such as anxiety and depression. In addition, sleep 
disturbances have a negative effect on HRQOL (Johansson et al., 2006). 
Sleep has been viewed as a facet in the physical health domain of QOL (The 
WHOQOL Group, 1998). Adequate sleep is essential for biological and mental 
restoration, protection, integration, and memory, not merely time out from daily living 
(Bootzin, Lahmeyer, Lilie, Hanawalt, & Shaver, 1994; Hodgson, 1991). Therefore, a 
good quality of sleep is associated with good health (Manocchia et al., 2001) and 
psychological well-being (Ford & Cooper-Patrick, 2001).  
The term sleep architecture is used to describe the components of sleep. It is 
constructed into six stages including periods of wakefulness, four-stages of non-rapid-eye 
movement (NREM), and rapid-eye movement (REM), creating several sleep cycles 
during normal sleep (Bootzin et al., 1994). During NREM sleep, the reduced metabolic 
rate increases parasympathetic nervous system tone, decreases sympathetic nervous 
system activity, and activates baroreflex sensitivity, resulting in decreases in heart rate, 
blood pressure, stroke volume, cardiac output, and systematic vascular resistance (Leung 
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& Bradley, 2001; Rao & Gray, 2005; Trupp, 2004). The greatest relaxation of the cardiac 
workload occurs during REM sleep (Trupp, 2004). Thus, sleep is normally a period of 
cardiac rest (McEvoy, 2004). In addition, sleep is required for adequate functioning in 
daytime. Research has suggested that NREM sleep is important to consolidate memory 
for facts, while REM sleep is crucial to help maintain mental health (Harvard Medical 
School, 2006). 
Sleep disorders can disrupt cardiovascular, respiratory, and automatic regulation, 
resulting in a high rate of HF morbidity and mortality (Kripke et al., 2002; Leung & 
Bradley, 2001; Newman et al., 2000; Youngstedt & Kripke, 2004). People with HF may 
experience insomnia (sleeplessness), hypersomnia (sleepiness), or both, which could 
interact to create a vicious cycle. For example, people suffering from low 
cardiopulmonary tolerance and fatigue may demand extra daytime sleep and longer 
nocturnal sleep to restore energy. Excessive daytime sleep, however, can interrupt the 
patient’s circadian rhythm and shorten nocturnal sleep, resulting in sleep fragmentation 
and reduced amounts of total sleep (Lainscak & Keber, 2003; Youngstedt & Kripke, 
2004). Subsequently, sleep disorders can interrupt daily activities, resulting in poor 
HRQOL in people with HF. Figure 1 illustrates the major concepts of HRQOL and sleep 





Figure 1. Conceptual Model for Health-Related Quality of Life and Sleep Disorders. 
In this model, HRQOL includes 4 domains: physical symptoms, functional status, 
psychological status, and social functioning. The concept of sleep is viewed as a correlate 
of HRQOL. Sleep disorders include various sleep situations, such as, sleep disruption, 
prolonged sleep latency, and extended sleep duration, occurring in either nighttime or 
daytime sleep. When sleep problems occur, however, they can affect people’s HRQOL. 
This conceptual model depicts a functional relationship between HRQOL and sleep 
disorders-- the fewer the sleep disorders, the higher the HRQOL. Both sleep disorders 
and HRQOL can be affected by individual characteristics and HF characteristics.  
In summary, this conceptual framework about HRQOL provided a guide for the 
study. The effects of sleep disorders on HRQOL in people living with HF need study.  
Research Questions 
The research questions for the study were: 
1. What sleep characteristics are reported by Taiwanese people living with HF? 
2. What are the perceptions of HRQOL and health among Taiwanese people living with 
HF? 
3. What are the relationships between HRQOL, sleep disorders, HF characteristics 
















(prescribed HF medications, duration of HF diagnosis, type of HF, New York Heart 
Association Functional Classification, and left ventricular ejection fraction), and 
individual characteristics including demographics (age, gender, education, living 
arrangement, marital status, financial status, employment status, and type of language) 
and health-related characteristics (body mass index, comorbidity, and perceived 
health)? 
4. What are the predictors of HRQOL among Taiwanese people with HF? 
Definitions of Terms 
The following definitions were used in the study. 
1. Heart Failure: a complex, chronic condition in which the ventricles are unable to 
efficiently fill with and/or eject sufficient blood to meet metabolic needs of the body 
(Hunt et al., 2005; Tendera, 2004). Because not all patients exhibit signs of fluid 
overload, the term “heart failure” is preferred over the traditional term “congestive 
heart failure” (Hunt et al., 2005). The diagnosis of HF was made by a physician and 
obtained from the medical records. 
2. Heart Failure Characteristics: five components including prescribed HF medications, 
duration of HF diagnosis, type of HF, New York Heart Association Functional 
Classification (NYHA) (The Criteria Committee of the AHA, 1994), and left 
ventricular ejection fraction (LVEF).  
(1) Prescribed HF medications: the number and type of prescribed HF medications. 
Data were obtained from the medical records. 
(2) Duration of Heart Failure Diagnosis: the time since the initial diagnosis of HF. Data 
were collected from the participants and medical records.  
(3) Types of Heart Failure: include diastolic, systolic, and valvular dysfunction. 
Generally, a LVEF less than 40% indicates systolic dysfunction and greater than 
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50% as diastolic dysfunction (Hunt et al., 2005). Valvular dysfunction refers to the 
HF that is primarily caused by valvular abnormality and difficult to differentiate it 
from either diastolic or systolic HF (Patel & Konstam, 2001). Data were obtained 
from the physicians or medical records. 
(4) New York Heart Association Functional Classification (NYHA): a subjective 
evaluation by healthcare providers, which places people into one of four functional 
classes (Kasper, 2003; Subramanian et al., 2005). Class I indicates people with 
heart disease who have no limitation in engaging in ordinary daily activity. Class II 
denotes people whose ordinary daily activity is slightly restricted by heart disease 
symptoms. They are comfortable at rest; however, ordinary activity may result in 
fatigue, palpitations, dyspnea or angina. Class III consists of people whose ordinary 
daily activity is markedly restricted by heart disease. They are comfortable at rest, 
but very minimal activity exertion results in aggravating symptoms. Class IV 
indicates people who have difficulty performing any daily activities. Symptoms of 
heart disease are present even at rest and any activity will cause discomfort (Kasper, 
2003; Subramanian et al., 2005). Data were collected from physicians and medical 
records. 
(5) Left Ventricular Ejection Fraction (LVEF): the percentage of end-diastolic left 
ventricular volume that is ejected per beat (Ganong, 1999). A LVEF of less than 
40% indicates systolic dysfunction with more severe HF and symptoms (Hunt et al., 
2005). The data were obtained from the medical records with LVEF derived from 
either echocardiogram or cardiac catheterization. 
3. Individual Characteristics: included demographics and health-related characteristics. 
(1) Demographic characteristics: consisted of age, gender, education, living 
arrangement, marital status, financial status, and employed status. Demographic 
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characteristics have been related to HRQOL (Lai et al., 2005) and sleep disorders 
in Taiwanese people (Chen, Kawachi, Subramanian, Acevedo-Garcia, & Lee, 2005). 
People with different characteristics may have varied perspectives and values 
regarding sleep disorders and HRQOL (Bootzin et al., 1994; Erickson et al., 2003; 
Johansson et al., 2006).  
(2)Health-related characteristics: comprised of body mass index, comorbidity, and 
perceived health. 
A). Body mass index: is a measure of body fat based on body height and weight that 
applies to both adult men and women (National Heart Lung and Blood Institute, 
2006). High body mass index is an independent factor for development of HF 
(Wilhelmsen et al., 2001) and sleep apnea (Principe-Rodriguez et al., 2005). 
Body mass index was calculated from self-reported weight (kg)/height2 (m2).  
B). Comorbidity: is the condition of having two or more diseases at the same time. It 
includes the number and seriousness of the comorbid condition(s). Data were 
collected using the self-reported Charlson Comorbidity Index (Katz, Chang, 
Sangha, Fossel, & Bates, 1996) and a chart-review list of concomitant health 
problems adapted from the American College of Cardiology/American Heart 
Association Task Force on Clinical Data Standards (Radford et al., 2005).  
C). Perceived Health: individuals’ overall evaluation of their existing health status. 
Perceived health is essential for determining HRQOL (Albrecht, 1994). It is an 
individual’s integration of all of the various aspects of health (Ferrans et al., 
2005). Perceived health was measured using the modified Self-Rated Health 
Subscale (SRHS) (Lawton, Moss, Fulcomer, & Kleban, 1982). 
4. Health-Related Quality of Life (HRQOL): an individual’s perception of her/his daily 
functioning impacted by HF and its consequent treatments, and the evaluation of the 
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degree of functional limitations on physical and psychosocial functioning. HRQOL 
was measured using the Kansas City Cardiomyopathy Questionnaire (KCCQ) (Green 
et al., 2000). HRQOL consisted of four domains in this study.  
(1) Physical symptoms: unpleasant physical feelings. Perceived physical symptoms are 
very individualized. Symptoms may reflect the effects of treatments and the 
necessity for patients to change their activities (Wenger, 1989). They also may 
affect functional capacity, psychosocial functioning, and perceived health status 
(Johansson et al., 2004; Smith, Avis, & Assmann, 1999; Wenger, 1989). Physical 
symptoms were measured using the symptom subscales of the Kansas City 
Cardiomyopathy Questionnaire (Green et al., 2000).  
(2) Functional status: an individual’s ability to carry out usual daily activities, roles, 
and tasks, including self-care, physical, and role activities. Functional status was 
measured using the physical subscale of the Kansas City Cardiomyopathy 
Questionnaire (Green et al., 2000). 
(3) Psychological Status. Psychological status includes both negative affect, as being 
discouraged, as well as positive affect such as enjoyment and satisfaction with life. 
Impairment of psychological functioning can result in the inability to perform tasks 
that require psychological health including dealing with difficulties and making 
decisions (Bosworth et al., 2004; Wilson & Cleary, 1995). Psychological status is 
particularly important because of the Chinese belief that psychological status has a 
mutual influence with physical status (Yu et al., 2004). Psychological status was 
measured using the QOL subscale of the Kansas City Cardiomyopathy 
Questionnaire (Green et al., 2000). 
(4) Social Functioning: the ability to maintain person-to-person interactions with 
family and friends (Cooley, 1998). Functional limitations can preclude patients 
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from maintaining normal social activities (Aaronson, 1988). Positive interpersonal 
relationships help people cope with stress and difficulties caused by HF and its 
treatments. However, negative interpersonal relationships can be harmful 
(Bosworth et al., 2004). Social functioning was measured using the social 
limitation subscale of the Kansas City Cardiomyopathy Questionnaire (Green et al., 
2000). 
5. Sleep characteristics: consisted of nocturnal sleep quality, daytime sleepiness, and 
daytime napping. Sleep characteristics were used to reflect sleep disorders in which 
individuals perceived they had poor nocturnal sleep quality and complaints of 
excessive daytime sleep. Excessive daytime sleepiness is identified as a symptom 
accompanying nocturnal sleep disorders. 
(1) Nocturnal sleep quality: an individual’s perception of their overall sleep aspects, 
including quality, duration, latency, efficiency, sleep disturbances, use of sleep 
medication, and daily dysfunction. Poor sleep quality is reflected by symptoms of 
sleep disorders. Nocturnal sleep quality was measured using the Pittsburgh Sleep 
Quality Index (PSQI) (Buysse, Reynolds, Monk, Berman, & Kupfer, 1989). 
Participants with a global score of PSQI greater than 5 will be identified as poor 
sleepers.  
(2) Daytime Sleepiness: an individual’s evaluation of the propensity to fall asleep in 
daily sedentary situations, such as while sitting and reading, watching TV, riding as 
a passenger in a car, and sitting quietly after lunch . Daytime sleepiness is different 
from daytime somnolence or drowsiness (Lai et al., 2005). Excessive daytime sleep 
primarily reflects whether sleep onset occurs at inappropriate settings and times, 
such as, working and driving. Daytime sleepiness not only affects work activities, 
social and marital life, and mood, but also results in a negative socioeconomic 
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impact, such as, car accidents and falling asleep during working (Gander, Marshall, 
Harris, & Reid, 2005; Ohayon, Caulet, Philip, Guilleminault, & Priest, 1997). In 
comparison with nighttime sleep disorders, daytime sleepiness might be a more 
important indicator of mortality and cardiovascular disease (Newman et al., 2000). 
Daytime sleepiness was measured using the Epworth Sleepiness Scale (Johns, 
1991). A score greater than 10 indicates excessive daytime sleepiness. 
(3) Habitual Daytime Napping: an individual’s habituation to take daytime naps after 
lunch or in afternoon. Habitual daytime napping is different from daytime 
sleepiness. Taking a 20-60 minutes nap after lunch is common and helpful for a 
better nocturnal sleep in Taiwanese people (Lai, 2005). In contrast, daytime 
sleepiness may indicate daytime fatigue and emotional distress (Edelll-Gustaffson, 
2002). Habitual daytime napping was measured using three additional items 
regarding prevalence, frequency and duration of daytime napping. 
 Assumptions  
The following assumptions were made for the study:   
1. Individuals are the best evaluators of their own HRQOL (Ferrans, 1996). 
2. A person’s perception of HRQOL may affect their choices of HF treatments. 
3. Sufficient sleep is essential to the restoration of a damaged myocardium. 
Limitations 
1. The generalizability of the study findings was limited because the study used a 
nonprobability sample and cross-sectional design that highlights associations, but not 
a causal relationship.  
2. Since the data were collected from one medical center and its affiliated hospital 
located in southern Taiwan, the study findings may not able to reflect the situations of 
the patients who were living in other areas of Taiwan. 
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3. The lack of objective sleep measurement data using laboratory devices and diagnostic 
criteria limited the ability to identify and diagnose sleep disorders. 
4. The findings may reflect a response bias in that people who were interested in the 
study topic may have been more likely to participate. 
5. Some people may have participated in the study because it was socially desirable 
since their own physicians recommended this study. 
6. Selection bias may be an issue of this study because participants were referred by a 
senior cardiologist. The actual refusal rate is unknown. 
7. The low Cronbach’s alpha for the SRHS limited the interpretability of the findings 
about perceived health.  
Summary 
This chapter provided an introduction to the proposed study, including 
background and significance, conceptual framework, research questions, definitions of 
terms, assumptions, and limitations. The purpose of this study was to describe sleep 
characteristics and HRQOL in Taiwanese people with HF, and to examine the 
relationships between HF characteristics, sleep disorders, and HRQOL. A conceptual 
model developed for this study was described. Recognition of sleep disorders in the HF 
population is extremely important to guide early diagnostic evaluations. HRQOL is a 
useful outcome measure in both clinical practice and research. Nurses can provide 
effective care needs of the patients based on their self-report data. The study enhances 
knowledge to guide effective nursing interventions aimed at helping Taiwanese people 
with HF improve their HRQOL.  
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Chapter 2: Literature Review 
This chapter provides a review of current literature to support this study. Topics 
include the following: an overview of HF including the clinical signs and symptoms, 
classifications, pathophysiology, and evidence-based management; HRQOL in HF; sleep 
disorders in HF; and the relationship between HRQOL and sleep disorders in people 
living with HF. Research studies describing findings about HROQL in both Western and 
Taiwanese people with HF and sleep disorders in Western HF population are also 
included. 
Overview of Heart Failure 
HF is a clinical syndrome caused by any structural or functional cardiac 
impairment that hinders the ventricles to relax to adequately fill with blood or to pump 
sufficient cardiac output to maintain systematic perfusion to meet the metabolic needs of 
the tissues (Hunt et al., 2005). It is characterized by a complex signs and symptoms, 
including fluid retention, fatigue, and shortness of breath, especially on exertion (Heart 
Failure Society of America, 2006). Although the development of HF is generally a 
progressive process, patients may suffer from several episodes of acute worsening (acute 
HF syndrome), resulting in unplanned hospitalizations or emergency room and physicians 
visits during the trajectory of HF (Gheorghiade et al., 2005; Nieminen & Harjola, 2005). 
Additionally, symptoms of HF can further impair people’s functional capacity and quality 
of life. 
The incidence of HF increases with age (Hunt et al., 2005). In a 5-year follow-up 
study in UK, the annual incidence of HF per 1000 ranged from 2.5 in middle-aged adults 
(57 to 60 years) up to 22.4 in older females (≧80 years) and 28.2 in older males (≧80 
years old) (van Jaarsveld et al., 2006). In addition, the mortality at higher ages (≧76 
years) was 2.1 time more likely than people who were younger. The high prevalence of 
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hypertension, coronary artery disease, obesity, and diabetes in older adults relates to this 
epidemic (Young, 2004). Indeed, the HF care has shifted from the view that HF is a 
dominant condition to a new paradigm that addresses HF as one of several comorbid 
conditions (Havranek, Masoudi, Rumsfeld, & Steiner, 2003). Treating associated 
comorbidity, thus, is important and necessary to postpone the appearance of left 
ventricular dysfunction. 
HF is categorized to either systolic or diastolic dysfunction. This classification 
considers normal systolic function and normal LVEF to be the same (Heart Failure 
Society of America, 2006). Traditionally, HF was viewed as synonymous with reduced 
left ventricular contractility or diminished LVEF less than 40% (systolic dysfunction) 
(Remme & Swedberg, 2001). However, recent research studies have found that 
approximately 20 to 60% of patients with HF have preserved systolic function with a 
normal LVEF but still suffer from severe signs and symptoms of HF (Hunt et al., 2005; 
Jessup & Brozena, 2003; Mann, 1999; Masoudi et al., 2002; Tseng, 2004). These patients 
have diastolic HF. 
Systolic dysfunction results from decreased chamber wall motion causing 
elevated diastolic filling pressure (preload), reduction in stroke volume and cardiac 
output, and an elevated systemic vascular resistance (afterload) (Carelock & Clark, 2001; 
Hunt et al., 2005). Systolic HF is often manifested with ventricle dilation and LVEF less 
than 40% (Heart Failure Society of America, 2006; Hunt et al., 2005). The dilated 
ventricle and changes in papillary muscle structure further cause functional heart valve 
problems including mitral and tricuspid regurgitation (Francis & Tang, 2003). The most 
common causes of systolic dysfunction include myocardial infarction, ischemic heart 
disease, coronary artery disease, and hypertensive heart disease (Saul & Shatzer, 2003). 
Diastolic HF is characterized by an impairment of ventricular relaxation that 
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results in elevated ventricular filling pressure with normal left ventricular volume and 
contractility (Hunt et al., 2005). Because such hearts contract normally, the LVEF is 
normal or higher (Braunwald, 1997; Jessup & Brozena, 2003). However, the impaired 
myocardial relaxation can further stiffen the ventricle. As a result, elevated diastolic 
pressure increases venous tone and arterial stiffness, both of which can further increase 
left atrial and pulmonary venous pressures, and may result in pulmonary and/or system 
congestion and even a reduction of cardiac output (Aurigemma & Gaasch, 2004). Most 
people with diastolic HF, however, eventually develop impaired systolic function 
(Braunwald, 1997; Hunt et al., 2005; Remme & Swedberg, 2001). 
Diastolic HF is usually accompanied by another heart condition, such as 
restrictive, infiltrative or hypertrophic cardiomyopathy, as well as uncorrected valvular 
disease, such as aortic stenosis or mitral regurgitation (Braunwald, 1997; Hunt et al., 
2005). In general, diastolic HF is most prevalent among elderly women and people who 
have comorbidities, such as hypertension, diabetes mellitus, coronary artery disease, or 
atrial fibrillation (Aurigemma & Gaasch, 2004; Hunt et al., 2005; Sander, Wilklow, & 
Giles, 2004; Tresch & McGough, 1995). Although diastolic HF causes fewer cardiac 
incidents and medical procedures than systolic HF, the long term costs and resource use 
for HF are similar (Liao et al., 2006). 
Clinical Signs and Symptoms of Heart Failure 
The progression of HF causes a constellation of signs and symptoms. Generally, 
patients experience at least one of three major clinical manifestations (Hunt et al., 2005): 
(1) no symptoms or symptoms of another cardiac or non-cardiac disease, such as, 
diabetes, arrhythmia, and acute myocardial infarction; (2) dyspnea and fatigue, which 
may restrict exercise tolerance; or (3) fluid retention, which may result in pulmonary 
congestion and peripheral edema. Symptoms in early stage of HF may be subtle. Patients 
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may initial experience fatigue and intolerance to carry out usual daily activities. The 
onset of shortness of breath may progress from exertion-related to dyspnea on mild 
activity. Other cardinal signs and symptoms of HF may include Cheyne-Stokes 
respirations, pulmonary rales or wheezes, neck vein distention, and the third heart sound. 
The development of paroxysmal nocturnal dyspnea and Cheyne-Stokes respirations can 
waken people from sleep (Carelock & Clark, 2001; Greenberg, 2002; Hunt et al., 2005). 
Because the heart is unable to provide sufficient blood supply to a variety of vital 
organs and systems, including renal, brain, lung, and autonomic systems, patients may 
also encounter symptoms such as, decreased urine output, cough, sleep disturbances, 
depression, and cognitive impairment (Clark & McDougall, 2006; Johansson et al., 2006). 
The most distressing symptoms reported by HF patients are dyspnea, fatigue, weakness, 
sleeping difficulty, edema, orthopnea, poor appetite, paroxysmal nocturnal dyspnea, and 
cough (Bennett et al., 1998; Friedman, 2003; Grady, Jalowiec, & White-Williams, 1996; 
Zambroski et al., 2005).  
Classifications of Heart Failure 
The New York Heart Association (NYHA) Functional Classification is most 
commonly used by clinicians and researchers (The Criteria Committee of the AHA, 1994). 
This classification system was constructed as NYHA Class I, II, III, and IV on the basis 
of people’s limitations in daily activities caused by cardiac symptoms. The higher classes 
indicate more severe functional limitations. Both NYHA functional Class III and IV have 
been viewed as indicative of advanced HF, and as a predictor of rehospitalization in 
advanced HF patients (Adams & Zannad, 1998; Van Cheng, 2001). Although cardiac 
function is impaired in people with NYHA Class I HF who have no limitation in daily 
activities, they may not aware that HF is life threatening and thus, not adhere to treatment 
(Greenberg, 2002; Remme & Swedberg, 2001). Receiving treatment is necessary for all 
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people with HF.  
In 2001, the American Heart Association (AHA) and American College of 
Cardiology (ACC) developed a new staging system for classification of HF (Hunt et al., 
2001). The development and progression of HF is classified into four stages. People in 
stage A and B are recognized as those who are at high risk for developing HF. Stage A 
includes people without structural heart disease or symptoms of HF, for example, those 
with hypertension, diabetes, obesity, metabolic syndrome, using cardiotoxins, or 
sleep-breathing disorders. Stage B denotes people who have structural heart disease, 
including previous myocardial infarction, left ventricular remodeling, and asymptomatic 
valvular disease, but without signs or symptoms of HF. Stage C includes those with 
structural heart disease with prior or current symptoms of HF, and stage D denotes people 
with refractory HF requiring treatments (Hunt et al., 2005). Once HF is diagnosed, the 
severity of symptoms in people who are in stage C and D should be assessed to guide 
therapy.  
Pathophysiology of Heart Failure 
The progressive nature of HF reflects a complex, interrelated combination of 
cardiac structural, functional, biological, genetic, and environmental alternations (Jessup 
& Brozena, 2003; Mann, 1999). Regardless of whether the HF is caused by systolic or 
diastolic dysfunction, the reduced cardiac output activates a number of complicated but 
interrelated compensatory mechanisms, including activation of the 
renin-angiotensin-aldosterone system (RAAS), stimulation of the sympathetic nervous 
system (SNS), and a complex neuroendocrine response (Parmley, 1992; Saul & Shatzer, 
2003). Although these mechanisms are initially helpful to the recovery of the 
cardiovascular system, they create a vicious cycle on the progression of HF (Piano & 
Prasun, 2003).  
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Three models are most often used to illustrate the cause, progression, and the 
compensatory mechanisms of HF (Jessup & Brozena, 2003; Mann, 1999; McMurray & 
Pfeffer, 2002a, , 2002b). The cardiorenal model describes HF as a problem with excessive 
salt and fluid retention that is caused by renal dysfunctions, manifested by decreased 
creatinine clearance. Cardiac output in this condition may be normal (Francis, 2006). The 
cardiocirculatory, or hemodynamic model, illustrates HF as a clinical syndrome of 
decreased cardiac output that is a consequence of decline in cardiac pumping capacity 
and excessive peripheral vasoconstriction. The most contemporary view is the 
neurohormonal model where progression of cardiac dysfunction is a result of the 
activation of the RAAS, the SNS, and a complex neuroendocrine response that includes a 
release of natriuretic peptides (Jessup & Brozena, 2003; Mann, 1999). This mechanism 
emphasizes that the impaired myocardial capacity eventually requires activating the 
neurohormonal compensatory systems to regulate renal and cardiovascular function to 
prevent systemic hypoperfusion (Bell, 2003). The activation of the compensatory 
mechanism involves a vicious cycle of physiological and pathological changes. 
The activation of the RAAS and SNS, however, leads to the progressive loss of 
cardiac myocytes because of accelerated programmed cell death (apoptosis) and necrosis, 
and further results in myocardial dysfunction. This process is known as ventricular 
remodeling (Bell, 2003; Mann, 1999). Left ventricular remodeling is the process of 
structure changes in the left ventricular in order to render a more spherical shape with a 
dilated and/or hypertrophic chamber (Carelock & Clark, 2001; Hunt et al., 2005). 
Remodeling occurs following injury of cardiac myocytes and extracellular matrix, and 
may play as an independent role in the progression of HF. Several factors including 
automatic, neurohormonal, and genetic are involved in the remodeling process to alter 
ventricular size, shape, wall stress, and both diastolic and systolic function (Jessup & 
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Brozena, 2003; Mann, 1999; McMurray & Pfeffer, 2002a). Neurohormonal activation not 
only results in the ventricular remodeling process, it also causes symptoms such as 
tachycardia, fatigue, dyspnea or sleep disturbances, resulting in limitations in physical 
and psychosocial functioning, and diminished HRQOL (Havranek et al., 2003).  
Evidence-Based Management of Heart Failure 
The AHA/ACC practice guidelines created by an expert panel emphasize that 
evidence-based management of HF includes control of risk factors, early detection, and 
therapeutic treatments comprising pharmacologic, non-pharmacologic, and device 
treatment options (Hunt et al., 2005). The goals for HF management are to reduce 
morbidity and mortality. The guidelines recommend therapies for each stage of HF as 
follows: for people in stage A, treatment includes addressing risk factors and using an 
angiotensin-converting enzyme inhibitor (ACEI) or angiotensin receptor blocker (ARB, 
when intolerant of ACEI) for vascular disease or diabetes; in stage B, treatment consists 
of appropriate lifestyle changes, a combination of ACEI or ARB and beta-blockers, 
implantable cardiac-defibrillator, and coronary revascularization; for stage C, 
recommendations include lifestyle changes, low salt diet, exercise training, avoiding 
non-steroidal antiflammatory drugs and antiarrhythmic drugs , a combination therapy of 
ACEI or ARB, beta-blockers, and spironolactone; and stage D therapy includes fluid 
restriction, cardiac assist devices, heart transplantation, inotropes, and end-life planning 
with patients and their families for hospice or palliative treatments (Hunt et al., 2005; 
Macabasco-O'Connell, Rasmusson, & Fiorini, 2006). The AHA/ACC Guidelines have 
also been used by healthcare providers in Taiwan to guide care of patients with HF (Chen, 
Chiang, & Lin, 2005; Hsu, Chang, Pai, Lo, & Ling, 2006). 
The expert panel addresses the need to use clinical guidelines to direct, 
standardize, and simplify care, and finally help translating effective interventions into 
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practice (Hunt et al., 2005). Research has found that although several pharmacologic and 
nonpharmacologic therapies have been developed to treat HF, the quality of care in HF is 
not optimal, particularly in elderly and those with diastolic HF (Hunt et al., 2005; Luthi, 
McClellan, Flanders, Pitts, & Burnand, 2006; Wu & Yu, 2005). The sheer number of 
available interventions creates difficulty for clinicians in decision making. Management 
that focuses on treatment of HF pathology may have a positive effect on HF prognosis, 
though limited in efforts to prevent early mortality (90 days) (Mehta & Cowie, 2006) and 
improved HRQOL (Dobre et al., 2006). Several evidence-based interventions, such as 
ACEI, beta-blockers, and cardiac resynchronization have shown benefits, however, they 
are underutilized (Luthi et al., 2006; Macabasco-O'Connell et al., 2006).  
A continuum of care is needed that incorporates inpatient and outpatient 
management using a multidisciplinary strategy to maintain or improve patients’ daily 
functioning, prevent frequent hospitalizations, and reduce mortality (Berkowitz, Blank, & 
Powell, 2005; McAlister, Stewart, Ferrua, & McMurray, 2004). Although the benefits of 
pharmacologic treatment to HF prognosis have been supported, research has also found 
that HRQOL in people who received evidence-based medications did not improve 
significantly (Dobre et al., 2006). The lack of significant effect on HRQOL may be 
associated with side effects of the medications. The greater number of medications and 
dose adjustments increases the chance of non-adherence and development of adverse 
effects (Stewart, Marley, & Horowitz, 1999). Combining non-pharmacologic 
interventions, such as lifestyle modifications, dietary control, exercise, and rehabilitation, 
thus, is needed to counteract those adverse effects (Dobre et al., 2006; Wu & Yu, 2005). 
Adherence problems may follow medication and life modifications if adjustments in daily 
activity are needed (Havranek et al., 2003). People may adhere to interventions according 
to their perceptions of the effectiveness of the treatment and the degree that their lives are 
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affected. Therefore, understanding how their life is affected and factors related to their 
HRQOL is important to implement effective HF management. 
Health-Related Quality of Life in Heart Failure 
HRQOL is one of the most important goals of HF management (Hunt et al., 2005). 
Rhodes and Bowles (2002) contended that assisting patients with HF to promote a 
positive attitude in daily life during the disease trajectory, especially in early stages, can 
result in important therapeutic outcomes and better HRQOL. A higher sense of HRQOL 
is important in maintaining a state of overall well-being that reflects an optimistic 
perspective (Acton, 1994; Spilker, 1996). In viewing themselves in a positive way, people 
with HF may have better motivation to adhere to long-term HF management. 
The impact on HRQOL caused by HF is greater than the normative population 
and other chronic illnesses, such as hypertension, recent myocardial infarction, Parkinson 
disease, and cancer (Bosworth et al., 2004; Juenger et al., 2002; Riedinger, Dracup, & 
Brecht, 2002). A secondary analysis of the Studies of Left Ventricular Dysfunction 
baseline data was conducted to compare HRQOL of 691 female HF subjects with that of 
a normative group and that of women with other chronic conditions (Riedinger et al., 
2002). The mean age in this sample was 60.6 years old with a range of 21 to 80. The 
mean education was 10.86±3.02 years. The mean left ventricular ejection fraction (LVEF) 
was 27±7%. The majority (61.2%) of subjects had a history of myocardial infarction and 
NYHA Class II or III HF. Most women suffered from HF symptoms, including dyspnea 
(69.5%), chest pain (44.6%), and dizziness (44.1%). HRQOL was measured using a 
HRQOL instrument comprising 90 items drawn from several questionnaires: the Profile 
of Mood States Inventory, Functional status Questionnaire, the Beta Blocker Heart Attack 
Trial Instrument, Symptoms Scale, Ladder Life, the RAND Medical Outcomes Study 
Instrument.  
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The study (Riedinger et al., 2002) found that women with HF reported poorer 
physical functioning than did those with hypertension. HF subjects performed basic daily 
activities, such as bathing, eating, dressing, and moving in and out of bed, better than 
people with chronic obstructive pulmonary disease (COPD), Parkinson disease, or elderly 
hospitalized adults, however, they had a more limited ability to perform intermediate 
daily living tasks, such as grocery shopping, climbing stairs, and walking several blocks. 
Likewise, HF women participants had significantly worse anxiety and depression scores 
than did people with hypertension, elderly people, and the normative population. They 
also had worse anxiety score than those patients with cancer. However, they had better 
depression scores than did patients with cancer, myocardial infarction after one month, 
and COPD. Likewise, the social activity in the women with HF was lower than normal. 
They also had poorer perceived health than did patients with other conditions. 
Similar findings were reported in a qualitative study using three different focus 
groups (each with five male outpatients with HF) by Bosworth et al (2004). Participants’ 
ages ranged from 47 to 82 years, and the majority (79%) were married. The LVEF ranged 
from 26 to 40%. Ten patients were classified with NYHA Class I/II and five with NYHA 
Class III/IV. Approximately 38% had a high school education, and 31% had college 
degree or graduate studies. The authors found that HF participants experienced worse 
physical, mental, and social functioning, and more severe and unpredictable physical 
symptoms, such as fatigue, dyspnea, and sleep disturbances, compared to prior studies of 
people with other chronic diseases. All participants expressed frustration about the loss of 
ability to carry out usual work or social role and its negative effect on HRQOL. In 
addition, the unpredictability and uncertainty of HF progression led to anxiety, depression, 
and fear. Participants also said that they feared being a burden to their family and friends. 
Likewise, Juenger and colleagues (2002) compared HRQOL in 205 outpatients 
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with stable HF and systolic dysfunction with a healthy reference population and with 
those with other chronic diseases in Germany. The mean age in this sample was 54±11 
years with a range of 19 to 74 years. The mean LVEF was 22±10% with a mean onset of 
HF of 4.7 years. The HF cause for most participants (57.6%) was dilated cardiomyopathy, 
and 25.4% coronary artery disease. Approximately 47.8% were in NYHA Class II, and 
40.4% were in NYHA Class III. HRQOL was measured using the RAND Medical 
Outcomes Study Short From-36 (SF-36). The authors found that people with HF had 
poorer HRQOL in eight domains of the SF-36 compared with a healthy reference 
population. HRQOL decreased significantly as the NYHA Class worsened, and the 
pattern of decrease was similar to patients on chronic hemodialysis. Furthermore, people 
with HF had lower scores in physical functioning, role functioning, physical health, and 
general health compared to patients with chronic hepatitis C infection. HF participants 
with NYHA Class III presented similar mental health problems to those with major 
depression in addition to reduced physical functioning. However, LVEF, length of 
diagnosis of HF, and age did not show any significant relationships with HRQOL. In 
addition, patients with a more severe impairment of functional capacity reported poorer 
HRQOL. However, functional indices [six-minute walk test (Guyatt, 1987) and peak 
oxygen uptake] only explained 51% of the impairment in HRQOL. The authors 
concluded that other potential determinants of HRQOL should be assessed to provide for 
better understanding.  
HRQOL in Western People With Heart Failure 
A variety of research studies have been conducted about HRQOL in Western 
people who are living with HF. Heo, Moser, Riegel, Hall, and Christman (2005) tested the 
feasibility of the HRQOL model developed by Wilson and Cleary (1995) showing the 
dynamic interrelationships of several patient outcomes such as functional status, 
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symptoms, biophysiological variables (e.g. biomarkers, LVEF and NYHA Classes), 
psychological variables (e.g. emotional support and relationship with families and 
friends), and QOL. The study was a secondary analysis of data from 293 hospitalized HF 
patients with NYHA Class II-IV from two randomized, controlled clinical trials of HF 
management interventions. The mean age in this sample was 73±11 years, and 53% were 
females. Participants were classified as the NYHA Class II (18%), III (50%) and IV 
(29%). Approximately 76% of participants had at least one comorbid condition, such as 
previous myocardial infarction (53%), diabetes (33%), and COPD (31%). 
In this study (Heo et al., 2005), the biophysiological factor was tested using the 
number of comorbidities, functional status was assessed using NYHA Class, and HRQOL 
was measured using the Minnesota Living with Heart Failure Questionnaire (MLHFQ) 
(Rector, Kubo, & Cohn, 1987). Results showed that health perception, symptom status, 
and age explained 29% and 21% of variance in HRQOL measured by the total MLHFQ 
and the emotional subscale. Furthermore, health perception, symptom status, and NYHA 
Class accounted for 28% of variance in HRQOL measured by the physical subscale. 
Health perception mediated the effect of symptom status on HRQOL. Moreover, NYHA 
Class did not mediate the relationship between symptom status and health perception. 
The researchers concluded that subjective variables rather than objective factors were the 
most consistent and significant components of HRQOL.  
The study (Heo et al., 2005), however, used only the NYHA Class to measure 
functional status which may be insufficient (Juenger et al., 2002). Other researchers have 
contended that functional status in HRQOL refers to the entire domain of daily 
functioning including physical, social, and psychological and can be measured by 
self-reported instruments (Aaronson, 1988; Cooley, 1998; Leidy et al., 1999; Wenger, 
1989). NYHA Classes are assessed by physicians and may not truly reflect the effects of 
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HF on daily functioning. A study by Subramanian (2005) found that 165 outpatients with 
NYHA Class ranging from I to IV (mean age 63±8.7 years) only had slight agreement 
between patients and healthcare providers in the assessment of severity of HF. Patients 
rated their HF at worse levels than did their providers, although provider ratings of 
NYHA Class was a better predictor of hospitalization.  
In this study (Subramanian et al., 2005), most participants (69.7%) were female, 
and the mean LVEF was 51±15%. Approximately 44.2% of the participants had NYHA 
Class II HF and 31.4% had NYHA Class III. On average, the participants had 3.63 
comorbid conditions, including hypertension (98.7%), coronary artery disease (82.1%), 
diabetes (75.0%), and COPD (41.7%). The mean Charlson comorbidity score (Deyo, 
Cherkin, & Ciol, 1992) was 3.74±2.1, indicating a high burden of illness. In addition, 
participants perceived themselves as being more ill than their healthcare providers did. 
The authors suggested that further research is needed to understand factors associated 
with patients’ perception of their symptoms and the severity of HF. 
Many research studies have found a consistently significant relationship between 
NYHA Class and HRQOL. In a descriptive, correlational study with 61 outpatients with 
advanced HF undergoing heart transplantation recruited from two university-affiliated 
hospitals, researchers found that NYHA Class was an important predictor for both mental 
and physical HRQOL (Westlake et al., 2002). The mean age in this sample was 56.8±13.8 
years and the mean LVEF was 21.8±6.1%. The majority of participants were men (74%), 
married (72%), and 41.7% were retired. They were classified as in the NYHA Class III 
(36.6%), Class II (26%), and Class IV (12%). Participants reported a low level of 
HRQOL measured by the SF-36. NYHA Class, six-minute walk distance, and 
neuroticism explained 49% of the variance in the mental health component of HRQOL. 
NYHA Class and time since symptom onset were significant predictors of the physical 
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health component of HRQOL. Participants with poorer functional status (measured using 
the NYHA Class and six-minute walk test) perceived their health to be worse.  
Similar findings regarding NYHA Class with a low level of HRQOL were 
reported in 87 HF patients with NYHA Class II to III recruited from three urban and 
suburban hospitals (De Jong et al., 2005). This study was a substudy of a prospective, 
randomized clinical trial aimed to determine the optimal disease management strategy. 
Data were collected at patients’ home after one week after their discharge from the 
hospital. Participants had a mean age of 72±11 years, mean education of 12±2 years, and 
mean LVEF of 38±15%. Approximately 47% were married, 31% were widowed, and 
51% were living alone. In terms of comorbitity, participants reported a history of 
hypertension (75%), coronary artery disease (70%), myocardial infarction (38%), and 
coronary artery bypass grafting (34%). HRQOL was measured using the Minnesota 
Living with Heart Failure Questionnaire (MLHFQ). The findings showed that NYHA 
Class, higher depression, and higher anxiety were important predictors of HRQOL. 
However, LVEF, comorbidity, and health perception were not correlated with HRQOL. 
The study supported the view that both physical and psychosocial functioning are 
important domains of HRQOL in people with HF. HRQOL in this study, however, was 
conceptualized as a component of health status. This is different from the notion that 
many researchers have when they view health status as synonymous with HRQOL 
(Berzon, 1998; Erickson, 2000; Guyatt et al., 1993; van der Steeg et al., 2004) or a 
constituent of HRQOL (Albrecht, 1994; Yao, 2000). Because the two studies above were 
cross-sectional, they did not address whether HRQOL changes over time in people with 
different NYHA Classes.  
Hauptman and colleagues (2004) conducted a descriptive study to examine the 
changes in HRQOL in 484 people with advanced or non-advanced HF over a six-week 
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period. Advanced HF was defined as NYHA Class III with a hospitalization within the 
preceding six months or in NYHA Class IV (n=118). Participants in the advanced HF 
group had lower LVEF (23±8% vs. 25±8%, p<.01), and elevated jugular vein pressure 
(36% vs. 10%, p<.001), compared to those in non-advanced group. However, the 
participants with advanced HF had lower but not significant percentages of medication 
use (ACEI and beta-blockers). HRQOL was measured using the Kansas City 
Cardiomyopathy Questionnaire (KCCQ), and perceived health was measured using the 
visual analog scale of the EQ-5D (also called EuroQOL) (Kind, 1996). The results 
showed that participants with advanced HF reported significantly worse KCCQ overall 
summary scores (46±21 vs. 66±22), EQ-5D scores (51±20 vs. 66±19), shorter six-minute 
walk distance (756±368 feet vs. 1039±371 feet), and higher levels of B-type natriuretic 
peptide (501±431 pg/ml vs. 359±381 pg/ml) than those with non-advanced HF. Except 
for the domains of self-efficacy and QOL, greater changes in the remaining KCCQ 
domains (physical and social limitations, symptom stability, frequency, and severity, 
clinical summary score, and overall summary score) were found in those with advanced 
HF at six weeks of follow-up. The authors concluded that NYHA Class is an important 
variable to document for advanced HF patients to track improvement or further 
deterioration in status (Hauptman et al., 2004). Though QOL (3 questions in KCCQ) was 
not significantly worse in advanced HF patients, HRQOL (23 questions in KCCQ) 
showed greater changes in this group. However, the authors did not further discuss 
whether greater changes in HRQOL among people with advanced HF were related to the 
increased use of medication over a six-week period.  
Several studies investigated the relationship between HRQOL and individual 
characteristics. Westlake et al (2002) did not find a significant relationship between 
HRQOL and demographic data including age, sex, marital status, education, and 
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employment. Similarly, age, gender, and living alone were not correlated with HRQOL in 
the De Jong et al (2005) study. However, age, gender, income, and ethnicity were 
significantly correlated with HRQOL in a descriptive, cross-sectional study by Clark and 
colleagues (2003) study. They (Clark et al., 2003) found that older participants perceived 
better health and reported better HRQOL than younger. Likewise, age and gender played 
important roles in HRQOL in Hou’s study (2004) with a 26-week follow-up period.  
Clark and colleagues (2003) reported a moderate level of HRQOL in 228 HF 
patients (32% males and 68% females) who lived in an urban community and were 
characterized by lower-income, lower-education, and limited resources. The participants 
had a mean age of 62.9±8.6 years, mean LVEF of 50±16%, varied NYHA Classes (23% I, 
51% II, 23%III, and 4% IV), and a mean Charlson comorbidity (Deyo et al., 1992) score 
of 3.7±2.1. HRQOL was measured using the KCCQ (functional and clinical summary 
scores) and the three domains (dyspnea, fatigue, and emotion) of the Chronic Heart 
Failure Questionnaire (CHQ) (Guyatt et al., 1989), and a single item of overall perceived 
health. Participants with greater age, better satisfaction with income, lower NYHA 
Classes, positive health beliefs, better social support, better communication with their 
physician, males, and black respondents reported better HRQOL. Greater age and more 
positive health beliefs were correlated with overall perceived health. The Charlson 
comorbidity score had a weak negative correlation with the KCCQ scores. However, 
perceived health, LVEF and comorbidity were not predictors any of the HRQOL 
measures. The study highlighted the significance of demographics, socio-cognitive 
factors, and environmental resources in HRQOL. The comorbidity result, however, was 
similar to findings reported by Feldman et al. (2004) that showed 371 patients with fewer 
comorbid conditions had better HRQOL. 
In Hou et al (2004) study, HRQOL was measured using the Chronic Heart Failure 
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Questionnaire (CHQ) (Guyatt et al., 1989) and two domains (physical and emotional) of 
the Minnesota Living with Heart Failure Questionnaire (MLHFQ) (Rector et al., 1987). 
Overall, a moderate level of HRQOL was found in 165 outpatients receiving care at two 
urban county hospitals (86 females and 79 males) with NYHA Classes from I to IV. Most 
participants (78%) had baseline NYHA Class II or III HF. HRQOL was improved 
significantly measured by the CHQ total, emotional, and dyspnea scales over a 26-week 
period. At baseline, people with HF less than 65 years old (n=119) reported poorer 
HRQOL on scores of the CHQ total scale, the dyspnea, fatigue, and emotional subscales 
of the CHQ, the MLHFQ total scale, and the emotional subscale than did older people 
(n=46). Women had poorer HRQOL on scores of the CHQ total scale, the dyspnea and 
emotional domains of the CHQ, and the emotional domain on the MLHFQ than did older 
people. At 26 weeks, participants younger than 65 years and women had significantly 
worse MLHFQ total scores compared to their counterparts. After controlling several 
factors including race, marital status, living arrangement, perceived income, educational 
level, baseline NYHA class, mental status scores, and baseline HRQOL, women under 65 
years reported significant improvements in CHQ total scores more than men under 65 
years and women ≧65 years. They also improved significantly more on the emotional 
symptoms than did men less than 65 years old and more on the CHQ fatigue scores than 
did women ≧65 years. However, there were no significant group differences in HRQOL 
changes measured by the MLHFQ. 
The Clark et al (2003) and Hou et al (2004) studies appear to support the view 
that women under 65 years who experience HF have more difficulties in adjusting 
lifestyles compared to men and older women, congruent with the findings from Plach, 
Napholz, and Kelber (2001). Women under 65 years often have multiple roles. 
Accordingly, they may experience more role impact and uncertainty with cardiac disease. 
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Decreased energy due to illness may disrupt their ability to perform responsibilities such 
as childcare, housework and work duties. More research studies regarding the impact of 
HF on this population, however, are needed.  
To compare changes in HRQOL among older and younger HF patients with left 
ventricular systolic dysfunction, a multicenter prospective study was carried out by 
Masoudi et al (2004). The study recruited 546 participants at the baseline, 484 of whom 
finished the 6±2-week follow-up. The mean LVEF for participants age less than (n=328) 
and greater than 65 years (n=218) were 24±8% and 26±8%, respectively. HRQOL was 
measured using the KCCQ. The results showed that both older and younger patients had 
moderate HRQOL and decreased functional capacity. At baseline, although older patients 
had worse functional capacity measured by the NYHA Class and the six-minute walk 
distance, they reported better HRQOL than younger patients. However, older patients 
with a decline in NYHA Class from baseline to follow-up also experienced significant 
declines in HRQOL compared to younger patients. The authors concluded that elderly 
patients with HF are at risk for worsening HRQOL with further decline in functional 
capacity. Maintaining functional status in older adults with HF is important to promote 
higher level of HRQOL for later life in elderly people with HF (Masoudi et al., 2004).  
Several studies provide insights to HRQOL in elderly patients with HF. A 
secondary data analysis of HRQOL with 138 older adults with HF (69 men and 69 
women) was conducted to investigate the differences in HRQOL between older adult 
men and women with HF (Friedman, 2003). Participants completed two interviews over a 
four to six-week period. The baseline data were collected face-to-face during the 
participants’ hospitalization for HF, and the second interview was done by telephone four 
to six-week later with the participants at home. The mean age in this sample was 
76.5±6.81 years, mean LVEF was 33.6±13.7%, and mean years since HF diagnosis was 
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4.4±5.4 years. On average, participants had 2.25 comorbid conditions, including coronary 
artery disease (71%), hypertension (51%), arrhythmia (40%), and diabetes (45%). The 
mean number of symptoms reported at time one was 7.2±2.6 and 4.0±2.5 at time two, 
including dyspnea, fatigue, weakness, edema, and orthopnea. The findings showed that 
participants’ HRQOL was significantly impacted by the decreased daily activities and 
symptoms (Friedman, 2003). Both older men and women had similar reported HF 
symptoms, rates of depression, and rehospitalization. Approximately 93% of males and 
96% of females reported that they had difficulties performing vigorous activities. 
Twenty-three percent of the participants were rehospitalized four to six weeks after the 
initial hospital discharge. However, older women reported more physical dysfunction 
than older men. Women’s physical functioning was significantly decreased at time two.  
Similar findings were found in a study of 191 Swedish elderly patients with HF 
with a mean age of 75.4±5.3 years (102 males and 89 females) (Cline, Willenheimer, 
Erhardt, Wiklund, & Israelsson, 1999). There were no significant differences in 
demographic data between men and women, including LVEF (33±11% vs. 36±11%), HF 
duration (2.5±3.9 vs. 2.2±3.7 years), NYHA Class (2.5±.8 vs. 2.7±.7), HF treatments, and 
comorbidities. HRQOL was measured by two subscales of the Quality of Life 
Questionnaire in Severe HF (QLQ-SHF) (Wiklund et al., 1987) and the Nottingham 
Health Profile (NHP) (Hunt et al., 1980) and Patients’ Global Self-Assessment. 
Compared to men, women had a significantly greater degree of somatic symptoms and a 
decrease in perceived physical capacity as measured by the QLQ-SHF. They also 
reported a higher level of disturbance on scores of all the NHP subscales: emotion, sleep, 
energy, pain, and activity and health-related problems, including housework, social life, 
home life, sex life, hobbies and interests, as well as the holiday subscale.  
In the Cline study (1999), except for gender, HRQOL was different among 
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participants with different NYHA Classes, marital status, and comorbidities. Researchers 
found that the higher the NYHA Class, the poorer HRQOL in patients with HF. Single 
patients had greater levels of social isolation and physical inactivity than did married. 
Conversely, married patients and those with a history of hypertension felt their health 
affected their sex life more than their counterparts. Patients with a history of angina 
reported a more significant impact on HRQOL in regard to emotion, sleep, energy, 
mobility, housework, and holiday than those without. However, no significant differences 
in HRQOL were found between patients with LVEF less and greater than 34%, smokers 
or non-smokers, with or without diabetes, or a history of myocardial infarction. 
Researchers, however, have defined HRQOL differently. HRQOL was 
constructed by concepts of health perception and functional status including activities of 
daily living and instrumental activities of daily living in a study by Chin, Zhang, and 
Rathouz (2003). Using the 1991 to 1994 data from the Medicare Current Beneficiary 
Survey, the authors identified 872 older adult patients with HF (311 males and 561 
females) in 1991. At baseline, the mean age in this sample was 79.2±.28 years. 
Approximately 54% of whom had less than 12 years of education, two-thirds had 
comorbid conditions, and 58% rated their health as “fair” or “poor.” At a one-year 
follow-up, 18% of the patients had died. A decline in HRQOL was more common in 
older adults who originally ranked health perception as “excellent” or “very good” health 
perception. The prior year’s HRQOL and cormobidity were important predictors of the 
subsequent year’s HRQOL. Health perception and functional status were strongly 
correlated with mortality. Subjects who reported poor health perception had higher 
chances of dying in the next year. Additionally, older women were more likely to have 
impairments in daily living activities, such as bathing, walking, and getting out of beds or 
chairs, as well as instrumental activities of daily living, such as doing light or heavy 
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housework, using the telephone, and shopping for personal items. The authors concluded 
that older adults with HF have worsening health status over time. Measures of prior 
health status are useful in predicting subsequent health state. 
Similar to others studies reviewed for this research, Arnold, Ranchor, Koeter, de 
Jongste, and Sanderman (2005) found no direct relationship between LVEF and general 
health perception measured by the SF-36 general health perception subscale in a 
descriptive, correlational study with 90 HF outpatients (22 females and 68 males) with 
LVEF less than 45%, although LVEF was independently related to physical functioning 
measured by the SF-36 physical functioning subscale. The subjects had a mean age of 
59.6±10.0 years, mean LVEF of 30.3%±9.4%, and mean HF duration of 6.5years. 
Self-reported physical functioning was significantly related to general health perception. 
Perceived personal health competency was strongly related to patients’ perceptions 
regarding their HRQOL, including symptom, physical functioning, and general health 
perception. 
To study the differences in HRQOL between patients with systolic and diastolic 
dysfunction, Jaarsma et al (1999) carried out a study with 186 HF patients. The mean age 
in this sample was 73±9 years (range 50-94) with the NYHA Class III or IV. The mean 
LVEF in the systolic HF group was 29.2±7.5% (n=150) and in the diastolic dysfunction 
was 56.4±9.9% (n=36). The findings showed that both groups had similar low HRQOL. 
Except for ankle edema reported more often by people with diastolic dysfunction, both 
groups experienced the same amount of symptoms. People in the diastolic dysfunction 
group were more likely to be elderly and female, and often had a history of hypertension. 
Although patients with systolic dysfunction had poor psychosocial adjustment to illness, 
they reported fewer problems with the medical system and treatment, and less ankle 
edema than those in diastolic group. The study findings, however, were limited by the 
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study design using an imbalanced sample size (150 vs. 36). 
HRQOL in Taiwanese and Chinese People With Heart Failure 
Several studies regarding HRQOL have been conducted with Taiwanese and 
Chinese people with HF. Wang (2005) reported a descriptive, cross-sectional study to 
investigate QOL and its correlates in Taiwanese people with HF. Eighty outpatients (43 
males and 37 females) with NYHA Class I to IV were recruited from a medical center 
located in Northern Taiwan. The mean age in this sample was 65.75±11.49 years (range 
27-96). The majority of the subjects were married (78.8%), unemployed (77.5%), an 
educational level of elementary school (41.2%) or illiteracy (25.0%), NYHA Class II 
(38.8%) or Class III or IV (56.2%), and history of hypertension (71.3%) and diabetes 
(50.0%), as well as a history of HF for six years and less (60%). The findings showed that 
participants had a moderate level of QOL measured by the five domains of Quality of 
Life Index (psychosocial, health, environment, intimate, and family factors) (Ferrans & 
Powers, 1985). Participants rated the psychosocial domain as most important but least 
satisfied. In contrast, the intimate factor was ranked as the least important, but the most 
satisfied factor among domains. QOL decreased significantly as NYHA Classes increased. 
Participants perceived moderate to high emotional support from families and relatives. 
Moreover, demographic data including age, gender, marital status, employment status, 
education, and length of diagnosis with HF were not correlated with QOL. The study 
highlighted the importance of psychosocial QOL in Taiwanese people with HF.  
The relationships between HRQOL, psychological factors, and perceived dyspnea 
were investigated in another descriptive, correlational study with 100 Taiwanese 
outpatients (54 males and 46 females) with HF (Cheng, 2004). The subjects had a mean 
age of 60.70 ±10.61 years with NYHA Class I (5%), II (42%), or III (53%). The majority 
were married (56%), unemployed (85%), living with families (85%), and illiterate (52%). 
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They had a mean LVEF of 43±19% (range 11-82) and mean HF duration of 3.59±2.23 
years (range 1-13). The mean number of medications used was 3.78±1.61, including 
digoxin (78%), ARB (56%), diuretics (52%), calcium blockers (30%), beta-blockers 
(17%), and ACEI (16%). The etiology for HF was heart valve disease (64%), ischemic 
heart disease (55%), hypertensive heart disease (37%), and dilated cardiomyopathy 
(15%). On average, participants had 1.89 comorbid conditions, including arrhythmia 
(39%), hypertension (37%), and diabetes (33%). HRQOL was measured by the Medical 
Outcome Study Short Form-12 (Ware, Kosinski, & Keller, 1996). The results showed 
that the participants had mild to moderate level of perceived dyspnea, fatigue, and 
depression. Participants who perceived more dyspnea and fatigue reported a poorer 
physical health component of HRQOL, whereas patients who had more depression and 
fatigue experienced a worse mental health component of HRQOL. Depression, however, 
mediated the effects of dyspnea on both physical and mental health domains of HRQOL. 
This study indicates the importance of psychological effects on HF symptom 
management and improvement in HRQOL, similar to findings in the Wang study (2005). 
These two studies, however, used QOL or generic HRQOL instrument that may be 
insufficient to measure HRQOL in people with HF, because the non-HF specific tool 
lacks sensitivity to measure effects of HF and its related symptoms on daily functioning 
(Bennett et al., 2003). 
Psychological distress was the strongest predictor of HRQOL in a study with 227 
Hong Kong Chinese people with HF (119 females and 108 males) (Yu et al., 2004). 
Participants had a mean age of 77.1±7.9 years (range 60-95), mean time for HF diagnosis 
of 3±2.64 years, and approximately 87.7% had one or more chronic comorbid conditions. 
Hypertension was the most common condition, affecting 50% of the participants. Most 
participants in this study were in NYHA Class II (49.8%) and III (33.9%). HRQOL was 
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measured using the Chronic Heart Failure Questionnaire. The results showed that 
participants had a moderate level of HRQOL with symptoms of fatigue being worse than 
those of dyspnea. In addition, more psychological distress, more functional impairment, 
perceived poor health, and a lower educational level were identified as predictors of 
poorer HRQOL. Furthermore, variables including age, social support, married status, and 
living arrangements were significantly related to HRQOL. Conversely, factors, such as 
gender, income, years of having HF, and number of comorbid conditions were not 
correlated with HRQOL. The authors (Yu et al., 2004) suggested the need to develop 
effective interventions to promote psychological and functional health and a positive 
attitude towards health status to enhance their HRQOL. 
In Yu and colleagues (2004) study, participants with higher education were more 
likely to report better HRQOL. The result is similar to findings in studies by Lam and 
Lauder (2000) and by Lai et al (2005) of people with chronic illnesses (not HF). Lam and 
Lauder (2000) studied 760 Chinese participants with a variety of chronic illnesses and 
found that educational level affected physical fitness scores on HRQOL. Lai et al (2005) 
found that educational level had a significant effect on all domains of HRQOL measured 
by the brief version of the World Health Organization Quality of Life Questionnaire in 465 
institutionalized Taiwanese elderly people in long-term care settings (The WHOQOL 
Group, 1998). Authors of these three studies, however, did not further discuss these 
findings regarding education on HRQOL. Clarifying whether patients with higher 
education have better resources and abilities to adjust their illnesses and life expectations 
could be useful. Hershberger et al (2001) found that HRQOL increased when patients’ 
recognition of HF symptoms and knowledge in self-care improved. Rockwell and Riegel 
(2001) proposed that people with more education might have better critical thinking 
abilities that enhance their behaviors to take care of themselves and thus, promoting 
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better HRQOL. Likewise, Shih (2002) found that HF participants with higher levels of 
education also reported better self-efficacy for daily activity. Perceived self-efficacy, 
however, is important to improve functional capacity and psychological status for 
Taiwanese people with HF (Tsay & Chao, 2002). 
Using tailored message strategies can be an effective way to avoid redundant 
educational content and to teach HF knowledge that patients actually need (Bennett, Hays, 
Embree, & Arnould, 2000). Shang (2002) tested the effectiveness of a coping skill 
training program that measured the effects of disease recognition, stress management, and 
self-care strategies on perceived stress, self-care self-efficacy, depression, and HRQOL. 
Forty hospitalized HF participants were classified into interventional (abbreviated as I, 
n=20) or control groups (abbreviated as C, n=20). Each group consisted of 11 (55%) 
females and nine males (45%). The demographic data, including age [66.10±13.78 years 
(I) vs. 67.45±10.13 years (C)], married status, living arrangement, education [7.45±4.27 
(I) vs. 7.10±4.08 (C)], and income did not significantly differ between the two groups. 
Eleven participants in the interventional group were in NYHA Class II, while 11 in the 
control group had NYHA Class III. The average number of HF symptoms was 5.55±1.23 
(I) vs. 4.8±1.24 (C), and the number of rehospitalization due to HF was 2.00±1.03 (I) vs. 
2.40±1.60 (C). 
The study (Shang, 2002) showed that participants who received coping skill 
training did not show better HRQOL than did those in the control group. The findings 
may indicate that the intervention did not fit patients’ needs or reflect the 
multidimensional and dynamic nature of HRQOL. Researcher attention to patients’ 
opinions of what they need to learn is an important part of engaging in HF care 
(Hagenhoff, Feutz, Conn, Sagehorn, & Moranville-Hunziker, 1994). Failure to identify 
factors that are most important could result in the treatment being ineffective and 
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inapplicable.  
Summary of Literature Related to HRQOL in HF 
In summary, research studies reviewed for this research showed that HRQOL in 
people with HF was moderate to low. Among domains of HRQOL, symptoms and 
functional status had the greatest impact. People with HF encountered significant 
psychological impact and emotional problems, such as depression, anxiety, and 
uncertainty, even though they perceived social and emotional support from families and 
friends. They also reported social limitation, such as maintaining social life and 
relationships with friends, especially for those with advanced HF. 
From the literature, HRQOL was affected by a variety of factors. These factors, 
however, did not show consistent relationships with HRQOL. Findings from these studies 
may support the view that HRQOL presents different meanings in varied cultures and 
populations (Fayers & Machin, 2000).  
Individual characteristics and HRQOL. For findings about demographics, 
HRQOL studies regarding age and gender in people with HF showed that elderly patients 
and men reported better HRQOL than younger people and women. Married people 
reported greater impact on their sex life, whereas single adults expressed greater 
restriction in social interaction and physical activity (Cline et al., 1999). A significant 
correlation between income and HRQOL was found in one study, however, it was 
conducted with patients with lower-income and limited resources. More studies are 
needed to clarify this finding. Furthermore, two variables, educational level and living 
arrangement, were found to be related to HRQOL among Chinese people, however, the 
relationship has not been found in studies conducted with Western populations. Finally, 
employment status, had a low but non-significant association with HRQOL.  
For findings regarding health-related characteristics, some studies did not support 
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the hypothesis that HF patients with fewer comorbidities have better HRQOL. Likewise, 
perceived poor health was found in several studies and had a significant impact on 
domains of HRQOL.  
HF characteristics and HRQOL. Studies reviewed did not find that people who 
have been diagnosed with HF for a longer time reported better or worse HRQOL. 
Although most studies showed that higher NYHA Classes caused greater impairment in 
HRQOL, researchers argued that this objective functional index only partly explained the 
impairment of HRQOL (Juenger et al., 2002). Furthermore, research studies did not find 
any significant relationship between HRQOL and LVEF. This is congruent with the 
studies showing no significant difference in HRQOL between diastolic and systolic HF. 
However, the evidence was insufficient. More research studies are needed to understand 
the influence of diastolic HF on HRQOL. 
Sleep Disorders in Heart Failure 
Distinguishing the symptoms of HF, such as lethargy, fatigue, cardiopulmonary 
intolerance, and paroxysmal nocturnal dyspnea, from the symptoms of sleep disturbances 
is not easy, especially if the symptoms are caused by sleep-related breathing disorders 
(SRBD) (Kohnlein, Welte, Tan, & Elliott, 2002; Lai et al., 2005). Researchers argue that 
more studies are needed to support the pathophysiological mechanism of sleep 
disturbances and HF. However, it has become evident that the sleep disturbances, periodic 
breathing, apnea-related surges in blood pressure and heart rate, and cardiac ischemia 
have created a vicious cycle that can hinder the restoration of the damaged myocardium 
and further increase the threat to patients’ lives (Lanfranchi & Somers, 2003; Leung & 
Bradley, 2001; Rao & Gray, 2005; Spieker & Motzer, 2003). 
Pathophysiology of Sleep-Related Breathing Disorders 
The pathophysiological effects of HF, however, show that cardiovascular 
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autonomic regulation can be interrupted by sleep disorders (Leung & Bradley, 2001). 
Two most common SRBD in HF are obstructive sleep apnea (OSA) and Cheyne-Stokes 
respiration with central sleep apnea (CSR-CSA). Both OSA and CSA-CSR share several 
features, and they result in similar adverse effects on HF, although they have different 
pathophysiology. Both have an adverse effect on a failing myocardium by: increasing the 
left ventricular filling pressure, activating the sympathetic nervous system, increasing 
cardiac oxygen demand and decreasing myocardial oxygen supply, and increasing 
arousals from sleep (Leung & Bradley, 2001; Spieker & Motzer, 2003). Two common 
features of SRBD, intermitted hypoxia and frequent arousals from sleep, further induce 
excessive daytime sleepiness, insomnia, difficulty initiating and maintaining sleep, light 
sleep, and early awakening, resulting in fatigue and a worsening of the cardiopulmonary 
function (Lanfranchi & Somers, 2003; Spieker & Motzer, 2003). As a result, a vicious 
pathophysiological cycle can be created whereby SRBD causes more severe HF and 
much worse SRBD. 
Arousal from sleep has been viewed as an important factor in sustaining the cyclic 
periodic breathing (Kohnlein et al., 2002). Arousal from sleep may activate sympathetic 
activity, resulting in catecholamine hypersecretion, vasoconstriction, and increased blood 
pressure (Leung & Bradley, 2001; Parker & Dunbar, 2002). As a result, the 
chemosensitivity is destabilized, and further triggers hyperventilation, which leads to 
lower levels of arterial carbon dioxide tension (PaCO2). When the reduction in PaCO2 
reaches the “apnea threshold,” apnea in sleep is precipitated (Kohnlein et al., 2002; 
Yamashiro & Kryger, 1993). The consequent apnea leads to an increase in PaCO2 and a 
decrease in arterial oxygen tension (PaO2) with consequent hyperpnea, which lowers 
PaCO2 and continues the breathing cycle (Yamashiro & Kryger, 1993).  
Left ventricular failure with the characteristics of high filling pressure, low 
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cardiac output, and inadequate myocardium perfusion can be worsened by the 
sympathetic activity and catecholamine release, and fluctuations of PaO2 and PaCO2 
(Leung & Bradley, 2001). Consequently, pulmonary edema can be precipitated which 
further triggers stimulation of pulmonary juxtapulmonary capillary receptors (J-receptors), 
initiating rapid and shallow breathing, hypotension, and bradycardia (McCance & 
Huether, 2006). Moreover, individuals may suffer from hypersomnolence and fatigue 
because of sleep disruption (Kohnlein et al., 2002; Leung & Bradley, 2001).  
A model illustrating the pathophysiology of SRBD is shown in Figure 2. Here key 
physiological relationships are identified. Pathophysiological mechanisms can potentially 
be used as a guide to further test effects of sleep disorders in people with HF. Both HF 
and sleep disorders can interact with each other and independently interrupt patients’ 
daily lives.  
 
Figure 2. Pathophysiological Concepts in Heart Failure and Sleep Disorders [Modified 
from Leung and Bradley (2001) and Kohnlein, Welte, Tan, and Elliott (2002)]. 
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Research Studies Related to the Pathophysiology of SRBD in Heart Failure 
Many studies regarding sleep disorders in HF focused on the effects of SRBD. 
Several studies have assessed the prevalence of SRBD in people with HF. Thirty-eight 
outpatients with HF were recruited to participate in a screening for SRBD at a heart clinic 
(Trupp et al., 2004). All participants were under age 65 years with a mean body mass 
index of 32.4kg/m2. Approximately 62% were male and 59% were in the NYHA Class III. 
The screening was done by asking participants to undergo an overnight study, and data 
included thoracic impedance, oxyhemoglobin saturation, and 2-lead electrocardiogram. 
SRBD was defined by using the respiratory disturbance index (RDI). The results showed 
that four participants (10%) had severe SRBD (RDI >15/hour), 12 patients (32%) had 
moderate SRBD (RDI= 5-15/hour), and 22 patients (55%) had mild or no significant 
SRBD (RDI <5/hour). Researchers did not classify the SRBD as obstructive or central 
sleep apnea. 
Generally, patients with HF and SRBD who have an apnea-hypopnea index (AHI) 
of more than 20 events per hour experience more sleepiness and fatigue than those with 
an AHI of less than 20 (Morrell, 2003). A significant difference, however, was not found 
in Jahaveri et al. (1995) in their study of forty-two HF patients with a LVEF less than 
45%. The results showed that 19 (mean age 63±10 years) participants had moderate to 
severe SRBD, and more than 50% of the apnea-hypopnea episodes were identified as 
central apnea. Participants with an AHI of over 20 events per hour had significantly 
higher arousal index (24±12 vs. 3±3 episodes), greater duration for oxyhemoglobin 
saturation (SaO2) drops less than 90% (61±63 vs. 7±13 minutes), greater severity of 
SaO2 drops (74±13% vs. 87±4%), increased number of episodes of nocturnal ventricular 
arrhythmias, and lower LVEF (22±9% vs. 30±10%) compared to those with an AHI of 20 
events or less per hour (n=23, mean age 63±10 years). However, arterial blood gases, 
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loud snoring, and sleep architecture values such as total sleep time, sleep onset, and sleep 
stages did not differ significantly between patients with an AHI of 20 or less and those 
with an AHI over 20. Furthermore, age was not correlated with SRBD. Body mass index 
was positively correlated with OSA, but not central apnea. LVEF was a significant 
predictor of the AHI. The lower the LVEF, the greater was the AHI in patients with 
moderate to severe SRBD. In addition, the central apnea index was a significant 
determinant of ventricular arrhythmias. 
A sample of 301 HF patients (262 males) with a LVEF less than 40% was used to 
test the association between daytime systolic blood pressure and the presence of OSA in a 
cross-sectional study (Rostagno et al., 2003). Those with an AHI greater than 10 events 
per hour during sleep were recognized as SRBD. The findings showed that 105 (35%) 
patients with HF had OSA (mean age 59.4±1.1 years) and 121 (40%) had CSA (mean age 
67.2±0.9 years). People with OSA had significantly higher daytime systolic blood 
pressure and body mass index (32.7±.2 vs. 26.1±.4 vs. 28.4±.1) and a history of snoring 
(79.1% vs. 41.1% vs. 49.2%), but they had significantly lower mean SaO2 during sleep 
(92.5±3.2% vs. 93.3±1.9% vs. 93.5±2.6%) than those patients with CSA and non-SRBD 
(n=75, mean age 56.9±16 years, LVEF 26.0±1.7%). Additionally, subjects with OSA had 
significantly higher diastolic blood pressure than those with non-SRBD. On the other 
hand, patients with CSA had a significantly lower LVEF (23.6±1.5% vs. 30.4±1.5%) and 
PaCO2 (38.2±6.8 mmHg vs. 44.7±6.7 mmHg) but a higher AHI than (40.3±2.0/hour vs. 
34.1±1.9/hour) did patients with OSA. After controlling for age, gender, LVEF, SaO2, 
and body mass index, the study showed that people with OSA were 2.89 times more 
likely to experience systolic blood pressure greater than 140 mmHg than those without 
OSA. A single blood pressure measurement, however, might be insufficient for 
representing the participants’ general blood pressure status. Furthermore, longitudinal 
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studies are needed to ascertain the causal relationship of OSA and high diastolic blood 
pressure. 
OSA and CSR-CSA may coexist in patients with HF (American Academy of 
Sleep Medicine, 1999). In a retrospective study, 22 men with OSA and HF, as well as 18 
men with OSA alone, were recruited for a comparison of the duration of the 
apnea-hyperpnea cycle (Ryan & Bradley, 2005). Those two groups were matched for age, 
body mass index, total sleep time, arousals, sleep-stage distribution, minimum SaO2, and 
mean transcutaneous PCO2. The mean LVEF for patients with HF and OSA was 26.8%. 
The diagnosis of OSA was based on an AHI of at least 10 events per hour during sleep, as 
obtained from previous overnight PSG data. The results showed that, compared to 
patients with OSA alone, patients with both HF and OSA had a significantly longer 
periodic breathing cycle, hyperpnea duration with more breaths, and 
lung-to-chemoreceptor circulation time. Furthermore, lung-to-chemoreceptor circulation 
time was significantly correlated with hyperpnea duration, breaths per hyperpnea, and 
time to peak tidal volume (TV), but it was not correlated with apnea duration. Following 
an apnea event, patients with OSA exhibited an abrupt rise and rapid decline in TV, 
whereas patients with HF and OSA presented a gradual rise and slow decline in TV. The 
study results supported the argument that, in people with HF and OSA, the increased 
circulatory delay may influence the physiological manifestations of OSA, for instance, by 
prolonging hyperpnea and shaping a CSR-like pattern. Furthermore, the study may also 
support the view that CSR-CSA becomes much more prevalent when the LVEF is below 
35% (Pepin, Chouri-Pontarollo, Tamisier, & Levy, 2006). 
Research Studies Related to the Patient’s Perspective About Sleep Disorders 
Only a few studies have investigated the relationship of sleep disorders in HF 
from the patient’s perspective. Researchers have investigated sleep disorders and their 
 54
effects on the physical and psychosocial health of patients with HF. Several studies have 
addressed the prevalence of sleep complaints. In the EuroHeart survey of 187 patients 
with HF (99 males), over 40% of the participants reported dyspnea during sleep and 23% 
were re-hospitalized within 12 weeks after being discharged from the hospital (Lainscak 
& Keber, 2003). The mean age in this sample was 70.6±11.4 years. Participants were 
classified as NYHA Class I (33%), II (45%), and III (18%). The prescribed HF 
medications included ACEI (70%), Furosemide (74%), digoxin (48%), and beta-blockers 
(27%). The findings showed that one-third of the participants woke up during the night 
due to dyspnea in the week prior to the interview. Over 60% of the participants 
experienced sleep disturbances, including an inability to get to sleep (63%), waking up 
and having difficulty getting back to sleep (69%), and lacking sufficient refreshing sleep 
(60%). They also suffered from several psychological symptoms including anxiety (70%), 
depression (50%), stress (48%), and cognitive impairment (53%).  
Similar findings were found in another survey study, one with 84 HF patients (59 
males and 25 females) with a mean LVEF of 21.7±6.3% (Erickson et al., 2003). The 
mean age for this sample was 54.1±10.8 years, and mean NYHA Class was 2.8±.8. 
Approximately 44.6% of the subjects had HF of ischemic etiology and 39% had obesity. 
Sleep complaints were measured using the 16-item Modified Sleep Disorder 
Questionnaire by the authors. Approximately 56% of the participants reported trouble 
sleeping. The most common symptoms were inability to sleep flat (51%), restless sleep 
(44%), trouble falling asleep (40%) and awakening early (39%).  
In the Erickson and colleagues (2003) study, sleep disorder symptoms were 
further tested, and correlations were found with demographics, clinical variables, and HF 
severity. The findings showed that increased age was associated with “not tired at 
bedtime” and “awaken with heart pain.” Male HF patients experienced more trouble 
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returning to sleep, but less daytime sleepiness. Although sleep disorders were not 
correlated with LVEF and peak oxygen uptake, daytime sleepiness was positively 
associated with NYHA Functional Classification and negatively related to the six-minute 
walk test (Guyatt, 1987). In addition, a higher NYHA Class was associated with several 
symptoms, including breathing cessation during sleep, restless legs, and waking before 
necessary. The researchers did not, however, provide correlation coefficients in the article, 
and information about the strength of associations between sleep disturbances and the 
independent variables is still limited (Erickson et al., 2003). 
Brostrom and colleagues (2001) conducted a qualitative study in which 20 HF 
patients were interviewed to explore sleep disorders. Age ranged from 38 to 82 years for 
the male participants (n=13) and 55 to 85 years for females (n=7). Thirteen were married 
and five were widows/widowers. The etiology for HF was ischemic heart disease (n=10), 
hypertension (n=4), cardiomyopathy (n=4), and heart valve disease (n=2). Twelve of 20 
were in NYHA Class II HF, five in Class III, and three in Class IV. The findings showed 
that the participants’ sleep was influenced by their daily activities, such as gardening and 
accidents; aspects of the HF itself, such as deterioration and side effects of medications; 
and cardiac symptoms, such as dyspnea, dysrhythmia, and cough. Sleep disturbances 
caused several adverse effects, including fatigue, listlessness, and loss of temper, and they 
also resulted in a need for daytime sleep, seclusion, counseling, and information. The 
participants dealt with sleep disturbances by adjusting their daily activities and looking 
for support from families and friends. 
The finding that HF participants reported poor sleep and thus demanded more 
daytime sleep in Brostrom and colleagues (2001) study is similar to findings in other 
studies conducted with general and elderly populations. Daytime sleepiness was common 
in people who were elderly; had nocturnal sleep disturbances, such as frequent 
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awakenings, difficulty in falling asleep again after nocturnal awakening and 
nonrestorative sleep, and loud snoring; and somatic diseases, such as, diabetes and 
cardiac diseases (Asplund, 1996; Ohayon et al., 1997; Whitney et al., 1998). However, 
daytime sleepiness occurred particularly in HF patients who habitually used sleeping 
medications and complained about nocturnal polyuria (Asplund, 2005).  
Summary of Literature Related to Sleep Disturbances and Heart Failure 
In summary, up to 70% of people with HF have been found to experience some 
type of sleep disorder. Although the pathophysiological mechanism between sleep 
disorders and HF is still not completely understood, it is clear that sleep disorders can 
cause negative effects on the progression of HF, resulting in a vicious cycle. Meanwhile, 
sleep disorders are associated with both physical and psychosocial health dangers. 
Several factors, such as age, gender, body mass index, HF symptoms, and SRBD have 
been linked to sleep related symptoms. Research focusing on the pathophysiology of 
SRBD tended to investigate physiological changes in HF. In contrast, studies concerning 
the patient’s perspective about sleep disorders were more likely to measure sleep 
symptoms and their impact on daily functioning. Study findings from literature, however, 
have suggested that identifying people’s sleep problems is important to HF management. 
Generally, people with more severe HF experienced poor sleep quality. The most 
common sleep disorders in HF are SRBD and insomnia. Daytime sleepiness may follow 
both SRBD and insomnia.   
The Relationship Between HRQOL and Sleep Disorders 
Most research studies have not presented consistent findings for the association of 
severity of HF and sleep disorders (Jahaveri et al., 1995; Principe-Rodriguez et al., 2005) 
nor sleep apnea and sympathetic activation (Mansfield et al., 2003; Solin et al., 2003). 
However, researchers did find consistent results in the effects of sleep disorders on 
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HRQOL in people with HF (Brostrom et al., 2004; Lainscak & Keber, 2003; Rao et al., 
2006; Redeker & Hilkert, 2005; Skobel et al., 2005; Villa et al., 2003). 
The effects of SRBD on HRQOL were investigated in 51 HF patients with LVEF 
less than 35% and NYHA Classes II (n=40, as 17 for SRBD and 23 for non-SRBD) to III 
(n=11, as 9 for SRBD and 2 for non-SRBD) (Skobel et al., 2005). All participants (36 
males and 15 females) presented with exercise intolerance and exertional dyspnea, but 
only patients with HF and SRBD had reduced peak oxygen uptake. An AHI of five events 
per hour was used to identify SRBD. Twenty-six (52%) participants with a mean age of 
61±11 years were diagnosed with SRBD: 12 for CSR, 5 for OSA, and 9 for mixed sleep 
apnea. The mean LVEF was 23±7% for the SRBD group and 26±6% for the non-SRBD 
group (n=19, mean age 52±10 years).  
Depression symptoms, HRQOL, and sleep quality were compared with those of 
10 age-matched healthy adults and 11 patients with OSA. Sleep quality was measured 
using the 19-item Pittsburgh Sleep Quality Index (Buysse et al., 1989), which showed 
that 37% of the patients with HF and SRBD were poor sleepers (Skobel et al., 2005). 
Patients with both HF and SRBD had poorer sleep quality, greater depression symptoms, 
and less total HRQOL compared to healthy adults and HF patients without SRBD. Three 
dimensions of HRQOL—physical health, bodily pain, and emotional functioning—had 
the greatest impact. Sleep quality, depression symptoms, and HRQOL were not 
significantly different among HF patients with different types of SRBD. Interestingly, the 
latter three variables in patients with both HF and SRBD were similar to those with OSA 
without HF. The findings suggested that SRBD adversely affected HRQOL, disturbed 
sleep itself, and resulted in depression symptoms in patients with HF. Improving SRBD is, 
therefore, important to improving HF status, sleep and HRQOL. 
In a study of 14 outpatients with severe HF (mean LVEF<30%) who were waiting 
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for heart transplantation, three (21%) were diagnosed with CSA , using the criterion of an 
AHI greater than 10 per hour (Villa et al., 2003). Patients with CSA reported less HRQOL 
and poorer tolerance to exercise than those without CSA. Furthermore, age (49.9 vs. 57.6 
years), LVEF (26.3±7.09% vs. 27.18±12.18%), NYHA Class (3 vs. 2.45±.6), pulmonary 
function tests (33% vs. 50%), body mass index (29.4±.8 vs. 28.4±5.3), snoring (33% vs. 
50%), hypersomnolence (34.8 vs. 43.5), and witnessed apneas (33% vs. 14.3%) were not 
significantly different between patients with and without CSA. Those findings, however, 
need confirmation by other studies, because the sample size in this study was small. 
Treatments of SRBD, including supplementary oxygen, medications, and 
continuous positive airway pressure (CPAP), have been widely used in clinical practice 
(Morrell, 2003; Naughton, 2005). In a randomized trial, Mansfield et al. (2004) examined 
the effects of CPAP on systolic heart function, sympathetic activity, BP, and HRQOL in 
patients with HF and OSA. One hundred and fifty-six patients with LVEF less than 45% 
and NYHA of Class II to IV were invited to undergo a polysomnography. An AHI greater 
than five obstructive events per hour was used to diagnose OSA. The results showed that 
69 (44%) patients met the criteria of OSA, and 55 were randomly assigned to either 
CPAP (n=28) or control (n=27) groups. The mean age for CPAP was 57±1.6 years, and 
for the control group was 57.2±1.7 years. Only three females enrolled in this study and all 
of them were in the CPAP group. There were no significant differences in baseline 
characteristics between the control group and CPAP group: mean LVEF (33.7±2.4% vs. 
37.1±2.3%), body mass index (34.6±1.2 kg/m2 vs. 33.5±.9 kg/m2), NYHA Class (2.4±.2 
vs. 2.5±.2), AHI (28.1±3.9 events/hour vs. 28.3±.4 events/hour), arousal index (30.4±4.3 
events/hour vs. 42.2±8.9 events/hour), Epworth Sleepiness Scale (9.2±.9 vs. 10.7±.7), 
minimum overnight pulse oxygen saturation (SpO2) (77.3±3.2% vs. 79.3±2.2%), urinary 
norepinephrine (21.8±1.8 nmol/mmol creatinine vs. 20.6±3.1 nmol/mmol creatinine), and 
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mean blood pressure (107±3 mmHg vs. 99±3 mmHg). However, peak oxygen uptake had 
a significant difference between the two groups (16.4±2.3 ml/kg/min vs. 20.3±1.2 
ml/kg/min). Forty out of the 55 participants finished a three-month follow-up. Compared 
with the control group of 21 patients, 19 patients in the 3-month overnight nasal CPAP 
treatment group had significant improvements in LVEF, overnight urinary norepinephrine, 
AHI, SpO2, daytime sleepiness, and HRQOL; however, mean blood pressure, peak 
oxygen uptake, NYHA Class, and body mass index did not significantly change after the 
CPAP treatment. 
Redeker and Hilkert (2005) examined the extent to which sleep quality, duration, 
and continuity were relative to functional performance and mental health among 61 
patients (39 males and 22 females) with stable systolic HF (LVEF less than 35%). The 
participants had a mean age of 59.5±12.85 years (range 28-83), mean body mass index of 
30.39±6.40, and mean LVEF of 22.9±8%. Most participants were in the NYHA Class II 
(n=34) and III (n=21). Comorbid conditions in this sample included cardiomyopathy 
(71%), hypertension (59%), dysrhythmias (34%), diabetes (39%), and coronary artery 
bypass (41%). The study was conducted using a descriptive, cross-sectional design. Each 
participant wore a wrist actigraphy to record nocturnal sleep duration, continuity, and 
daily activities for three days while living at home. Sleep quality was measured using the 
PSQI and HRQOL including physical and mental functioning was evaluated by the 
SF-36.  
Results showed that there were no statistically significant relationships with age, 
gender, comorbidity, and sleep variables (Redeker & Hilkert, 2005). However, 
participants with a higher NYHA Class reported poor sleep quality (r=.40, p<.001). 
Approximately 34% of the patients used sleeping medication at least occasionally. There 
were small to moderate negative correlations between PSQI and physical functioning 
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(r=-.40, p<.001), six-minute walk distance(r=-.42, p<.05), and mental functioning (r=-.34, 
p<.01). Time in bed was negatively correlated with physical functioning (r=-.31, p<.05) 
and daytime activity (r=-.31, p<.05). Longer sleep latency was related to poor physical 
functioning (r=-.27, p<.05). After controlling for age, gender, comorbidity, and NYHA 
Class, self-reported sleep quality and actigraph-recorded wake time and wake bout time 
accounted for 9% to 20% of the variance in the functional performance variables 
(daytime activity level, 6MWT, SF-36 physical functioning) and mental health. There 
were no statistically significant relationships between sleep duration and functional 
performance. The study suggested that sleep quality and continuity are more important 
than quantity. Perceived sleep quality may be most relevant to mental health, whereas 
objective data for sleep continuity may be most relevant to functional performance. The 
authors also suggested the need to examine the effects of sleep problems and insomnia in 
HF patients with non-SRBD (Redeker & Hilkert, 2005).  
In Redeker and Hilkert (2005) study, the finding that sleep duration was not 
associated with functional performance is different from other researchers’ view that 
sleep duration is a risk factor that affects health and daily functioning (Dement, 2005; 
Lauderdale et al., 2006). Sleep duration has effects on improving neurocognitive 
performance and eliminating fatigue during daytime and sleep debt (Dement, 2005). 
More research is needed to clarify this area. 
A cross-sectional study was conducted to test the effects of sleep difficulties and 
daytime sleepiness on the HRQOL of 223 patients with HF (Brostrom et al., 2004). 
Approximately one-third of the HF participants felt they did not get enough sleep, and 
another third reported they slept too much. Difficulties in maintaining and initiating sleep 
were the most often reported sleep complaints. The highest frequency of nocturnal 
awakening was 10. Furthermore, 25% of the participants were awake one to three hours 
 61
per night. Approximately 90% of the 133 men (mean age: 75±9 years) and 80% of the 90 
women (mean age: 78±9 years) experienced nocturia. About 50% felt sleepiness and 
fatigue during daytime and habitually took a nap during the day. Estimated sleep needs 
were greater for males than for females. Additionally, patients suffering difficulties in 
maintaining and initiating sleep, early morning awakenings, and excessive daytime 
sleepiness reported significantly lower HRQOL compared with patients without sleep 
difficulties. The three dimensions of HRQOL most influenced by sleep disturbances were 
general health, vitality, and social functioning (Brostrom et al., 2004). 
Excessive daytime sleepiness, HRQOL, and neurohumoral markers were assessed 
in a study with 84 HF outpatients who underwent an overnight recording of respiratory 
impedance, SaO2, and heart rate using a home-based, wireless monitor (Rao et al., 2006). 
SRBD was identified by using an AHI greater than 15 events/ hour. Results showed that 
the prevalence of SRBD was 24% in all participants, 15% in participants (n=53) with 
LVEF greater than 35%, and 38.7% in those (n=31) with LVEF less than 35%. The 
participants with SRBD had a significantly higher level of B-type natriuretic peptide and 
urinary noradrenaline levels than those without SRBD. However, the B-type natriuretic 
peptide was much higher than the normal range for all participants, indicating that 
patients with HF had a high level of neurohumoral activation. The more severe HF, the 
higher B-type natriuretic peptide. The authors suggested that the increased sympathetic 
nervous activation in HF was related to HF rather than the SRBD. Likewise, in 
comparison with a normal reference group (Walter, Munro, & Brazier, 2001), all domains 
of HRQOL showed significant impairments for all HF participants except for mental 
health. There were no significant differences in HRQOL and excessive daytime 
sleepiness between HF patients with and without SRBD. The study indicated that SRBD 
occurred in patients with mild to moderate HF. Furthermore, a disease-specific instrument 
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may be more appropriate in measuring HRQOL for this particular population.  
Based on the finding that patients with SRBD did not rate themselves as 
excessively sleepy, Rao and colleagues (2006) suggested the need to further clarify 
whether HF patients take napping to prevent sleepiness in the daytime, particularly for 
elderly patients. However, daytime napping was significantly associated with greater 
sleep efficiency, longer sleep duration, and better global sleep quality in the Lai (2005) 
study of 60 Taiwanese community-dwelling older adults. In this study, the majority (64%) 
of participants reported habitual napping 20 to 60 minutes in the daytime, especially after 
lunch. This finding (Lai, 2005), however, was different from the Ohayon et al (1997) 
study that found increased daytime napping was strongly associated with moderate to 
severe daytime sleepiness in the British population. Lai (2005), however, did not measure 
daytime sleepiness in the study. Concerning ethnic differences in physiology and the fact 
that after-lunch napping is prevalent among Taiwanese people, further studies are needed 
to clarify the relationship between sleep quality, daytime napping, and daytime 
sleepiness. 
Summary of the Relationship Between HRQOL and Sleep Disorders 
Sleep disorders have been found to negatively affect HRQOL. Although 
comparison studies did not show consistent findings in HRQOL between HF populations 
with SRBD and non-SRBD, many studies found that functional capacity and 
psychological functioning were the two domains of HRQOL most affected by sleep 
disorders. Likewise, sleep disorders can cause several negative consequences in daily 
activities.  
Summary and Conclusion 
The literature reviewed for this chapter has supported the need for investigating 
HRQOL in Taiwanese people with HF. An overview of HF, its pathophysiology and 
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evidence-based management were described. A review of the research literature about 
HRQOL, sleep disorders, and their relationship were presented. Sleep disorders in HF 
may be an area that has been overlooked by healthcare providers. Sleep disorders can 
create a vicious cycle of HF pathophysiological changes. The need to understand the 
relationship between sleep disorders and HRQOL in Taiwanese people with HF is 
imperative. This understanding will be necessary to design and test future assessments 





 Chapter 3: Methods 
This chapter describes the methods that were employed to conduct this study. It 
includes a discussion about research design, population and sample, procedures for data 
collection, instruments, data analysis methods, and the protection of human subjects. The 
findings from a pilot study to translate one of the key instruments are described. 
  Research Design 
A cross-sectional, descriptive correlational design was used to determine the 
relationships between individual characteristics, HF characteristics, sleep disorders and 
HRQOL. A cross-sectional design is applied to measure an existing phenomenon at a 
given point in time for the purpose of inferring trends over time (Polit & Beck, 2004; 
Trochim, 2001). Cross-sectional data can be used to infer time sequence under two 
conditions: when there is evidence for logical reasoning indicating that one variable 
preceded the other, and when a strong theoretical framework guides the analysis (Polit & 
Beck, 2004). Correlational research also is well-known as ex post facto study (Polit & 
Beck, 2004). The descriptive correlational study design is based on a conceptual 
perspective to describe a phenomenon that naturally occurs in the present and is 
considered to have causes that can be found in the past. Accordingly, this design looks for 
cause-and-effect relationships in the result but without indicating the direction of the 
relationships at the beginning of the study (Brink & Woo, 2001). Also, the study results 
cannot infer a cause-and-effect relationship because of the lack of control over the 
independent variables (Polit & Beck, 2004). Correlational research is strong in reflecting 
real phenomena and useful to provide evidence to resolve practical problems (Polit & 
Beck, 2004).   
The cross-sectional, descriptive correlational design is appropriate for this 
research study based on several factors: (1) HRQOL is an existing phenomenon in people 
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with HF, and it can be changed over the course of HF. Understanding current HRQOL is 
helpful to predict HRQOL in later life; (2) although the concept of HRQOL in HF is not 
fully understood, previous studies have shown that several variables are believed to be 
related, such as sleep disorders and severity of HF; (3) variables in this research including, 
sleep quality, individual characteristics, and HF characteristics, cannot be manipulated in 
reality and ethically; and (4) ex post facto is efficient and effective to collect a large 
sample in a short period of time (Brink & Woo, 2001; Polit & Beck, 2004). 
Population and Sample 
The target population of this study was people with HF living in Taiwan. The 
sample was recruited from a large medical center and its affiliated hospital located in 
southern Taiwan. A non-probability sampling method was employed to recruit 
participants. Taiwanese HF patients who were treated at the outpatient departments for 
HF at either of these two hospitals were invited to participate in this study. Inclusion 
criteria were as follows: (1) a diagnosis of HF with any Class of NYHA I, II, III, or IV 
(The Criteria Committee of the AHA, 1994) as determined by physicians, (2) age 18 or 
older, (3) community-dwelling, (4) able to communicate either by speaking Mandarin or 
Taiwanese or writing Mandarin (the official Chinese language), and (5) willing to 
participate in this study. Data were collected for approximately four months from October 
2006 to January 2007. The first 125 participants who met the criteria were enrolled to 
take part in the formal data collection.  
The sample size was calculated using the software Power Analysis and Sample 
Size (PASS) 2005 based on Cohen’s (1988) statistical power analysis method. The effect 
size was estimated using the Spearman rank correlation coefficients (sr) for the 
associations between sleep variables and HRQOL from the pilot study (n=13) for this 
research. The findings showed that the Kansas City Cardiomyopthy Questionnaire 
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(KCCQ) demonstrated the following associations: Self-Rated Health Status (SRHS) 
(sr=.85, p<.001); Epworth Sleepiness Scale (ESS) (sr=-.60, p<.05); and with the Pittsburg 
Sleep Quality Index (PSQI) (sr=.26, p>.05). In order to obtain a statistically significant 
association between the sleep variables and HRQOL, a small effect size (.26) was used. 
Finally, using correlation analysis with a level of power of 0.8 at a significant alpha level 
of .05, a sample size of 125 was recommended.  
Procedures for Data Collection 
The study included two parts: a pilot study and the formal data collection. Prior to 
the formal data collection, a pilot study was conducted to translate the KCCQ from 
English into Chinese, to assess cultural equivalence of the KCCQ between two languages 
(English and Mandarin), and to test the psychometric properties of all questionnaires. 
Procedures and findings from the pilot study are described at the end of this chapter.  
In the formal data collection phase, 125 participants receiving care at the 
outpatient departments for HF at the two hospitals were recruited and invited to complete 
the questionnaires. All participants were referred by a senior cardiologist though some 
participants were seen by other cardiologists at the same hospitals. Before data collection, 
the physician and his research assistants in the hospitals who helped with recruitment 
were given a flyer that described the purpose and subject inclusion and exclusion criteria. 
The principal investigator discussed participant recruitment and asked for help in 
informing patients about the study. The senior cardiologist who was blind to the KCCQ 
scores reported by the participants rated all participants’ NYHA Classes and noted each 
participant’s functional class in the medical record. After receiving potential participants’ 
names, types of HF, and NYHA Classes from the physician or research assistants, the 
principal investigator contacted the potential participants individually. A cover letter with 
the principal investigator’s contact information was given to each potential participant. 
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Meanwhile, an oral explanation about the study was done for all participants who 
verbally agreed to participate in the study. Only two potential participants refused to 
enroll the study during the recruitment. The principal investigator individually 
interviewed 120 participants in a private location in the clinic sites, and 3 at their homes. 
Only two participants could not complete the questionnaires while in the hospital, and 
were given the questionnaires and a stamped pre-addressed envelope and asked to 
complete and return them within 10 days. The principal investigator was available to 
assist them as needed and a cell phone contact number was provided. The completion 
time for the instruments ranged from 20-60 minutes. Data including concomitant health 
problems, prescribed HF medications, types of HF, NYHA Classes, and LVEF were 
collected from the hospital medical records after receiving participants’ permissions.  
Instrumentation 
Seven instruments were used for this research study after authors’ permissions 
were obtained. They included: (1) a demographic questionnaire comprising individual 
characteristics and HF characteristics; (2) the Charlson Comorbidity Index (CCI) and a 
chart-review list of 10 major concomitant health problems for measuring comorbidities; 
(3) the modified Self-Rated Health Subscale (Lawton et al., 1982) for measuring 
perceived health; (4) the Kansas City Cardiomyopathy Questionnaire (KCCQ) (Green et 
al., 2000) for measuring HRQOL; and (5) two questionnaires about sleep disturbance: the 
Pittsburgh Sleep Quality Index (PSQI) (Buysse et al., 1989) and Epworth Sleepiness 
Scale (ESS) (Johns, 1991). They are described in the following section. A summary of the 
study variables and instruments is shown in Table 1. 
Demographic Questionnaire 
Individual characteristics. The demographic questionnaire was developed by the 
principal investigator. Demographic data, including age, gender, education, marital status, 
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living arrangement, financial status, employment status, and type of language, and 
health-related characteristics, including body mass index and comorbidity, were obtained 
from participants.  
 
Table 1   
Study Variables and Instruments 













Body Mass Index Demographic  1 
Self-report CCI  16 Comorbidity 
Chart-review list  10 
Health-related 
Perceived Health SHRS Entire subscale 4a 
Prescribed HF medications 
Time since diagnosis of HF 








Subjective sleep quality 1 
Sleep duration 1*
Sleep latency 2 
Habitual sleep efficiency 3*
Sleep disturbances 9 
Use of sleeping medication 1 
Daily dysfunction 2 
Nocturnal Sleep Quality PSQI 
Snoring 6 
Total 24*
Daytime Sleepiness ESS Entire index 8 
Sleep 
Disorders 
Daytime nap Additional items  3 
Physical Symptoms  Symptom frequency, 
severity, and stability 
4+3+
1= 8 
Functional Status Physical limitations 6 
Psychological Functioning Quality of life 3 






Total items for this study 102 
*One item overlaps (habitual sleep efficiency subsumes sleep duration).   
# Not included in the conceptual framework. 
a Excluded 2 items from the data analysis (using the 2-item modified SHRS for the inferential statistics) 
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Charlson Comorbidity Index. The Charlson Comorbidity Index (CCI) was 
originally developed by Charlson, Pompei, Ales, and MacKenzie (1987) as an approach 
of quantifying preexisting comorbidities using medical record data. The CCI lists 19 
comorbidities and is calculated using assigned weights for each condition (zero, 1, 3, or 
6). The total weighted score reflects both the number and the seriousness of the 
comorbidities. The CCI has been validated as a predictor of 10-year mortality in a cohort 
study of 685 inpatients with breast cancer (Charlson et al., 1987). It also has been widely 
adapted for use as risk adjustment and predictor of mortality, length of stay, and resource 
utilization in administrative datasets, such as, patients with ischemic heart disease 
(D'Hoore, Bouckaert, & Tilquin, 1996) and with coronary artery bypass graft surgery 
(Wen et al., 2006).  
A self-reported version of the CCI was developed by Katz et al (1996). The 
16-item self-reported CCI has been validated using a sample of 170 inpatients age greater 
than 55 years. Respondents were asked to evaluate their comorbid conditions on a 2 
-point scale (yes/no). The self-reported CCI score was significantly higher than the 
medical record-based CCI. Intra-class coefficient and Spearman coefficient for test-retest 
reliability at an interval of 7 to 8 months for the self-reported CCI was 0.91 and .73, 
respectively (n=26). Spearman correlation between the self-report method and the 
medical record-based Charlson index (Charlson et al., 1987) was 0.63. The self-reported 
CCI has been used in American people with HF (Rockwell & Riegel, 2001). However, 
the study did not report reliability and validity of the CCI. It was translated by the 
principal investigator for this study.  
Cronbach’s alpha for this sample was .28 that was calculated using those 
conditions reported by the participants. The low internal consistency reliability might 
result from several comorbid conditions that were reported by few participants only, such 
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as, cancer (n=1) and hemodialysis (n=3). Likewise, several conditions were not reported 
by any participants and thus, were removed from the calculation of internal consistency 
reliability.  
In addition to the CCI, a chart-review list of 10 concomitant health problems 
adapted from the American College of Cardiology/American Heart Association Task 
Force on Clinical Data Standards (Radford et al., 2005) also was used to assess 
comorbidity. The list contained more specific cardiovascular diseases that could 
complement the CCI. The data were collected from the hospital medical records by the 
principal investigator.  
Heart failure characteristics. HF characteristics included prescribed HF 
medications, type of HF, time since the HF diagnosis, NYHA Class, and LVEF. Time 
since the diagnosis of HF was obtained from the participants; types of HF, NYHA Class, 
and LVEF were collected from participants’ medical records. Because 29 (23.2%) 
participants with HF who enrolled in this study did not have LVEF data in their medical 
records, LVEF was excluded from the analysis of the data. 
Modified Self-Rated Health Subscale. The modified 2-item Self-Rated Health 
Subscale (SRHS) was used to measure perceived health. The SRHS was a subscale of the 
Philadelphia Geriatric Center Multilevel Assessment Instrument (MAI) (Lawton et al., 
1982). The MAI was developed to systematically evaluate behavioral competence in the 
domains of health, activities of daily living, cognition, time use, and social interaction 
and in the dimensions of psychological wellbeing and perceived environmental quality 
among older adults. The SRHS was used to measure the domain of physical health status. 
Respondents were asked to evaluate their own health on a 3- to 4-point scale based on the 
designs of the questions. The total score for these 4 items ranges from 4 to 13 with higher 
score indicating better health perception. Cronbach’s alpha for internal consistency 
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reliability was .76 in a sample of 590 Western older adults who were independent 
community residents, public housing tenants, in-home services cases, or persons awaiting 
admission to an institution. The reproducibility reliability for 22 elderly in an interval of 3 
weeks was .92 (Lawton et al., 1982).  
Validity was assessed using several approaches (Lawton et al., 1982). Multiple 
correlation coefficient (R) and summary rating correlation between the SRHS and the 
physical health domain for internal validity in the 590 participants was .47 and .67, 
respectively. Correlation between independent (community residents plus public housing 
tenants) and dependent (in-home plus waiting list) groups for discriminant validity 
was .32. Finally, correlation coefficients between the SRHS and the physical health 
domain for the content validity rated by the 47 clinicians and 180 housing administrators 
were .63 and .52, respectively (Lawton et al., 1982).  
Related research studies reported moderate to high internal consistency reliability 
of the SHRS. Lusk, Ronis, and Kerr (1995) calculated the reliability of the SHRS using 
the theta coefficient, which is a weighted coefficient of Cronbach’s alpha and is 
appropriate for scales with few items or when the scale is anticipated to be 
multidimensional (Armor, 1973-4). The theta was .76 in 504 blue-collar workers. In 
another study, Kerr, Lusk, & Ronis (2002) reported a moderate reliability with a 
Cronbach’s alpha of .56 and a theta of .59 in 119 Mexican American workers. 
Literature on the use of the SRHS in people with HF has not been found. However, 
the SRHS has been translated into Chinese-Mandarin by Cheng (2006) for measuring 
postpartum perceived health status among Chinese immigrant mothers. The Cronbach’s 
alpha of the SRHS in a pilot study with 30 mothers was .66 and the two-week test-retest 
correlation was .75. The SRHS was negatively correlated with the number of postpartum 
health conditions and number of days of not feeling mentally well of mothers in the 
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postpartum period (Pearson r=-.36 and -.45, respectively). Overall, the reliability and 
validity were satisfactory in Cheng’s study. Based on the fact that perceived health in 
people with HF can change dramatically during one year, the time period of “3 years ago” 
in the item “Is your health now (1) better, (2) about the same, or (3) not as good as it was 
3 years ago?” was modified to “one year ago” in this present study. Permission for the 
modification has been received from the copyright holder of the SRHS, Ms. Rachel R. 
Rensnick.  
Cronbach’s alpha for the 4-item SRHS in this study with 125 HF participants 
was .44. Correlated item-total correlation for each item was: .40 (perceived overall 
health), .29 (health compared to one year ago), .15 (health problems limiting ability to do 
things they wanted), and .20 (compared with most people’s health at the same age). Due 
to the low Chronbach’s alpha of the SHRS, the two items with low corrected item-total 
correlation were excluded from the inferential analyses of the data. Cronbach’s alpha for 
this modified 2-item SRHS was .55, and corrected item-total correlation was .39 for each.  
Kansas City Cardiomyopathy Questionnaire  
The KCCQ was developed by Spertus and colleagues (Green et al., 2000). Dr. 
Spertus has served as a KCCQ consultant on the present study. The KCCQ is a 23-item 
self-reporting questionnaire designed to quantify several HF-specific domains of HRQOL: 
physical limitations (6 items); symptoms, including frequency (4 items) and severity (3 
items); symptom stability (1 item); self-efficacy (2 items); social limitation (4 items); and 
quality of life (QOL, 3 items) (Green et al., 2000). Two summary scores have been 
developed to enhance the interpretability of the KCCQ. A clinical summary score is 
generated by combining scores for physical limitations and symptom domains. An overall 
summary score is computed by totaling the scores of the clinical summary score, QOL 
and social limitation domains (Green et al., 2000). Two domains, symptom stability and 
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self-efficacy, are not included in the computation of KCCQ overall score because they are 
not direct measures of HRQOL (Spertus, 2003). Patients are asked to answer questions on 
how HF has affected their lives over the previous two weeks. Items are scored using an 
ordinal response scale ranging from 1 to 7. To facilitate comparisons among domains and 
with other HRQOL questionnaires, such as the Medical Outcome Study Short Form-36 
(MOS SF-36) (Ware & Sherbourne, 1992), the KCCQ is scored according to the RAND 
(Research and Development) criteria, with each domain being transformed to a 0–100 
scale. A higher score indicates better health status. The average completion time for the 
KCCQ is approximately 4 to 6 minutes (Green et al., 2000). 
In the psychometric testing study with 70 patients with stable HF, Cronbach’s 
alpha of internal consistency for the KCCQ was physical limitation 0.90, symptoms 0.88, 
self-efficacy 0.62, social limitation 0.86, quality of life 0.78, clinical summary 0.93, and 
overall summary 0.95 (Green et al., 2000). Paired t-tests of reproducibility in 39 patients 
with HF remained stable over three months of observations. Except for symptom stability 
and self-efficacy domains, criterion-related validity was supported using the SF-36, the 
Minnesota Living with Heart Failure questionnaire (MLHFQ) (Rector et al., 1987), 
six-minute walk test (6MWT) (Guyatt, 1987), and NYHA Classifications for remaining 
domains of the KCCQ in 129 patients (sr =-0.45 to 0.84, p<0.001 for all). 
For discriminant validity, the end point of survival or hospitalization was used to 
test the predictive ability of the KCCQ using independent t-test. The baseline KCCQ 
clinical summary (35.1 vs. 55.3) and overall summary scores (34.1 vs. 52.1) were 
significantly higher among participants with event-free survival than participants who 
died or who were hospitalized (Green et al., 2000). In addition, stable HF patients had 
significantly higher mean scores in domains of symptom stability and self-efficacy 
compared to patients who were hospitalized (Green et al., 2000). ANOVA tests showed 
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that mean scores on subscales of symptoms, clinical summary, and overall summary were 
significantly different among patients with different NYHA Classes (Green et al., 2000). 
Furthermore, responsiveness to change was evaluated using paired t-tests and 
responsiveness statistic (Deyo, Diehr, & Patrick, 1991). All domains of the KCCQ 
demonstrated important positive clinical changes ranging from 15.4 to 40.4 points (all 
p<.001, except for social limitation, with p=.004). Responsiveness statistic ranged from 
0.62 to 3.19 (Green et al., 2000). 
The KCCQ has been translated into several languages and its psychometric 
properties have been tested for patients with either HF or myocardial infarction (Miani et 
al., 2003; Pettersen, Reikvam, Rollag, & Stavem, 2005; Soto et al., 2004), LVEF greater 
and less than 40% (Clark et al., 2003; Pettersen et al., 2005), and different ages, gender, 
diseases, and countries (Masoudi et al., 2004; Miani et al., 2003; Pettersen et al., 2005). 
Furthermore, studies supported the view that the KCCQ is an indicator of disease severity 
and predictive of deaths, hospitalizations, and depressive symptoms (Miani et al., 2003; 
Rumsfeld et al., 2003; Soto et al., 2004; Spertus, Green, Porter, & Bresnahan, 2000).  
Two translated versions of KCCQ supported similar evidence of validity of the 
English version of KCCQ (Miani et al., 2003; Pettersen et al., 2005). All domains of the 
Italian version of the KCCQ were significantly correlated with the MLHFQ (sr= .20-.60) 
except symptom stability and the MLHFQ emotional component (sr=.16) in 50 Italian 
patients with HF (Miani et al., 2003). Except for the domains of physical limitation, 
symptom stability and self-efficacy, the remaining domains of KCCQ were significantly 
different between NYHA Class I-II and III. Participants with NYHA Class I-II reported 
higher KCCQ scores than those with Class III. However, no significant difference was 
found between the levels of LVEF higher or lower than 30% (Miani et al., 2003). 
Furthermore, except for the domains of symptom stability and self-efficacy, the 
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remaining domains of the Norwegian version of KCCQ discriminated between patients 
with and without medication for HF, and among three levels of left ventricular ejection 
fraction (LVEF, lower than 40%, 40-50%, and greater than 50%) in 408 patients with 
previous MI (Pettersen et al., 2005). Furthermore, Cronbach’s alphas were from 0.66 
(self-efficacy) to 0.95 (overall summary score) in a sample of 408 patients with previous 
myocardial infarction (MI) (Pettersen et al., 2005). 
In a cross-sectional study, the clinical summary and overall summary scores of 
KCCQ demonstrated moderate correlations with the Chronic Heart Failure Questionnaire 
(Guyatt et al., 1989) three domains (dyspnea, fatigue, and emotional function, r=0.52 to 
0.68), and low with NYHA Classification (r=-0.20 to -0.33), comorbidity (r=-0.16), and a 
single item of perceived overall health (r=0.28 to 0.37) among 228 HF patients with a 
mean EF of 50% (Clark et al., 2003). However, clinical summary and overall summary 
scores were not correlated with LVEF.  
The KCCQ was translated into Mandarin for this study. Knowledge about cultural 
equivalence between the original and translated versions was used to guide the translation 
(Flaherty et al., 1988; Herdman, Fox-Rushby, & Badia, 1998). The procedures for 
translating and validating the KCCQ are described in the pilot study section. Although the 
domain of self-efficacy was not included in the conceptual framework of this proposed 
study, it was used to help interpret the KCCQ domains and overall scores (Spertus, 2003). 
Cronbach’s alpha for each domain was: physical limitations .89 (correlated item-total 
correlation .60 to .81); symptoms .75 (correlated item-total correlation .34 to .66); 
self-efficacy .50 (correlated item-total correlation .34); quality of life .67 (correlated 
item-total correlation .48 to .51); social limitation .75 (correlated item-total 
correlation .16 [intimate relationship] to .72 [go out for visiting friends]); clinical 
summary score .87 (correlated item-total correlation .35 to .77); and overall summary 
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score .90 (correlated item-total correlation .13 [intimate relationship] to .77 [doing 
yardwork, housework, or carrying groceries). 
Pittsburgh Sleep Quality Index 
The Pittsburgh Sleep Quality Index (PSQI) was developed by Buysse and 
colleagues (1989). The PSQI is comprised 19 self-report items (including one question 
asking participants whether they have a bed partner or roommate) and five questions 
rated by the participants’ bed partner or roommate. These six questions are not calculated 
in the scoring of the PSQI and used for clinical information only. The remaining 18 items 
are used to assess sleep quality and disturbances and grouped into seven components: 
subjective sleep quality (1item), sleep latency (2 items), sleep duration (1 item), habitual 
sleep efficiency (3 items), sleep disturbances (9 items), use of sleeping medication (1 
item), and daytime dysfunction (2 items) over 1-month period. Subjective sleep quality 
refers to how people rate their overall sleep quality. Sleep latency is defined as the time 
the individual usually takes to fall asleep. Sleep duration refers to the length of an actual 
night’s sleep. Sleep efficiency indicates the ratio of sleep duration divided by time in bed. 
Sleep disturbances refers to difficulties in initiating and maintaining sleep. Items ask 
about causes including nocturia, bad dreams, pain, having troubles in breathing, cough or 
snore loud, and feelings of extreme cold or warmth. Use of sleep medication refers to 
how often the people have taken medicine to help sleep. Daytime dysfunction is defined 
as having trouble staying awake while driving, eating or engaging in social activity. 
The PSQI uses a standardized approach to score the patient’s sleep quality. Each 
component of the PSQI is weighted equally with a possible scale range of 0-3. The seven 
component scores are then summed to produce a global score ranging from zero to 21. A 
higher score indicates a poor sleep quality. The index takes respondents five to 10 
minutes to complete. Reliability and validity of the PSQI was supported during the 
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testing phase in 148 adults, in four subgroups: healthy controls (n=52), depressives 
(n=34), disorder of initiating and maintaining sleep (n=45), and disorders of excessive 
somnolence (n=17). Cronbach’s alpha for internal consistency was .83 and stability 
reliability was .85 (Buysse et al., 1989). Discriminant validity was evidenced with 
significant differences between the four groups after controlling age and gender. 
Concurrent validity was partially supported by the polysomnographic findings (Buysse et 
al., 1989). A global PSQI score greater than 5 yielded a sensitivity of 89.6% and a 
specificity of 86.5% as a cutoff point for identifying poor sleepers. 
Several research studies using the PSQI to measure sleep quality in Western 
patients with HF did not report psychometric properties of the PSQI (Redeker & Hilkert, 
2005; Sinha et al., 2004; Skobel et al., 2005). The PSQI has been used in varied groups, 
such as postpartum women, menopausal women, patients with end-stage renal failure, 
older adults, and people with insomnia (Huang, Carter, & Guo, 2004; Lai, 2005; Lu et al., 
2005; Tsai et al., 2005; Tsai, Chi, Lee, & Chou, 2004; Tsay, Rong, & Lin, 2003), although 
the PSQI has not been used in Taiwanese patients with HF. 
The psychometric properties of the Chinese version of the PSQI (CPSQI ) were 
evaluated in 208 Taiwanese adults (Tsai et al., 2005). Among them, 51 adults were 
insomniacs identified by using the Diagnosis and Statistical Manual of Mental Disorders 
(American Psychiatric Association, 1994). Cronbach’s alpha for internal consistency 
reliability was 0.83 for all 208 adults and 0.72 for 51 primary insomniacs. Pearson 
correlation coefficient for the test-retest reliability was 0.85 for all participants and 0.77 
for 51 primary insomniacs at an interval of two to three weeks. Discriminant validity of 
the CPSQI was evidenced using two-sample method. The CPSQI score was significantly 
different between the insomnia (n=51) and control groups (n=157). In primary 
insomniacs, the CPSQI global score had a significant low correlation with the Sleep 
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Quality Visual Analogue Scale (r=-.30), which was used to measure an individual’s 
subjective feeling of overall sleep quality with a range of 0-10 (Tsai et al., 2005). 
Additionally, the CPSQI was significantly correlated with sleep onset latency (r=.30) and 
sleep efficiency (r=-.37) derived from the 7-day Daily Sleep Log. However, one domain 
of the CPSQI, daytime sleep dysfunction, was not significantly related to the Stanford 
Sleepiness Scale (Hoddes, Zarcone, Smythe, Phillips, & Dement, 1973) and the Chinese 
Epworth Sleepiness Scale (CESS) (Chen et al., 2002). Although the CPSQI demonstrated 
a 98% sensitivity in distinguishing poor from good sleepers using a cutoff point of 5, the 
specificity was only 55% which indicated the CPSQI may not be an effective screening 
tool for discriminating people with primary insomnia from healthy controls (Tsai et al., 
2005). 
Several studies reported acceptable internal consistency reliability for the CPSQI. 
In the Lai (2005) study, the overall Cronbach’s was 0.74 and the split half reliability was 
0.79 for the CPSQI in 60 community-dwelling, elderly people with insomnia. Likewise, 
the alpha for 98 patients with end-stage renal disease and sleep disturbance was .82 (Tsay 
et al., 2003). In the Hsu and Lin (2005) study, Cronbach’s alpha was .78 in a pilot test, 
and .74 in the final study of 197 menopausal women. However, two studies reported 
moderate level of alphas. Cronbach’s alpha was .63 in a study with 80 institutional 
elderly people (Tsai et al., 2004). Likewise, in Huang and colleagues (2004) study, the 
Cronbach’s alpha for 163 first time postpartum mothers was .53. In addition, the authors 
found that the subjects had large variances in component means, which might be an effect 
of the population variance on reliability (Huang et al., 2004). Therefore, they suggested 
that using components of the CPSQI to interpret sleep quality for healthy people may be 
more applicable than using the global score only.  
In the present study, the alphas for both the global and components of the CPSQI 
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are reported. Cronbach’s alpha for domains of PSQI was: sleep latency .78 (correlated 
item-total correlation .64); sleep disturbances .51 (correlated item-total correlation 
from .12 to .30); daytime dysfunction .79 (correlated item-total correlation .67); and 
global PSQI .70 (correlated item-total correlation from .08 [coughed or snored loudly] 
to .61 [subjective sleep quality]).  
Epworth Sleepiness Scale 
The Epworth Sleepiness Scale (ESS) was developed by Murray Johns in 1991 to 
evaluate the general level of daytime sleepiness in adults (Johns, 1991). The 
self-reporting ESS consists of 8 items that ask respondents to rate the chances that they 
would fall asleep or doze off in 8 specific life situations, such as, sitting and reading, 
watching TV, or sitting stopped in traffic. Each of the 8 items is rated in a 4-point Likert 
scale from 0 (would be never doze) to 3 (high chance of dozing). The total score ranges 
from 0 to 24 with a lower score indicating low sleep propensity. An ESS score less than 8 
reflect that the participants are physically not very influenced by their daytime sleepiness. 
However, an ESS greater than 10 is defined as excess daytime sleepiness, and 16 and 
above indicates a high level of daytime sleepiness (Johns, 1991).  
Validity for the ESS has been assessed in 150 adults with and 30 without sleep 
disorders (Johns, 1991). The finding showed that the ESS scores significantly 
distinguished adults with sleep disorders from those healthy controls. Furthermore, the 
ESS was significantly correlated with the multiple sleep latency test (MSLT) and 
overnight polysomnography in the total of 180 respondents (Johns, 1991). Cronbach’s 
alpha for internal consistency reliability was .88 in 150 adults with various sleep 
disorders and .73 in 104 healthy medical students (Johns, 1992). Pearson correlation 
coefficient for reproducibility in a 5-month interval for 87 healthy students was .82. 
Factor analysis for construct validity revealed that the ESS had only one factor in both 
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patient and healthy student groups (Johns, 1992). Johns (1991) concluded that an 
individual can provide a meaningful self-report daytime sleepiness from their own 
perspective. 
The ESS has been used in Western people with HF. Brostrom, Stromberg, 
Dahlstrom, & Fridlund (2004) used a cutoff point of 10 to identify HF patients with 
excessive daytime sleepiness. The Cronbach’s alpha was .71 in a study of 223 
participants with HF. However, other HF studies did not provide information about 
psychometrics of the ESS (Brostrom et al., 2005; Rao et al., 2006). 
The ESS has been translated into Chinese-Mandarin (CESS) and used to evaluate 
daytime sleepiness among people in Taiwan (Chen et al., 2002). To ensure the success of 
translation, the authors invited 31 bilingual patients with sleep-disordered breathing (SDB) 
to assess the discrepancy between the ESS and CESS. Participants answered the ESS first 
and then the CESS at 1-2 weeks intervals. The result showed that no significant 
difference was found between two versions. Next, the CESS was validated using 359 
people with SDB (Chen et al., 2002). Cronbach’s alpha for internal consistency reliability 
in this sample was .81. Test-retest reliability using Spearman correlation coefficient 
was .74 for 30 of the 359 patients at an interval of 2-4 weeks. Validity was evidenced 
using a two-sample method and the relationship with PSG. The CESS scores for all 359 
participants were significantly higher compared to 31 seemingly healthy controls who 
were matched for gender, age, and body mass index. The CESS presented a significant 
low correlation (rs=.22, n=251) with the Respiratory Disturbance Index (RDI), which was 
a parameter of the PSG and a measure of the severity of SDB. In addition, the CESS was 
sensitive to detect clinically important changes at 3 months after radio-frequency palate 
surgery in 94 people who had initial control of their symptoms (Chen et al., 2002).  
Overall, not many research studies reported the psychometric properties of the 
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CESS. Most researchers merely cited Chen and colleagues (2002) reliability results for 
their studies (Li, 2004; Li, Chen, Shu, & Wang, 2004; Li, Wang, Hsu, Chen, & Fang, 
2005). Huang and colleagues (2004) reported a Cronbach’s alpha of .73 for the study with 
163 first time postpartum mothers. In another study, the alpha was .86 for 80 
institutionalized elderly people (Tsai et al., 2004). In addition, the CESS has been used as 
a screening tool for identifying people with excessive daytime sleepiness. Lai and Good 
(2006) used the CESS to select participants for a music intervention. Older 
community-dwelling people who scored greater than 16 on the ESS were identified as 
with severe daytime sleepiness and excluded from their study because of their severe 
daytime sleepiness. For the ESS, Cronbach’s alpha for the present study was .74. 
Correlated item-total correlation ranged from .29 to .61. 
The summary of internal consistency reliability for the instruments in this study is 
shown in Table 2.  
Table 2   
Summary of Internal Consistency Reliability for Instruments (n=125) 
Instruments/ Subscales Items Cronbach’s α 
Modified Self-Rated Health Subscale 2 .55 
Charlson Comorbidity Index 19 .28 
Kansas City Cardiomyopathy Questionnaire 
Physical limitation 6 .89 
Symptom stability 1 NA 
Symptom total 7 .75 
Self-efficacy 2 .50 
Quality of life 3 .67 
Social limitation 4 .75 
Overall summary score 20 .90 
Chinese Pittsburgh Sleep Quality Index 18 .70 
Subjective sleep quality 1 NA 
Sleep duration 1 NA 
Sleep latency 2 .78 
Habitual sleep efficiency 3* NA 
Sleep disturbances 9 .51 
Use of sleeping medication 1 NA 
Daytime dysfunction 2 .79 




Data collected for this study were analyzed using the Statistical Package for the 
Social Science (SPSS for Windows, Release 14.0). Before data analysis, data were 
checked for entry errors, missing values, distributions, normality, homogeneity of 
variance, homoscedasticity, and linearity for each statistic procedure. The normality of 
main variables was examined using the kurtosis, skewness, and Kolmogorov-Smirnov 
analyses (Munro, 2001; Norusis, 2004). The results showed that the normality of the 
variables was acceptable, except for the variable of time since diagnosed with HF 
(kurtosis statistic greater than 2.0). Data analysis approaches included (1) descriptive 
statistics (means, standard deviations, frequency, percentage, range, and mode) for 
individual characteristics [demographics (age, gender, education, marital status, living 
arrangement, financial status, employed status, and type of language) and health-related 
characteristics (body mass index, comorbidity, and perceived health)], HF characteristics 
(prescribed HF medications, length of time since the diagnosis of HF, type of HF, and 
NYHA Classification), and major variables; (2) Cronbach’s alphas for internal 
consistency reliability of the KCCQ, CPSQI, CESS, modified SRHS, and CCI; (3) 
independent t-tests and one-way ANOVA methods for comparing differences between 
groups, such as gender and NYHA Classification; (4) Bivariate correlations for testing 
relationships between variables; and (5) hierarchical multiple regression analyses for 
identifying significant predictors of HRQOL. The level of significance was set at 0.05 for 
all statistical analyses. 
Research questions of this study were analyzed as follows. 
Research Question 1. “What sleep disorders are reported by Taiwanese people 
living with HF?” To answer this question, descriptive statistics (means, standard 
deviations, and ranges) were used to describe the seven components of nocturnal sleep 
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quality (subjective sleep quality, sleep duration, sleep latency, habitual sleep efficiency, 
sleep disturbances, use of sleeping medication, and daily dysfunction), daytime sleepiness, 
and daytime napping. Frequencies and proportions were employed to describe the 
prevalence of poor sleep quality (PSQI score>5), excessive daytime sleepiness (ESS 
score>10), and daytime napping.  
Research Question 2. What is the perception of HRQOL and health among 
Taiwanese people living with HF? Descriptive statistics including means, standard 
deviations, and ranges were used to describe perceived health and the four domains of 
HRQOL, including physical symptoms, functional status, psychological status, and social 
functioning.  
Research Question 3. What are the relationships between HRQOL, sleep disorders, 
HF characteristics (prescribed HF medications, duration of HF diagnosis, types of HF, 
New York Heart Association Functional Classification, and left ventricular ejection 
fraction), and individual characteristics (age, gender, education, living arrangement, 
marital status, financial status, employment status, type of language, body mass index, 
comorbidity, and perceived health)? Bivariate correlations or one-way ANOVAs were 
used to test the relationships between these variables.  
Research Question 4. What are the predictors of HRQOL among Taiwanese 
people with HF? Multiple regression analyses were used to determine how much variance 
in the HRQOL could be explained by these independent variables. Before employing the 
hierarchical multiple regression analysis, the data were examined to ensure that they meet 
the assumptions of multiple regression analysis. The assumptions included: (1) the 
dependent and independent variables should be distributed normally. The normality of the 
Studentized residual (takes into account the differences in variability from point to point) 
was examined using analyses of a stem-and-leaf plot and a histogram in addition to a Q-Q 
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plot; (2) all of the observations are independent, meaning that one observation is not 
correlated with other observation. Independence was assessed using the Durbin-Watson 
test with SPSS software (normal range from 1.5 to 2.5) (Norusis, 2004); (3) the 
relationship between the dependent and the independent variables is linear, as well as 
each group of the independent variables. Linearity assumption was evaluated by plotting 
Studentized residuals against the KCCQ overall summary score; and (4) for every 
independent variable, the distribution of the dependent variable has the same variance, 
which in turn is homoscedasticity. Homoscedasticity was examined by plotting the 
Studentized residuals against the predicted values. Moreover, multicollinearity were 
assessed for all variables that were entered into the regression model by using correlation 
coefficients (less than .80), tolerances (equal or greater than .2), and variance inflation 
factors (VIF, less than 5) (Hutcheson & Sofroniou, 1999). 
Hierarchical regression, one of strategies of multiple regression, is useful to test 
the effect of key independent variables after controlling extraneous variables that cannot 
be changed, such as age and gender, and those that are thought of as causally or 
temporally prior to others. During analysis, the independent variables are entered into the 
equation in steps. Researchers determine the numbers of steps and variables included in 
each step, and control the order of variable entry based on logical or theoretical rationale. 
The variables can be entered one at a time or in subsets. When variables are added as a 
block, the analysis is a simultaneous regression for those variables at that step (Huck, 
2004; Munro, 2001; Polit & Beck, 2004).  
For this study, Pearson correlation was initially performed to identify variables 
that had significant associations with the dependent variable, KCCQ overall summary 
score. Two variables, type of language and CCI-severity, were eliminated from the 
hierarchal multiple regression analysis because of the concern for multicollinearity. 
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Language was moderately correlated with education (r=.68, p<.001), and CCI-severity 
was highly associated with CCI-number (r=.95, p<.001). A total of 3 covariates and 11 
predictor variables were entered to the regression model. Based on the insights from the 
literature review and the theoretical aspects, individual characteristics (age, education, 
and financial status) were first entered into the model, then NYHA Classification, 
CCI-number, chart-review non-cardiovascular concomitant problems, and modified 
SRHS, and finally sleep variables (daytime sleepiness and all components of nocturnal 
sleep quality except for the use of sleeping medication).  
A summary of statistical methods is shown in Table 3. 
 
Table 3   




 Individual and HF characteristics Descriptive statistics 
Question 1 To describe the self reports of nocturnal sleep 
quality, daytime sleepiness, and daytime napping 
Descriptive statistics 
 
Question 2 To describe the individuals’ subjective evaluation 
of HRQOL and health 
Descriptive statistics 
 
Question 3 To answer the relationship between variables Bivariate correlations and 
One-way ANOVAs 
Question 4 To investigate the predictors of HRQOL Hierarchical multiple 
regressions 
 Psychometrics: Internal consistency            Cronbach’s alphas 
Protection of Human Subjects 
Approval to conduct this study was obtained from the School of Nursing 
Departmental Review Committee and the Institutional Review Board (IRB) of the 
University of Texas at Austin. In addition, approval from the IRB of the facilities in 
Taiwan was obtained. A cover letter rather than a signed consent form was used to obtain 
informed consent. This decision was based on the pilot study which showed that 
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participants wanted to give verbal consent but were unable to or reluctant to sign a 
written consent form. 
Respect for the participants and their confidentiality guided the study. The 
principal investigator has been trained in procedures to respect the rights of human 
subjects and to protect privacy and confidentiality of the participants. Participants who 
agreed to take part in this study received the cover letter that described the purpose of the 
study, procedures for data collection, potential benefits and risks, time for completing the 
questionnaires, and ways to contact the researcher. All information provided by 
participants was treated with confidentiality. Names and identifying data from 
participants, whether on the transcripts from the focus group discussions or on the 
questionnaires, were removed and the data were coded numerically. Findings are 
presented as group data only to eliminate the possibility that information can be linked to 
individual participants. Questionnaires and the codebook were kept in a locked file 
cabinet in a safe place. The audiotapes were played by the investigator only for research 
purposes, and they were erased after they were transcribed. Any identifying information 
will be destroyed after the study is published. 
No discomfort or physical or emotional harm was anticipated for the participants 
in this study. They were informed that they were free to stop or postpone the completion 
of questionnaires if they experience temporary discomfort, such as dyspnea or fatigue. To 
minimize the participants’ potential psychological stress, the researcher informed them 
that not participating in the study would not affect their health care in any way. There 
were no direct benefits to the participants, however, they may gain some increased 
awareness about the effects of HF and sleep disturbances on HRQOL.  
Pilot Study 
A pilot study was conducted prior to the main dissertation study and findings are 
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reported in this section. The purposes of this pilot study were to: (1) translate the Kansas 
City Cardiomyopathy Questionnaire (KCCQ) from English to Chinese-Mandarin and to 
test its usefulness and applicability in measuring HRQOL in Taiwanese patients with 
heart failure (HF); (2) test the psychometric properties of the KCCQ and three additional 
questionnaires—the Chinese versions of the Self-Rated Health Sub-index (SRHS), 
Pittsburgh Sleep Quality Index (PSQI), and Epworth Sleepiness Scale (ESS) in this 
population; and (3) examine for potential flaws in the procedures for data collection in 
preparation for the larger study. 
Sample in the Pilot Study 
A convenience sample was used. Participants were referred by a physician from 
the outpatient department of a large medical center in southern Taiwan. Participants were 
recruited for this pilot study according to the following criteria: 1) a diagnosis of HF, 2) 
age 18 or older, and 3) proven base-line competency in speaking or writing Mandarin or 
speaking Taiwanese. Participants with any previous diagnosis of mental disorders were 
excluded. All participants received both an oral and written explanation of the study 
purpose and procedures by the principal investigator. They were informed that their 
current treatments would not be interrupted regardless of whether they participated or not. 
Six participants completed the cognitive interview, four did the focus group discussion, 
and 13 were in the psychometric testing part (see Table 4). However, most all participants 
refused to sign an informed consent after verbally agreeing to take part in this study. 
Some expressed that they were illiterate. In those cases, a copy of the informed consent 
agreement with the principal investigator’s signature was given to them. Only five 
participants in the baseline measure and two in the re-test accepted the reimbursement of 
$NTD300 (approximately USD 9.5). 
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Table 4   
Summary of Procedures and Participants for the Pilot Study 




Assess the understandability, readability, and clarity of the 









Assess the psychometrics of the KCCQ, SRHS, PSQI, and ESS, 
and two additional questionnaires: Demographics and the SF-36 
13 
Re-test For retest: the KCCQ, SRHS, PSQI, and ESS 8 
Procedures and Findings of the Pilot Study 
The pilot study was conducted in two phases. Phase one was a measurement study 
used to translate the KCCQ and test for cultural equivalence between the KCCQ, which 
originated in America, and the responses of Taiwanese people with HF. Procedures for 
validating the KCCQ included: (a) group discussions for conceptual and item 
equivalences by a team of experts; (b) translation and back-translation of the KCCQ for 
semantic equivalence; and (c) interviews, cognitive and focus groups for item and 
semantic equivalences. Phase two involved psychometric testing for operational and 
measurement equivalences of the KCCQ and the additional three questionnaires. A re-test 
of all questionnaires was performed with eight participants two weeks later. The 
measurement study was conducted between July 2005 and March 2006, and the 
psychometric testing was performed in April 2006. 
Phase One 
Group discussions by a team of experts. Two experts in cardiology, familiar with 
both American and Taiwanese cultures, were invited to discuss the conceptual 
equivalence of the KCCQ (Flaherty et al., 1988). One expert was a senior cardiologist, 
and the other a nursing professor. They were asked to examine the conceptualization of 
the KCCQ, the definitions of HRQOL and its domains, and the appropriateness of 
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questionnaire items. The discussions were held by e-mail because the two experts were 
living in Taiwan and consensus was reached. The experts agreed that the concept HRQOL 
in KCCQ fit both Chinese and Taiwanese cultures and all 23 items of the KCCQ should 
be translated into Chinese- Mandarin.  
Translation of the KCCQ. Two trilingual Taiwanese doctoral students in nursing 
who spoke English, Chinese, and Taiwanese and who were familiar with both American 
and Taiwanese cultural nuances translated the English version of the KCCQ into 
Chinese-Mandarin independently of each other. Since most Taiwanese people older adults 
speak only Taiwanese and often have rudimentary literacy skills, it was necessary to 
make the items in the Chinese-Mandarin version of the KCCQ meaningful and natural 
sounding to native speakers of both Mandarin and Taiwanese. The translators were asked 
to preserve the meaning of the original English version rather than follow the exact 
wording (Lange, 2002). In addition, they were asked to translate the KCCQ into the 
Taiwanese language so as to maintain the meaning of each item as well as the scale as a 
whole. They were also encouraged to use more idiomatic language that would be better 
understood by the participants (Streiner & Norman, 2003).  
The two translators found that four terms were difficult to translate into 
Chinese-Mandarin: (1) no appropriate term could be used to translate the phrase “walking 
a block,” thus, “walking a section of street (block)” was used; (2) most Taiwanese use the 
Chinese terms “tired” and “fatigue” interchangeably, therefore, it was difficult to 
distinguish symptoms of “fatigue” from those of “tired,” although the Chinese characters 
for these two words are slightly different; (3) literal translation for the term “enjoyment of 
life” was not appropriate because many Taiwanese interpret the term “enjoyment of life” 
as boasting, based on a cultural convention against the overt mention of enjoying 
activities; (4) the term “carrying groceries” was not a fit for elderly people who are not 
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responsible for shopping foods and other items for families.  
Because some terms were translated differently by the two translators, discussions 
were held to achieve a consensus and produce the first translated version. However, since 
it was not clear whether the translated version could be understood by Taiwanese HF 
patients, questions about the clarity and terms, particularly four terms above, were 
proposed and discussed in the cognitive interview and focus group discussion. 
Back-translation of the KCCQ. Two additional trilingual Taiwanese translators 
who had no knowledge (professional or otherwise) of the KCCQ and its purpose, 
independently back-translated the KCCQ from Chinese-Mandarin to English. One 
back-translator was a doctoral candidate in foreign language with research focusing on 
translation and interpretation, and the other one was a doctoral student in nursing who 
finished her bachelor and master degrees in the US. After discussing the differences 
between these two back-translated versions with the two back-translators, the principal 
investigator finalized the Chinese-Mandarin and back-translated versions.  
Next, the principal investigator invited the developer of the KCCQ, Dr. John 
Spertus (M.D., MPH, FACC), to examine the differences between the original and 
translated versions of the KCCQ. Based on his comparison, the Chinese-Mandarin 
version of the KCCQ was modified to produce the most accurate and appropriate 
translation of the KCCQ questions. Dr. Spertus indicated that semantic equivalents for 
each item were found in going between the original and back-translated versions. Several 
response options in the back-translated version could have same meaning in Chinese as 
those in the original version. However, they were awkwardly stated in English, e.g. 
“medley” in the back-translated vs. “mildly” in the original and “not much sure” in the 
back-translated vs. “not very sure” in the original. The back-translated version, thus, was 
modified according to the recommendations from Dr. Spertus. 
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Cognitive interviews. Six bilingual Taiwanese people with HF were invited to 
individually evaluate the completion time, readability, clarity, and understandability of 
the KCCQ. Participants were encouraged to think-aloud and repeat back information in 
their own words, and they were asked specific questions about their understanding of the 
questionnaire (for example, what does “enjoyment of life” or “walking a block” mean to 
you after we review this question?) (Jobe & Mingay, 1989). The investigator observed 
and audio-taped all participant responses. Suggestions and opinions were used to modify 
the Chinese-Mandarin version of KCCQ. 
Of the six participants, two were female and four were male. Ages ranged from 26 
to 74 years with a mean of 52.04 years, LVEF .17 to .79 (with a mean of .47), and NYHA 
Classes from I to IV. Only one participant was diagnosed with diastolic dysfunction. All 
participants had at least one comorbidity, such as coronary artery disease, diabetes, or 
hypertension. One participant had a spinal cord injury for 25 years, and one had mitral 
regurgitation with severe ascites for six years. Four were married and two were single. 
One lived alone. Four participants graduated from elementary school; two from high 
school.  
Participants stated that they understood the meaning of items of the KCCQ. 
However, most said that they could not verbally repeat the questions after hearing them 
read by the principal investigator as recommended by Jobe and Mingay (Jobe & Mingay, 
1989). They answered the questions directly (Levine, Fowler, & Brown, (2005). For 
example, after listening to the sentence in question 1, “some feel shortness of breath 
while others feel fatigue,” one participant said “I do have shortness of breath but not 
fatigue,” whereas another participant said she had both, and described how these two 
symptoms affected her daily life. Likewise, two participants said HF affects several 
aspects of their lives, while one participant said it affected his exercise tolerance only. For 
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item 9, “… to sleep sitting up in a chair or with at least three pillows to prop you up 
because of shortness of breath?," participants answered that they used 2 or more pillows 
or quilts rather than three pillows. For question 10 concerning how to deal with HF when 
it gets worse, many participants answered that they would call their families or 911 and 
then go to emergency room immediately. Otherwise, they did not know what further steps 
to take.   
For the question 12 regarding limitation of “enjoyment of life,” one participant 
answered, directly “many limitations! Diet and water intake are the most affected.” A 
female participant age 40 said, “effects of HF on enjoyment of life in younger people 
certainly are more severe than on older adults. Younger people have many responsibilities. 
I have to take care of my kids and do household chores. I live with my parents-in-law. I 
do everything I can do, even though I feel so tired and physical uncomfortable.” For item 
13, “if you had to spend the rest of your life with your heart failure the way it is right now, 
how would you feel about this?,” participants had difficulties with the response choices 
about “satisfaction.” Thus, the question was modified to “if you…, how satisfied would 
you feel about this?” When asked this question, the participant with a spinal cord injury, 
immediately answered, “I would be unsatisfied, life has become meaningless…I have so 
many complications. HF is the most serious disease. If the person can walk, the life is 
perhaps all right, but I cannot. It is not necessary to live longer. Isn’t the disease too tiring? 
I feel so tired.”  
Some participants said that the meanings of certain terms seemed ambiguous. One 
participant identified “shortness of breath” not “short” but “rapid.” Therefore, a more 
general term “pant” used by Taiwanese people was parenthesized after the term “short of 
breath.” Similarly, “edema” was parenthesized after the term “ankle swelling,” and 
“tired” was parenthesized after the term “fatigue.” Two participants stated that they did 
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not really understand the meaning of “walking a section of street (block);” therefore, the 
phrase “walking from an intersection to next intersection” was parenthesized after the 
phrase “walking a section of street (block).” Another participant explained the phrase 
“intimate relationships with loved ones” as “loving each other and providing necessities 
including both physical and psychological,” while others construed the phrase to mean 
“building good relationships with families.” The loved ones included families rather than 
a spouse or a partner only. However, two participants interpreted the term “intimate 
relationships” as “having sex with spouse.”  
The participants said they could distinguish the differences between scale options 
for items of the KCCQ. However, they interpreted the options in different ways. For 
example, one participant indicated the option of “extremely limited” as 85 to 100% of 
limitation, “quite a bit limited” as 70-85%, “moderately limited” as 50-60%, “slightly 
limited” as lower than 50%, and “not at all limited” as 0%. Some participants rated 
situations that they did not dare to do anymore in the option of “extremely limited” or 
“extremely bothered” situations, while others scored them in the level of “did not do the 
activity.” However, some participants, especially female, said they were still engaging in 
those extremely limited activities everyday even though those activities caused them 
extreme discomfort. Furthermore, for item 13 assessing the emotional response to the 
prospect of living with HF, one participant suggested an option of “slightly satisfied” vs. 
“mostly dissatisfied” in the original version of the KCCQ.  
In summary, the cognitive interviews suggested that participants interpreted terms 
and scale options differently based on their own experiences and situations living with HF. 
Parenthesizing more general terms used by Taiwanese, including “pant,” “tired,” and 
“edema” after the literally translational terms may help Taiwanese participants to 
understand the items of the KCCQ and diminish the cultural differences between the 
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Chinese-Mandarin and English versions of the KCCQ. Furthermore, there is a need to 
make the scale responses for items of the Chinese-Mandarin version more distinguishable. 
Likewise, question 9 should be modified to "...or with quilt or with more pillows than 
usual (for example, 2 or more). 
Focus group discussion. Four participants took part in the focus group discussion, 
three of whom had also participated in the cognitive interviews, along with another 
participant with HF, to examine the item equivalence of the Chinese-Mandarin version of 
the KCCQ. All participants were male with systolic dysfunction. They ranged in age from 
26 to 70 years old, NYHA Classes I to IV, and LVEF from .17 to .61. Three were married 
and one was single. All lived with families. Two had completed elementary school, and 
two had graduated from high school. Three were retired, and the other participant had 
been forced to quit work because of HF. Three participants had HF secondary to dilated 
cardiomyopathy (DCM), while the other suffered from valvular heart disease and 
coronary artery disease. No other major comorbidity was reported by the four participants. 
The mother of the youngest participant also joined the group discussion. A 90 minute, 
audio-taped discussion ensued.  
The participants were asked to discuss the meaning of each item, judging them in 
terms of relevance, clarity, unambiguousness, and intelligibility. They also considered 
whether the Chinese-Mandarin version of the KCCQ correlated with the main themes of 
HRQOL (Streiner & Norman, 2003). The interview was held in a small private meeting 
room at the medical center, and was processed using the following set of interview 
questions: (1) Have you heard of the term “health-related quality of life? (2) Can you tell 
me what you think it means? (3) This questionnaire (KCCQ) includes eight domains, 
physical limitation, symptoms,…, and functional status, in your opinion, are the eight 
domains appropriate for health-related quality of life? (4) In you opinion, what domains 
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does the questionnaire not contain related to health-related quality of life? (5) In your 
opinion, what domains of health-related quality of life should be excluded from the 
questionnaire (KCCQ)? And (6) in your opinion, which item(s) on this questionnaire 
(KCCQ) is/are not appropriate for the term of health-related quality of life?  
The focus group discussion was conducted with a basic qualitative descriptive 
study design (Sandelowski, 2000). Basic qualitative description occurs when researchers 
deliberately choose to describe a phenomenon in regard to a conceptual, philosophical, or 
other highly abstract framework. It is used when researchers look for descriptive validity, 
interpretive validity, an accurate accounting of phenomena or experiences that most 
people observing the same event would agree is accurate, or an accurate accounting of the 
meanings participants attributed to those phenomena or experiences that those 
participants would agree is accurate (Sandelowski, 2000). Basic qualitative description fit 
this current study because the researcher intended to seek the meaning of the concept and 
domains of HRQOL and items of the KCCQ given by Taiwanese people with HF.  
The audiotaped discussion was transcribed in Chinese by the principal 
investigator. The transcription then received multiple readings to assure accurate 
interpretation of the participants’ descriptions. Themes were extracted according to the 
interview questions. The principal researcher formulated meanings from the significant 
statements, and related the meaning to other statements and themes. Similar meanings 
were grouped together as supporting quotations. The quotations were then translated from 
Chinese into English (Patton, 2002).  
All participants said that they had heard the term “quality of life.” Only two, 
however, had heard of “health-related quality of life.” In the opinion of all participants, 
health was the heart of HRQOL, meaning that an unhealthy body negates quality in life. 
HRQOL included eating, dressing, housing, transportation, education, and entertainment. 
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The highest level of HRQOL was that a person can “let everything down (放下 fang xia, 
in Chinese).” To achieve this goal, they said that a person should not (1) “worry about 
things they cannot control, and (2) “over-insist on his own opinions and ideas.” All 
participants agreed that the eight domains and 23 items of the KCCQ were appropriate 
for measuring the concept HRQOL, although they also suggested domains of nutrition, 
environment, safety, freedom, economy, and politics.  
Participants interpreted the domains of the KCCQ using their life experiences. 
They viewed physical limitation as the inability to do what they want to do. They said 
that they did not want to burden their families so that they would like to do everything by 
themselves if they had ability to do so. However, the ability to perform daily activities 
was most affected by HF symptoms. One participant said that he often got dizzy since he 
had been taking a medication for his heart disease, and had not traveled outside of Taiwan 
since his second heart attack five years ago, due to his worry about his symptoms 
reoccurring. For all participants, preventing the reoccurrence of symptoms and 
maintaining symptom stability were the most important among daily tasks. One 
participant said that he took medications every day since he had a bad experience in 
which, after discontinuing the medication treatment, such severe symptoms had occurred 
that he had almost had to receive a heart transplant. All agreed that they would not force 
themselves to do things that strained their physical abilities for fear that the HF symptoms 
would occur or get worse. 
Regarding social functioning, three participants maintained their interests, such as 
traveling outside their hometowns or within Taiwan. They reported no difficulties driving 
a car or riding a motorbike. However, all married participants stated that HF decreased 
their interactions with friends and families, particularly with their wives. They said that 
they got angry easily if their wives talked or complained to them too much. To prevent 
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this, they tried to decrease conversations with their wives and others. Similarly, all 
participants agreed that maintaining psychological balance might be the hardest 
adjustment they had to make. Because of their susceptibility to emotional swings, they 
said they gradually lost the belief that they would achieve their ideal goals. However, if 
requested by others to do something, they still had confidence in their competence to 
perform such tasks, though, they might refuse to comply with those requests if it caused 
physical troubles. Three participants said that they were the most dominant person in their 
families (as a father and a husband). Due to the responsibilities of “managing the family,” 
they kept everything going, and tried to not to worry too much about their real situations 
in order to maintain harmony of their families. Participants discussed the concept of 
“enjoyment of life,” and the three older participants said that they had already enjoyed 
many things in their lives, thus, they did not feel sorrow over when they were told the 
diagnosis of HF by their physicians. One participant said that having a desire to live and 
living a life with ease were basic to the sense of enjoying life: “If a person is willing to 
live, he will feel life is colorful, then he will feel that it is easy to continue living.” A sick 
person, according to the participants, should adjust her/his own emotion and life to make 
oneself happy. 
In summary, the participants identified the relevance of the questionnaires to their 
quality of life in respect to the KCCQ domains of physical and social limitations, 
functional status, symptoms (severity, frequency, and stability), self-efficacy, and 
psychological functioning based on their experiences living with HF. However, they 
suggested that HRQOL should be more multidimensional and noted several factors 
contribute to influencing one’s outlook on one’s quality of life. Moreover, domains can 
interact with each other; for example, poor functional status affects emotion and further 




Psychometric testing. After the focus group interview, psychometric testing was 
conducted to test psychometric properties of the questionnaires. Each instrument was 
assessed for its internal consistency reliability and test-retest reliability. In addition, 
convergent validity of the KCCQ was assessed using the Taiwan version of the Medical 
Outcome Study Short Form-36 (SF-36) (Lu, Tseng, & Tsai, 2003). Thirteen participants 
completed the baseline measure with six questionnaires including the demographic 
questionnaire, KCCQ, SRHS, PSQI, ESS, and SF-36. Participants were interviewed 
individually by the principal investigator. The duration of the interviews was 
approximately 30 to 60 minutes. Eight of these participants completed a re-test measure 
with the same questionnaires (except for demographics) two weeks later. Five 
participants were interviewed at their home by the principal investigator, and the 
remaining three completed the re-test by themselves and then mailed the questionnaires 
back to the principal investigator. Only one participant had missing data (on the backside 
of all questionnaires) but completed them within five days and sent back when requested. 
Thirteen participants (6 females and 7 males) with HF completed the baseline 
measure (see Table 4). The mean age was 65.03 (SD 13.22) with a range from 40 to 86 
years. Ten participants (76.9%) were married, while three (23.1%) were 
widows/widowers. All participants were living with families. Educational levels varied, 
five participants (38.5%) were illiterate, and five had completed elementary school. 
Employment status was as follows: five participants (38.5%) were employed, four 
(30.8%) were non-employed due to diseases, and three (23.1%) were retired. Five 
participants perceived their financial status as poor, while eight answered they had 
sufficient economic condition. The time span from time of HF diagnosis was from 2 
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months to 16 years with a mean of 4.1 years. The majority (84.6%) were in NYHA Class 
II, and nine participants (69.2%) had at least two other comorbidities. The mean LVEF 
was .49 (SD .22) with a range from .17 to .87. Eight (61.5%) had systolic HF, and seven 
had diastolic dysfunction. 
The quantitative data were analyzed by using the Statistical Package for the Social 
Sciences (SPSS) Version 14.0 for Windows (SPSS Inc., 2005). The individual and HF 
characteristics and major variables were analyzed for descriptive statistics, including 
means, standard deviations, frequencies, and percentages. Cronbach’s alpha coefficients 
were used to calculate internal consistency reliability, and Spearman rho correlation 
coefficients were used to examine test/re-test reliability of the KCCQ, SRHS, PSQI, and 
ESS, and the relationships between the KCCQ subscales and the SF-36 subscales. 
Descriptive data for the KCCQ, PSQI, and ESS scores for the 13 participants are 
shown in Table 5. 
Table 5   
Descriptive Data for the KCCQ, PSQI, and ESS Scores (n=13) 
Questionnaires Mean (SD) Range Minimal-Maximal Skewness(SD) 
KCCQ     
Physical Limitation 88.19 (16.02) 0-100 50.00-100.00 -1.60(.64) 
Symptom Stability  51.92 (18.99) 0-100 .00-75.00 -1.48(.62) 
Total Symptom 86.14 (11.75) 0-100 58.33-100.00 -.96(.62) 
Self-Efficacy 55.77 (31.30) 0-100 .00-100.00 -.10(.62) 
Quality of Life 78.21 (22.45) 0-100 25.00-100.00 -1.18(.62) 
Social Limitation 83.33 (31.28) 0-100 .00-100.00 -2.21(.62) 
Overall Summary 84.06 (16.78) 0-100 41.15-100.00 -1.70(.62) 
Global PSQI core 5.69 (2.39) 0-21 2.00-10.00 .09(.62) 
ESS score 6.46 (3.21) 0-24 1.00-11.00 -.10(.62) 
Reliability of the questionnaires. Reliability for each questionnaire is shown in 
Table 6. Some participants could not distinguish scale response “not very” from 
“somewhat” and “occasionally” from “rarely.” These scale responses were designed for 
items 10, 11, 13, and 14. 
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Table 6   
Reliability for the KCCQ, SRHS, PSQI, and ESS 
Instruments/ Subscales Items Cronbach’s α 
(n=13) 
Spearman rho for 
test-retest (n=8) 
Kansas City Cardiomyopathy Questionnaire 
Overall summary score 20 .86 .60 
Clinical summary score 13 .70 .62 
Physical limitation 6 .64 .66 
Symptom stability 1 NA -.38 
Symptom frequency 4 .21 .71 
Symptom severity 3 .29 .47 
Symptom total 7 .42 .67 
Self-efficacy 2 .29 .15 
Quality of life 3 .76 .59 
Social limitation 4 .80 .94*** 
Self-Rated Health Subscale 4 .73 .67 
Chinese Pittsburgh Sleep Quality Index 18 .64 .92** 
Subjective sleep quality 1 NA .50 
Sleep duration 1 NA .90** 
Sleep latency 2 .74 .67 
Habitual sleep efficiency 2 NA .76* 
Sleep disturbances 9 .60 .81* 
Use of sleeping medication 1 NA -- 
Daytime dysfunction 2 .97 .82* 
Chinese Epworth Sleepiness Scale 8 .52 .70 
Spearman rank correlation coefficients for convergent validity of the KCCQ are 
shown in Table 7. The predicted substantial associations between the KCCQ subscales 
and SF-36 subscales are underlined (Pettersen et al., 2005). Except for the associations 
between the KCCQ quality of life subscale and SF-36 general health subscale (rs=.17), 
KCCQ social limitation subscale and SF-36 social functioning (rs=.23), and KCCQ 
overall summary score and SF-36 social functioning (rs=.05), the remaining 17 predicted 
associations between the KCCQ and SF-36 were from .46 to .94, and 12 were above .60, 
indicating that the KCCQ subscales had moderate to substantial associations with the 
SF-36. 
For the four items of SRHS, Cronbach’s alpha for internal consistency reliability 
was .73, and Spearman rank correlation coefficient for the two-week test/re-test reliability 
was .67. Cronbach’s alpha for internal consistency reliability was .64 for the global PSQI 
(18 items), .74 for sleep latency (2 items), .60 for sleep disturbances (9 items), and .97 for 
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daily dysfunction (2 items). The two-week test/re-test reliability coefficient for the global 
PSQI was .92, and for the domains of the PSQI ranged from .50 (sleep quality) to .97 
(daily dysfunction). However, the two-week test/re-test reliability for the item “use of 
sleep medication” was not calculated, because no participants answered positively to the 
question of sleeping medications usage in either baseline and re-test measures. 
 
Table 7   

















Limitation .94*** .77** .30 .49 .63* .80** .10 .39 
Symptom 
Stability .13 -.09 .12 .34 .16 -.04 .10 .000 
Total 
Symptom .57* .46 .15 .42 .68* .53 -.10 .20 
Self- 
Efficacy  .64* .74** .22 .49 .46 .52 -.10 .16 
Quality of 
Life .36 .53 .40 .09 .17 .80** .05 .59* 
Social 
Limitation .66* .57* -.05 .42 .57* .67* .23 .40 
Clinical 
Summary .75** .62* .20 .48 .66* .63* -.07 .22 
Overall 
Summary  .73** .74** .24 .44 .64* .88*** .05 .46 
Note: Predicted substantial associations are underlined. 
*** Correlation is significant at the 0.001 level (2-tailed). 
** Correlation is significant at the 0.01 level (2-tailed). 
* Correlation is significant at the 0.05 level (2-tailed). 
Cronbach’s alpha for internal consistency reliability for the ESS was .52, and the 
two week test/re-test reliability coefficient was .70. Five participants, however, had 
difficulties answering the item “sitting and reading.” Furthermore, the item “driving a car, 
while stopped for a few minutes in the traffic” in the Chinese version of the ESS was not 
meaningful to participants who did not drive a car. Likewise, several participants 
answered that they took daytime naps habitually. 
Spearman rank correlation coefficients for associations between the key variables 
are shown in Table 8. 
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Table 8   









Overall SRHS PSQI ESS 
Age -.545 -.564 .070 -.562* -.516 -.317 -.436 .493 
Gender .413 .222 -.063 .382 .247 .383 -.104 -.541 
Married -.195 .199 .596* .000 .146 .101 .197 .098 
Education .574* .312 -.130 .361 .303 .342 .041 -.496 
Employ -.428 -.619* -.410 -.536 -.574* -.290 -.574* .294 
Financial -.042 .052 .172 -.138 .000 .022 .256 -.128 
Comorbidity -.640* -.768** -.084 -.744** -.651* -.324 -.334 .426 
Onset of HF -.348 -.122 .480 -.234 -.080 .190 -.111 .557* 
LVEF .165 .014 -.341 -.027 -.110 -.088 -.499 -.302 
HF type .085 -.050 -.516 -.069 -.169 -.065 -.405 -.320 
NYHA -.122 -.312 -.142 .005 -.192 .014 -.278 -.211 
SRHS .599* .792** .570* .676* .853**    
PSQI .208 .363 .174 .305 .258 -.139   
ESS -.784** -.559 -.047 -.621* -.601* -.527 -.006  
**  Correlation is significant at the 0.01 level (2-tailed).  
*  Correlation is significant at the 0.05 level (2-tailed). 
Finalizing the KCCQ 
Modifications of terms and scale options in the Chinese-Mandarin version of the 
KCCQ were further discussed with the back-translator whose major focused on foreign 
language translation and interpretation, and a doctoral candidate who majored in 
linguistics. The scale option “somewhat” was then translated with the meaning of 
“moderately” to make it more distinguishable from the option “not very” or “rarely.” The 
Chinese-Mandarin and back-translated versions of the KCCQ were again sent to the 
original developer, Dr. Spertus. Because of concerns that the item “walking from an 
intersection to next intersection” might not match against the participants’ environment, 
Dr. Spertus suggested a more appropriate alternative “walking 100 meters on level 
ground” for the item “walking a block on level ground.” He agreed that all of the 
remaining modifications as translated should be suitable for the study. 
Discussion 
Several subscales of the KCCQ and the ESS had a low to moderate level of 
Cronbach’s alphas (less than .60), lower than found in other research studies. The sample 
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was restricted in terms of characteristics, such as NYHA Class, however, that could be 
explained by the small sample size. A larger representative sample of the population is 
required for the formal data collection.  
The pilot study suggested several issues, including social desirability, methods 
(self-reporting vs. interview), and other cultural issues have to be taken into account in 
HRQOL assessment. The study was held in a medical center where participants were 
referred by their physician, and interviewed in person by the principal investigator. They 
may have answered the questions with a desire to please. This suggests that the 
interviewer needs to stress that being in the study will not impact their treatment by their 
physician. Moreover, several participants completed the questionnaires either in family 
settings or with family present; it was not clear whether their responses were affected by 
this. A related factor involves response variances introduced by different settings and 
methods. For example, one participant answered in the baseline measure in his interview 
that he did not feel depressed after being diagnosed with HF. However, he indicated that 
he was depressed in the retest that he filled out by himself at home. It is not clear whether 
the responses resulted from differences in settings, family presence, interview effects, or 
true emotional changes in the previous two weeks.  
There are also questions posed by the possible interference of culturally generated 
images of self-efficacy. For instance, some participants may have exaggerated their 
ability to deal with HF and its systems in order to shield themselves from “victim 
blaming,” that is, being blamed by healthcare professionals for not knowing good 
self-care. For example, when asked if he understood the questions, one participant 
responded that although he had only graduated from high school, he continued to educate 
himself. Likewise, the Taiwanese convention of understating one’s achievements and 
accomplishments to people as a sign of humbleness may affect responses to questions 
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worded to bring out honest self assessments (Cheng et al., 2001). For example, most 
participants said that the only thing they could do if their HF symptoms got worse was to 
go to emergency room, they did not know what further steps to take. However, when 
further clarifying the questions with them, they described various strategies to make them 
feel comfortable, such as, using oxygen, taking medications, seeking help from their 
families, and finding out and diminishing the causes. To mitigate potential effects, the 
principal investigator will explain that the questions are not going to be used to critique or 
judge the respondent in any way. 
Because 5 participants were illiterate, they had difficulties answering the item 
“sitting and reading” of the ESS. Furthermore, few participants could answer the item “in 
a car, while stopped for a few minutes in the traffic.” Therefore, the principal investigator 
contacted the translator of the Chinese version of the ESS, Dr. Chen, Ning-Hung. A 
decision was made to replace these two questions by asking about alterative situations, 
such as doing boring and monotonous tasks. Thus, the item, “driving a car, while stopped 
for a few minutes in the traffic” was modified as “driving or sitting in a car…” to make it 
a better match with people’s real situations. 
Based on the fact that several participants in the psychometric testing claimed to 
take daytime naps habitually, three items in respect to the prevalence, frequency and 
duration of daytime napping developed by the principal investigator were added into the 
ESS. In addition, body mass index was added into the demographic questionnaire for the 
main study because some participants, particularly those with greater body weight, said 
that they snored (Javaheri, 2006; Sin et al., 2003).  
In summary, the pilot study demonstrated that the domains and items of the 
KCCQ were appropriate for the concept HRQOL based on the participants’ perspectives. 
However, the pilot study suggested the need for modifications in wording and items of 
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the questionnaires, including the KCCQ, ESS, and demographic questionnaire, as well as 
the need to waive a signed consent form for the dissertation study. After these 
modifications of the tools and procedures to address cultural biases in responding, the 
questionnaires and data collection method proposed by this research were ready for use in 
Taiwanese people with HF.  
Summary 
This chapter provided a description of the methodology to be used for this 
proposed study. This study used a descriptive correlational design to answer the proposed 
research questions. The population and sample were Taiwanese people with HF. 
Information about psychometric properties for instruments, including the KCCQ, 
modified SRHS, PSQI, and ESS were described. A detailed explanation of data collection 
procedures and data analysis was provided. Finally, a description of the pilot study was 
given, including procedures for translating the KCCQ from English into 
Chinese-Mandarin, sample and procedures, construct validity for the KCCQ, and 
reliability for each instrument. The pilot study supported the feasibility of this main 




This chapter describes the results of th e research study. The findings include the
demographic characteristics, health-related characteristics, and the HF characteristics of
the sample. The chapter then presents descriptive data for major variables and
interpretations of the inferential findings specific to the relationships between the
variables and predictors of HRQOL.
Description of Sample
A total of 134 participants with HF initially agreed to participate in this study .
However, nine participants were excluded from the study, thus final sample was
comprised of 125 people. Eight who were excluded said they did not know about their
HF diagnoses until this study, even though they said that they understood their heart
function was in decline and had been treated for heart conditions such as mitral
regurgitation and coronary artery disease  for sometime. The ninth participant did not
finish the sleep questionnaires because of fatigue. Otherwise, all participants  completed
the questionnaires.
Demographic Characteristics of Participants
The demographic data for  the final sample of 125 Taiwanese are summarized in
Table 9. The mean age for the sample was 67.79 (SD = 12.19) with a median of 68.93 and
a range of 29.78 to 86.86 years. The majority of the participants (70.4%) were married,
and 29 (23.2%) were widows or widowers. One hundred and ten participants were living
with families, while 15 were living alone. Educational levels varied; 38 participants
(30.4%) were illiterate, and 36 (28.8%) had completed elementary school. Forty
participants (32%) were employed or working, 55 (44.0%) were unemployed, and 30
(24.0%) were retired. Ninety-two participants (73.6%) answered that their economic
conditions were sufficient for them to meet  daily expenses, whereas 26 (20.8%) perceived
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their financial status to be poor. Approximately half (52.0%) of the participants spoke 
Taiwanese only, and 44% could speak both Taiwanese and Mandarin. 
 
Table 9   
Demographic Characteristics of Participants        (n= 125) 
Variable Categories n % 









































Education  Illiterate 
Illiterate, but less than 6 years 
Elementary 
Junior high school  
Senior high school 
Some college 















Employed Status Yes 
No 




























Heart Failure Characteristics 
HF characteristics, including the type of HF, NYHA Functional Classification, 
prescribed HF medications, and time since the diagnosis of HF, are shown in Table 10. 
The results showed that 50 participants (40.0%) had systolic HF, 51 (40.8%) had diastolic 
dysfunction, and the remaining (19.2%) had valvular HF. The majority (72.0%) was in 
NYHA Class II, and 24% were in Class III. The mean number of prescribed HF 
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medications used was 3.58 (SD = 1.51). Approximately 25% of the participants took 4 HF 
medications daily, while those taking two and three prescriptions per day represented 
20% each. Nine subjects used only one medication, and two received eight pills daily. 
The time since the HF diagnosis ranged from one month to 16 years, with a mean of 
35.66 months (SD = 43.81). Approximately 28% of the sample reported they had been 
diagnosed with HF for 1 to 6 months, 21.6% for 2 to 5 years, and 19.2% for 1 to 2 years. 
 
Table 10  
Heart Failure Characteristics of the Participants                (n= 125) 


























Number of prescribed HF medications Mean=3.58, SD=1.51, Range=1-8 
 One 9 7.2 
 Two 25 20.0 
 Three 26 20.8 
 Four 31 24.8 
 Five 20 17.6 
 Six 9 7.2 
 Seven  1 .8 
 Eight 2 1.6 
Type of prescribed HF medications 
 Vasodilator 78 62.4 
 Diuretics 63 50.4 
 Angiotensin-receptor blocker 54 43.2 
 Aspirin 53 42.4 
 Calcium channel blocker 49 39.2 
 Beta-Blocker 35 28.0 
 Digitalis 33 26.4 
 Aldosterone inhibitor 20 16.0 
 Angiotensin-converting enzyme inhibitor 15 12.0 
 Lipid-lower 11 8.8 
 Blood thinner 10 8.0 
 Anti-arrhythmia 10 8.0 
 Alpha adrenergic antagonist 9 7.2 
Time since diagnosed with HF (month) Mean=35.66, SD=43.81, Range=1-192 
 1-6 months 35 28.0 
 6-12 months 17 13.6 
 13-24 months (1-2 years) 24 19.2 
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 25-60 months (2-5 years) 27 21.6 
 61-120 months (5-10 years) 13 10.4 
 >121 months (>10 years) 9 7.2 
Health-Related Characteristics 
Health-related characteristics included BMI, comorbidity, and perceived health. 
Data for each variable is described as follows. 
Body mass index. The participants had a mean BMI of 25.55 kg/m2 (SD = 4.37), 
ranging from 16.62 kg/m2 to 40.83 kg/m2. According to the Classification of Overweight 
and Obesity published by the Taiwan Department of Health, approximately 40% of the 
participants had normal weight, 20.8% were overweight, and 24.8% were mildly obese. 
Distribution of the BMI in this sample is shown in Table 11. 
 
Table 11  
Distribution of BMI in the Participants       (n= 125) 
 Frequency Percent 
Mean=25.5 kg/m2, SD=4.37, Skewness= .63, SD=.22 
≦18.4 1 0.8 
18.5-23.9 (normal) 50 40.0 
24-26.9 overweight 26 20.8 
27-29.9 mild obesity 31 24.8 
30-34.9 moderate obesity 14 11.2 
≧35 severe obesity 3 2.4 
*Based on the Classification of Overweight and Obesity by Taiwan Department of Health 
Comorbidity. The study used both self-report Charlson Comorbidity Index (Katz 
et al., 1996) and chart-review methods (Radford et al., 2005) to measure comorbidity. If 
HF is excluded, Charlson comorbidity severity scores ranged from 0 to 8, with a mean 
score of 2.39 (SD = 1.88). Thirteen participants (10.4%) had a Charlson comorbidity 
score of 0. The mean number of comorbidities measured by the Charlson Comorbidity 
Index (CCI) was 1.86 (SD = 1.25). Approximately 38.4% of the participants reported they 
had had a heart attack, including angina pectoris and myocardial infarction, and 31.2% 
had diabetes with or without end organ damage. Twenty-nine participants reported they 
were receiving treatments for gastrointestinal problems and 25 (20.0%) for chronic 
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pulmonary diseases. Likewise, 19 participants complained they suffered from 
osteoarthritis (n = 18) and polymyostitis (n = 1), which are types of connective tissue 
diseases (Encyclopædia Britannica, 2007). Thirteen participants had a history of strokes 
or transient ischemic attacks, and three had the complications of hemiplegia; however, 
they could walk using assisting devices such as canes or walkers. Three participants were 
receiving hemodialysis treatment regularly. The CCI scores and comorbid conditions 
measure by the CCI are shown in Table 12. 
 
Table 12  
CCI Score and Comorbid Condition of the Participants   (n=125) 
 Frequency Percent 
CCI—Severity (Mean=2.39, SD=1.88, Skewness=1.08, SD=.22) 
CCI—Number (Mean=1.86, SD=1.25, Skewness=1.25, SD=.22)  
 Zero 15 12.0 
 One 39 31.2 
 Two 36 28.8 
 Three 24 19.2 
 Four 5 4.0 
 Five 6 4.8 
CCI--Comorbid condition   
 Heart attack 48 38.4 
 Ulcer disease 29 23.2 
 Chronic pulmonary disease 25 20.0 
 Chronic renal disease 24 19.2 
 Diabetes without end organ damage 23 18.4 
 Liver disease 22 17.6 
 Connective tissue disease 19 15.2 
 Stroke, transient ischemic attack 16 12.8 
 Diabetes with end organ damage 16 12.8 
 Peripheral vessel disease 6 4.8 
 Hemiplegia 3 2.4 
 Dementia 1 .8 
 Cancer 1 0.8 
The mean number of chart-review concomitant health problems was 4.88 (SD = 
1.83, with a range of one to 10), which included both cardiovascular problems, ranging 
from one to seven with a mean of 3.05 (SD = 1.16), and noncardiovascular problems, 
ranging from 0 to 6 with a mean of 1.83 (SD = 1.46). In addition to HF, approximately 
65.6% of the participants had hypertension, 56.0% had valvular heart disease, 44% had 
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coronary artery disease, 41.6% had atrial arrhythmia, and 32.8% had problems with high 
cholesterol or triglycerides. For 13 (10.4%) of the participants, HF was caused by dilated 
cardiomyopathy, and for three (2.4%) participants, it was caused by hypertrophic 
cardiomyopathy. Information about the chart-review concomitant cardiovascular problem 
is given in Table 13. 
 
Table 13  
Chart-Review Concomitant Cardiovascular Problems of the Participants (n= 125)  
 Frequency Percent 
Number of concomitant cardiovascular problems 
One  10 8.0 
Two  30 24.0 
Three 45 36.0 
Four 28 22.4 
Five 9 7.2 
Six 2 1.6 
Seven  1 .8 
Type of concomitant cardiovascular problems 
Hypertension 82 65.6 
Valvular heart disease 70 56.0 
Coronary artery disease 55 44.0 
Atrial arrhythmia 52 41.6 
Dyslipidemia 41 32.8 
Percutaneous coronary intervention  14 11.2 
Cardiomegaly 14 11.2 
Dilated cardiomyopathy 13 10.4 
Myocardial infarction 12 9.6 
Ventricular arrhythmia 6 4.8 
Rheumatic heart disease, surgical post 4 3.2 
Angina pectoris 4 3.2 
Coronary artery bypass graft 3 2.4 
Hypertrophic cardiomyopahty 3 2.4 
Left ventricular hypertrophy 3 2.4 
syncope 2 1.6 
Coronary spasm 1 .8 
Peripheral arterial disease 1 .8 
Carotid atherosclerosis 1 .8 
Pulmonary hypertension 1 .8 
The list of chart-review concomitant health problems was based on the ACC/AHA 
national key data elements (Radford et al., 2005) and used to measure more 
comprehensive comorbid conditions that were not measured by the CCI. The 
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chart-review approach presents prevalence of diabetes and cancer similar to those 
measured by the self-report method (see Table 14). The results showed that over one-third 
(36.8%) participants had at least one musculoskeletal problem such as gout (15.2%), 
osteoarthritis (12.8%), and spondylosis (6.4%), and this type of problem accounting for 
the most common comorbid conditions for this sample. The second most prevalent 
problem was diabetes, which affected 31.2% of the participants. Next, over one-fourth 
(25.6%) of the participants had gastrointestinal problems, including gastric/peptic ulcer 
(8.0%), abnormal liver functions (7.2%), and hepatitis (7.2%). Approximately 31 of the 
participants (24.8%) had at least one chronic pulmonary disease, which included 13.6% 
with chronic obstructive pulmonary disease and 6.4% with chronic bronchitis. There were 
22 participants (17.6%) with neurological problems and 17 with chronic renal 
insufficiency. Ten of the participants (8.0%) had suffered from chronic pain, such as 
headache and lower-back pain, for a period of time, and eight were bothered by insomnia. 
Likewise, 9.6% had benign prostatic hyperplasia, resulting in a high frequency of 
nocturia. 
 
Table 14  
Concomitant Non-Cardiovascular Problems of the Participants       (n= 125) 
 Frequency Percent 
1. Musculoskeletal disease n=44 36.8 
 Gout /Gouty arthritis 19 15.2 
 Osteoarthritis 16 12.8 
 Spondylosis 8 6.4 
 Osteoporosis 7 5.6 
 Herniation of intervertebral disc 2 1.6 
 Ankyolosing spondylitis 1 .8 
 Polymyositis 1 .8 
 Frozen shoulder 1 .8 
2. Diabetes/high blood sugar n=39 31.2 
3. Gastrointestinal Disease n=32 25.6 
 Gastric ulcer/ peptic ulcer 10 8.0 
 Abnormal liver function 9 7.2 
 Hepatitis 7 5.6 
 Gastrointestinal upset 7 5.6 
 Hemorrhoid 4 3.2 
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Table 14 (Continued) 
 Frequency Percent 
 Constipation 3 2.4 
 Liver abscess 2 1.6 
 Liver cirrhosis 2 1.6 
 Reflex esophagitis 1 .8 
4. Chronic Pulmonary Diseases n=31 24.8 
 Chronic obstructive pulmonary disease 17 13.6 
 Chronic bronchitis 8 6.4 
 Allergic rhinitis 3 2.4 
 Emphysema 2 1.6 
 Respiratory failure 2 1.6 
 Pleural effusion 2 1.6 
 Asthma 1 .8 
 Sleep apnea 1 .8 
 Old tuberculosis 1 .8 
5. Neurological Disease n=22 17.6 
 Transient ischemic attack 6 4.8 
 Stroke/Cerebrovascular accident 5 4.0 
 Parkinsonism 2 1.6 
 Hearing impairment 2 1.6 
 Meniere’s syndrome 2 1.6 
 Dementia 1 .8 
 Cerebral atrophy 1 .8 
 Polyneuropathy 1 .8 
 Epilepsy 1 .8 
6. Renal Disease n=19 17.6 
 Chronic renal insufficiency 17 13.6 
 Hemodialysis 3 2.4 
 Hydronephrosis 1 .8 
 Proteinuria/ hypoalbuminemia 1 .8 
7. Psychological /Mental Health   
 Pain 10 8.0 
 Insomnia 8 6.4 
 Anxiety 2 1.6 
 Depression 1 .8 
 Neurosis 1 .8 
8. Thyroid 4 3.2 
 Hyperthyroidism 2 1.6 
 Goiter 2 1.6 
9. Cancer 1 .8 
10. Other   
 Benign prostatic hyperplasia 12 9.6 
 Cataract/Glaucoma  5 4.0 
 Anemia 4 3.2 
 Pancytopenia 1 .8 
Perceived health. Perceived health was measured using the SHRS. The total score 
for the 4-item SHRS ranges from 4 to 13, with higher scores indicating better health 
 114
perception. For this study, the SHRS score ranged from 4 to 11 with a mean of 7.18 (SD 
= 1.70). Data for the 4-item SHRS are listed in Table 15. However, as described in 
Chapter three, Cronbach’s alpha for the 4-item SRHS was .44. Two items, items 3 and 4, 
were eliminated from the data analysis with inferential statistics because they showed low 
corrected item-total correlations. The modified 2-item SRHS score ranged from 2 to 7 
with a mean of 3.26 (SD = 1.07).  
 
Table 15  
SHRS Scores of the Participants                      (n = 125) 
 Mean (SD) Median Mode Range Skewness (SD) Kurtosis (SD)
Modified SRHS 3.26 (1.07) 3.00 2 2-7 .49 (.22) -.22 (.43) 
SHRS 7.18 (1.70) 7.00 8 4-11 -.03 (.22) -.44 (.43) 
Perceived overall health 1.70 (.56) 2.00 2 1-4 .31 (.22) 1.12 (.43) 
Health compared to 1 year ago 1.57 (.72) 1.00 1 1-3 .87 (.22) -.58 (.43) 
Health problems limiting ability 
to do the things they wanted 2.12 (.79) 2.00 3 1-3 -.22 (.22) -1.36 (.43) 
Compared with most people’s 
health in the same age 1.79 (.70) 2.00 2 1-3 .31 (.22) -.92 (.43) 
Table 16 presents descriptive data for each item of the SHRS. Generally, 62% of 
the participants evaluated their overall health as fair, and 34% rated it as poor. 
Approximately 56.8% of the subjects reported that their health was poorer than it was one 
year ago and 13.6% perceived that their health was better. Forty-seven (37.6%) 
participants believed that their health problems did not limit their ability to do the things 
they wanted, whereas 25.6% reported a large number of restrictions. However, participants 
had different interpretations for item 3. Several participants stated that they were too old to 
pursue their dreams or goals, particularly since they were living with severe illnesses. 
Nearly half of the participants viewed their health as being as good as that of most people 
their age, and 36.8% said their health was poorer than that of most of their peers. 
However, several participants expressed that they did not know how to answer question 4 
because it was not easy to do the comparisons with other people’s health. Those 
participants believed that their health was poorer when comparing with peers who could 
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do many things with low limitations, such as, walking, traveling, and doing chores in 
their farms. On the other hand, they also felt they had better health than that of others 
when comparing to those people who had to use canes or wheelchairs for walking or 
suffered from other more vulnerable situations, such as hemodialyisis or cancer with 
frequent chemotherapies. Particularly, participants who were over 80 years old described 
that their health should be better than that of their peers even though they had severe 
declines in daily functioning because most of their peers had died. 
 
Table 16  
Perceived Health of the Participants    (n=125) 
  n % 
Perceived overall health 
Poor 43 34.4 
Fair 78 62.4 
Good 3 2.4 
Excellent 1 .8 
Compared health to 1 year ago 
Not as good 71 56.8 
Same 37 29.6 
Better 17 13.6 
Health problems limiting ability to do the things they wanted 
A great deal 32 25.6 
A little 46 36.8 
Not at all 47 37.6 
Compared with most people’s health in the same age 
Not as good 46 36.8 
Same 59 47.2 
Better 20 16.0 
Research Questions 
This section describes the findings of the analysis for each of the four research 
questions of this study. Tables are used to clarify the analytical results. 
Question 1. What are the sleep characteristics reported by Taiwanese people living with 
HF? 
Nocturnal Sleep Quality 
Nocturnal sleep quality was measured with the PSQI. For each of the seven 
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components of the PSQI, the possible score ranges from 0 to 3. The desired score is 0 or 1. 
The total score can range from 0 to 21, with a higher score indicating poor sleep quality. 
The global PSQI scores of the 125 participants ranged from 0 to 20, with a mean score of 
9.06 (SD 4.64), a median of 8.00, and a mode of 4.00. With a cutoff point of 5 (Buysse et 
al., 1989), 93 (74.4%) participants were identified as poor sleepers (PSQI > 5) and 32 
(25.6%) as good sleepers. Approximately half of the participants, however, rated their 
sleep as fairly good, and only 42.8% rated their sleep as fairly bad or very bad. For the 
PSQI components, the score of sleep latency was the highest, and use of sleeping 
medication had the lowest score. The global and component scores of the PSQI for the 
125 participants are summarized in Table 17. 
 
Table 17  
Global PSQI and Component Scores of the Participants                (n=125) 
 Mean (SD) Median Mode Range Skewness (SD) Kurtosis (SD) 
Global PSQI 9.06 (4.64) 8.00 4 0-20 .24 (.22) -.85 (.43) 
Sleep latency 1.71 (1.12) 2.00 3 0-3 -.25 (.22) -1.32 (.43) 
Sleep duration 1.70 (1.04) 2.00 2 0-3 -.32 (.22) -1.05 (.43) 
Subjective sleep quality 1.55 (.91) 1.00 1 0-3 .36 (.22) -.87 (.43) 
Sleep disturbances 1.46 (.59) 1.00 1 0-2 .14 (.22) -.41 (.43) 
Habitual sleep efficiency 1.42 (1.29) 1.00 0 0-3 .10 (.22) -1.70 (.43) 
Daytime dysfunction .71 (1.03) 0.00 0 0-3 1.13 (.22) -.17 (.43) 
Use of sleeping medication .50 (1.08) 0.00 0 0-3 1.79 (.22) 1.37 (.43) 
Findings for the seven components of the PSQI are shown in Table 18. Overall, 
the mean daily sleep duration was 5.62 hours (SD = 1.72 hours). Thirty-six percent of the 
participants reported they had a total night’s sleep of 5 to 6 hours, and 25.6% slept less than 
5 hours a night. The mean sleep latency was 46.02 minutes (SD = 57.63 minutes). 
Approximately 40.8% of the participants took less than 15 minutes to fall asleep, whereas 
19.2% took more than 1 hour to fall asleep. The mean habitual sleep efficiency was 73% 
(SD = 22%). Forty-seven (37.6%) had habitual sleep efficiencies of 85%, and 32.8% had 
sleep efficiencies of less than 65%. A large proportion (80.8%) of the participants did not 
use sleeping medications, whereas 14.4% took sleeping pills three or more days a week 
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during the last month. Similarly, most participants (62.4%) reported they did not suffer 
from daytime dysfunction, whereas 9.6% had severe problems performing their daily 
functions. 
 
Table 18  
Descriptive Data for Seven Components of Nocturnal Sleep Quality  (n=125) 
Components of PSQI Frequency Percent 
Subjective sleep quality    
 Very good 10 8.0 
 Fairly good 62 49.6 
 Fairly bad 27 21.6 
 Very bad 26 20.8 
Sleep duration (mean=5.62 [SD 1.72], median=5.5, mode=5.0 hours) 
 Over 7 hours 22 17.6 
 Over 6 hours, less than 7 hours 26 20.8 
 Over 5 hours, less than 6 hours 45 36.0 
 Less than 5 hours 32 25.6 
Sleep latency (mean=46.02 [SD 57.63], median and mode=30 minutes) 
 Equal or less than 15minutes 51 40.8 
 16-30minutes 32 25.6 
 31-60minutes 18 14.4 
 Greater than 60minutes 24 19.2 
Habitual sleep efficiency (mean=73% [SD 22%], median=76%, mode=100%) 
 Equal or greater than 85% 47 37.6 
 84-75% 19 15.2 
 74-65% 18 14.4 
 Less than 65% 41 32.8 
Sleep disturbances   
 0 3 2.4 
 1-9 64 51.2 
 10-18 55 44.0 
 19-27 3 2.4 
Use of sleeping medication   
 Not during the past month 101 80.8 
 Less than once a week 3 2.4 
 Once or twice a week 3 2.4 
 Three or more times a week 18 14.4 
Daytime dysfunction   
 No problem at all 78 62.4 
 Only a very slight problem 17 13.6 
 Somewhat of a problem 18 14.4 
 A very severe problem 12 9.6 
Regarding sleep disturbances, only three participants stated that they did not 
suffer from any kind of sleep disruption during the past month. For an understanding of 
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the prevalence of sleep disturbances in this sample, the total frequency for each condition 
relating to sleep disturbances was calculated by summing the scores 2 and 3. As shown in 
Table 19, the most frequent event regarding sleep disturbances was “have to get up to use 
the bathroom at least one to three or more times a week.” That type of sleep disruption 
was reported by 104 participants (83.2%). Among those participants, 99 had episodes of 
nocturia three or more nights a week. Several participants mentioned that they had two or 
more episodes of nocturia every night. The second most prevalent condition related to 
sleep disturbances was “cannot get to sleep within 30 minutes,” which occurred in 62.4% 
of the participants. Approximately half of the 125 participants (52.8%) had difficulties 
initiating sleep within 30 minutes three or more nights a week. The next most prevalent 
event for this sample was “wake up at midnight or early morning,” which affected 70 
(56.0%) of the participants, with 54 participants aroused from sleep at midnight or during 
the early morning three or more times a week. 
Thirty-four (27.2%) of the participants complained they had dreams during sleep 
that resulted in their feeling a lack of refreshing sleep when getting up in the morning. 
Twenty-eight (22.4%) experienced pain while sleeping. The most common causes of pain 
were muscle cramp, muscle pain, and chest discomfort. One-fifth of the participants 
(20.8%) stated that they coughed or snored loudly during sleep occasionally or frequently. 
Several participants, however, said they had difficulties answering this question because 
they did not know whether they snored during sleep every night. Twenty-three (18.4%) of 
the participants reported they could not breathe comfortably and had to use more pillows 
to prop themselves up for sleep or they had to sleep in a lateral position. Finally, 
conditions such as feeling too cold or too hot and having dry mouth bothered a small 




Table 19  
Conditions Regarding Sleep Disturbances of the Participants     (n=125) 
Score Mean (SD) 0 1 2 3 Total for 2-3
Condition  n (%) n (%) n (%) n (%) n (%) 
Have to get up to use the bathroom 2.51 (1.29) 14 (11.2) 7 (5.6) 5 (4.0) 99 (79.2) 104 (83.2) 
Cannot get to sleep within 30 minutes 1.90 (1.29) 32 (25.6) 15 (12) 12 (9.6) 66 (52.8) 78 (62.4) 
Wake up at midnight or early morning 1.63 (1.35) 45 (36.0) 10 (8.0) 16 (12.8) 54 (43.2) 70 (56.0) 
Had bad dream .92 (1.25) 73 (58.4) 18 (14.4) 5 (4.0) 29 (23.2) 34 (27.2) 
Have pain .66 (1.14) 90 (72.0) 7 (5.6) 9 (7.2) 19 (15.2) 28 (22.4) 
Cough or snore loudly .63 (1.10) 89 (71.2) 10 (8.0) 9 (7.2) 17 (13.6) 26 (20.8) 
Cannot breathe comfortably .52 (1.01) 95 (76.0) 7 (5.6) 11 (8.8) 12 (9.6) 23 (18.4) 
Feel too hot .25 (0.72) 109 (87.2) 7 (5.6) 3 (2.4) 6 (4.8) 9 (7.2) 
Feel too cold .21 (0.73) 109 (87.2) 9 (7.2) 0 (0.0) 7 (5.6) 7 (5.6) 
Dry mouth 1 (0.8) 1 (0.8) 2 (1.6) 10 (8.0) 1 (0.8) 
Stress 0 (0.0) 4 (3.2) 0 (0.0) 1 (0.8) 4 (3.2) 






0 (0.0) 0 (0.0) 0 (0.0) 1 (0.8) 0 (0.0) 
* Score 1: not during the past month; Score 2: less than once a week; Score 3: once or twice a 
week; Score 4: three or more times a week 
Daytime Sleepiness 
Daytime sleepiness was measured with the ESS. The total range of scores on the 
ESS is 0 to 24, with higher scores indicating that the participants were more likely to fall 
asleep or doze off in sedentary life situations. In this study, the ESS scores ranged from 0 
to 22, with a mean score of 6.99 (SD = 5.07), a median score of 6.00, and a mode score of 
3.00. Overall, the findings indicated that the HF participants were not physically 
influenced by their daytime sleepiness. When a cutoff point of 10 was considered (Johns, 
1991), most participants (76%) did not describe a high propensity to fall asleep in daily 
sedentary situations, while 30 (24%) of the participants had excessive daytime sleepiness. 
It is worth noting that, 9 (7.2%) of the participants had an ESS score of 16 or above, 
indicating a high level of daytime sleepiness. Regarding the eight special life situations, 
participants reported that they were most likely to fall asleep or doze off while “lying 
down to rest in the afternoon” (mean = 2.06, SD = 1.27), and the least daytime sleep 
propensity occurred in the situation of “sitting in a car, while stopped for a few minutes in 
the traffic” (mean = .07, SD = 34).” The ESS total score and scores for each situation are 
summarized in Table 20. 
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Table 20  
ESS Scores of the Participants                        (n=125) 
 Mean (SD) Median Mode Range Skewness (SD) Kurtosis (SD)
ESS total 6.99 (5.07) 6.00 3 0-22 .79 (.22) .10 (.43)
Lying down to rest in the afternoon 2.06 (1.27) 3.00 3 0-3 -.79 (.22) -1.18 (.43)
Sitting quietly after a lunch without 
alcohol 
1.36 (1.40) 1.00 0 0-3 .21 (.22) -1.85 (.43)
Watching TV 1.18 (1.18) 1.00 0 0-3 .44 (.22) -1.33 (.43)
As a passenger in a car for an hour 
without rest 
.98 (1.29) .00 0 0-3 .77 (.22) -1.23 (.43)
Sitting and reading .66 (1.06) .00 0 0-3 1.30 (.22) .18 (.43)
Sitting, inactive in a public place .54 (1.00) .00 0 0-3 1.75 (.22) 1.62 (.43)
Sitting and talking to someone .13 (.54) .00 0 0-3 4.51 (.22) 20.13 (.43)
In a car, while stopped for a few 
minutes in the traffic 
.07 (.34) .00 0 0-3 6.21 (.22) 46.18 (.43)
Frequencies of situations in which the participants reported a propensity to sleep 
are summarized in Table 21. A total score for the frequency for each situation was 
calculated by summing all frequencies of chance (slight, moderate, and high) to yield the 
total number of HF participants to fall asleep or doze off in that situation. The results 
showed that the top three situations causing daytime sleepiness within this sample were 
“lying down to rest in the afternoon,” “watching TV,” and “sitting quietly after a lunch 
without alcohol.” In those three situations, 77.6% to 53.6% of the participants reported a 
propensity to fall asleep, with most of the participants rating their chances to doze off as 
high. Situations with lower frequencies were “sitting and talking to someone” and “in a 
car while stopped for a few minutes in the traffic,” accounting for 6.4% and 5.6%, 
respectively. 
Daytime Napping 
The results showed that 102 (81.6%) of the participants reported they were prone 
to habitual daytime napping after lunch. Among them, 78 (62.4%) of the 125 participants 
took daytime naps everyday, and six took naps three to four days per week. 
Approximately five subjects stated that they had to take naps several times during 
daytime because of fatigue. The mean duration of daytime napping for the 102 
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participants who napped was 82.3 (SD = 50.42) minutes, with a range from 10 minutes to 
240 minutes. Information about daytime napping among the participants is shown in 
Table 22.  
 
Table 21  
Frequencies for Situations Causing Daytime Sleepiness             (n= 125) 
Score 0 1 2 3 Total for 1-3
Situation n (%) n (%) n (%) n (%) n (%) 
Lying down to rest in the afternoon 28 (22.4) 12 (9.6) 10 (8.0) 75 (60.0) 97 (77.6) 
Watching TV 50 (40.0) 29 (23.2) 19 (15.2) 27 (21.6) 75 (60.0) 
Sitting quietly after a lunch without 
alcohol 
58 (46.4) 13 (10.4) 5 (4.0) 49 (39.2) 67 (53.6) 
As a passenger in a car for an hour 
without rest 
72 (57.6) 15 (12.0) 6 (4.8) 32 (25.6) 53 (42.4) 
Sitting and reading 83 (66.4) 15 (12.0) 13 (10.4) 14 (11.2) 42 (33.6) 
Sitting, inactive in a public place 89 (71.2) 19 (15.2) 2 (1.6) 15 (12.0) 36 (28.8) 
Sitting and talking to someone 117 (93.6) 3 (2.4) 2 (1.6) 3 (2.4) 8 (6.4) 
In a car when stopped for a few minutes in 
the traffic 
118 (94.4) 6 (4.8) 0 (.0) 1 (.8) 7 (5.6) 
* Score 0: would never doze; Score 1: slight chance of dozing; Score 2: moderate chance of 
dozing; Score 3: high chance of dozing  
 
Table 22  
Daytime Napping of the Participants    (n= 125) 
  Frequency Percent 
Nap           
No 23 18.4 
Yes 102 81.6 
Frequency of daytime napping 
Everyday 80 64.0 
5-6 days/week 4 3.2 
3-4 days/week 12 9.6 
1-2 day(s)/week 6 4.8 
Duration of daytime napping (median and mode: 60 minutes) 
10-30 minutes 19 15.2 
31-60 minutes 36 28.8 
61-120 minutes 30 24.0 
120-240 minutes 15 12.0 
Question 2. What is the perception of HRQOL among Taiwanese people living with HF? 
HRQOL was measured using the KCCQ where HRQOL is a conceptual model 
that comprises four domains: physical symptoms, functional status, psychological status, 
and social. An overall summary score was calculated by summing scores in those four 
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domains. The possible KCCQ domains and overall summary scores range from 0 to 100, 
with high scores indicating better HRQOL. The mean KCCQ overall summary score for 
the 125 participants was 70.50 (SD = 19.63), with a range from 11.98 to 95.83. The 
physical symptom domain had the highest score (mean = 73.98, SD = 21.31), and 
psychological status was the lowest (mean = 65.60, SD = 24.72). In addition to the four 
domains of the KCCQ, two other domains—symptom stability and self-efficacy—were 
used to help in the interpretation of the KCCQ for the participants with HF. Data of the 
KCCQ are shown in Table 23.  
 
Table 23  
KCCQ Scores of the Participants                             (n=125) 
 Mean (SD) Median Mode Range Skewness (SD) Kurtosis (SD)
Overall Summary 70.50 (19.63) 73.96 73.96 11.98-95.83 -.79 (.22) -.11 
Physical symptoms 73.98 (21.31) 78.13 100.00 6.25-100.00 -.78 (.22) -.02 
Frequency 66.70 (25.23) 68.75 100.00 4.17-100.00 -.45 (.22) -.67 
Burden 81.27 (21.89) 91.67 100.00 8.33-100.00 -1.28 (.22) .89 
Symptom stability 52.00 (19.73) 50.00 50.00 0.00-100.00 -.34 (.22) 1.33 
Functional status 73.14 (23.70) 79.17 91.67 0.00-100.00 -1.21 (.22) .91 
Psychological status 65.60 (24.72) 66.67 83.33 0.00-100.00 -.52 (.22) -.61 
Social functioning 69.27 (25.08) 75.00 93.75 0.00-100.00 -.71 (.22) -.33 
Self-efficacy 77.70 (27.71) 87.50 100.00 0.00-100.00 -1.33 (.22) .92 
Physical Symptoms 
Physical symptoms were measured with the KCCQ symptom total subscale, 
which included symptom frequency and symptom burden. Overall, the participants had a 
mean physical symptoms score of 73.98 (SD = 21.31). The score range varied from 6.25 
to 100.00. It is worth noting that 14 (11.2%) of the participants had full scores (100) in 
the domain of physical symptom, indicating that they did not perceive any HF symptoms 
or symptom burdens over the past two weeks (see Table 24). 
Symptom frequency. The mean score for the four-item symptom frequency 
subscale was 66.70 (SD = 25.23) with a range of 4.17 to 100. As shown in Table 24, 94 
(75.2%) of the participants did not have swelling feet, ankles, or legs when awaking in 
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the morning, whereas 31 participants experienced the symptoms occasionally or everyday 
in the two weeks prior to their interviews for this study. Approximately 70% of the 
subjects reported that fatigue or tiredness stopped them from doing what they wanted to 
do during the previous two weeks. Eighty-five participants had experienced shortness of 
breath or dyspnea when doing activities such as working, walking, climbing stairs, and 
sitting. Additionally, during the previous two weeks one-fourth of the participants had to 
sleep in a chair or with a quilt or more pillows than usual to prop themselves up because 
of shortness of breath. 
Table 24  
Physical Symptom of the Participants          (n=125) 
 Mean (SD) Possible Range  Frequency Percent
Symptom frequency (mean = 66.70, SD = 25.23) 
Yes 31 24.8 Having swelling    4.13 (1.60) 1-5 No 94 75.2 
Yes 87 69.6 Having fatigue 4.33 (2.29) 1-7 No 38 30.4 
Yes 85 68.0 Having shortness of breath  
(SOB) 4.34 (2.16) 1-7 No 40 32.0 
Yes 30 24.0 Slept in a chair or with more 
pillows 4.10 (1.64) 1-5 No 95 76.0 
Symptom burden (mean = 81.27, SD = 21.89) 
Yes 22 19.6 Bothered by swelling 5.38 (1.22) 1-6 No 103 80.4 
Yes 55 44.0 Bothered by fatigue  4.46 (1.50) 1-6 No 70 56.0 
Yes 71 56.8 Bothered by SOB 4.23 (1.61) 1-6 No 54 43.2 
Symptom burden. The mean score of symptom burden was 81.27 (SD = 21.89). 
Symptom burden consisted of three items asking about burdens from the symptoms of 
swelling, fatigue, and shortness of breath in the two weeks prior to the interviews for this 
study. A large proportion (80.4%) of the participants stated that they were not bothered by 
the symptom of swelling during the previous two weeks. Forty-four percent of the 
participants reported that they suffered from the burden of fatigue, and 56.8% said that 
they experienced the burden of shortness of breath or dyspnea over the previous two 
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weeks. Overall, several participants answered that they did not perceive any symptom 
burden although they were living with one or more HF symptoms. 
Symptom Stability 
Stability was a single item that asked participants whether their symptoms had 
changed compared to what they were two weeks ago prior to the interviews for this study. 
Over 60% of the participants were living with stable conditions regarding their HF 
symptoms. Approximately 20% of this group noted that they felt a little better, and four 
participants reported they were much better, especially those who were recently 
discharged from the hospital. Eighteen participants felt a little worse or much worse 
compared to their conditions two weeks previously. Data for symptom stability are shown 
in Table 25. 
 
Table 25  
Symptom Stability of the Participants    (n=125) 
  Frequency Percent 
Much worse 6 4.8 
A little worse 12 9.6 
No change 77 61.6 
A little better 26 20.8 
Much better 4 3.2 
Functional Status 
Functional status was measured using the KCCQ physical limitation subscale. 
The average functional status score was 73.14 (SD = 23.70), with a range from 0 to 100. 
Functional status comprised six questions that asked participants to evaluate their 
limitations in performing six daily activities over the two weeks prior to the interviews 
for this study. The possible range was from 1 (extremely limited) to 5 (not limited). As 
shown in Table 26, the most difficult daily activities performed by the participants was 
“hurrying or jogging” (92.8%). Eighty-three participants reported slight to extreme 
limitations in doing yardwork or housework and carrying groceries. Several participants 
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mentioned that they did not even attempt to perform those tasks after being diagnosed 
with HF. Sixty percent of the subjects had problems with climbing stairs without stopping. 
Several participants mentioned that they still climbed stairs because their houses or 
apartments did not have elevators, even though they had a moderate to severe limitation 
in doing so. In contrast, some participants had stopped climbing stairs although they had 
only slight to moderate limitations in that activity. Fifty-seven (45.6%) of the participants 
stated that they had no difficulties walking on the level ground if there were no time 
limits; however, over half of the participants had limitations in walking one block (100 
meters). Additionally, 22.4% to 26.4% of the participants perceived slight to extreme 
limitations in dressing and taking a shower or bath, and some had to depend on assistance 
of family members. 
 
Table 26  
Functional Status of the Participants        (n= 125) 
Activity Mean (SD) Possible Range Lmt Frequency Percent
Yes 28 22.4 Dressing yourself 4.68 (.76) 1-5 No 97 77.6 
Yes 33 26.4 Showering/ Bathing 4.55 (.93) 1-5 No 92 73.6 
Yes 68 54.4 Walking 1 block on level ground 4.10 (1.10) 1-5 No 57 45.6 
Yes 83 66.4 Doing yardwork, housework or 
carrying groceries 3.75 (1.29) 1-5 No 42 33.6 
Yes 75 60.0 Climbing a flight of stairs without 
stopping 3.74 (1.44) 1-5 No 50 40.0 
Yes 116 92.8 Hurrying or jogging (as if to 
catch a bus) 2.67 (1.44) 1-5 No 9 7.2 
Psychological Status 
Psychological status was assessed using the KCCQ quality of life subscale, which 
consisted of three items (see Table 27). The mean score for this domain was 65.60 (SD = 
24.72). Approximately half of the participants perceived they had slight to extreme 
restrictions in their enjoyment of life over the two weeks prior to the interviews for this 
study because of lifestyle modifications, including eating low-salt or low-fat diets and 
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taking HF medications everyday, as well as adjusting to other limitations, such as those 
affecting their ability to travel inside or outside the country. Over 84% of the participants 
reported slight to complete dissatisfaction with the prospect of “spending the rest of your 
life with your HF the way it is right now.” More than half of the subjects “felt 
discouraged or down in the dumps” about their HF. The frequency for that item ranged 
from only once or twice to all of the time over the previous two weeks.  
 
Table 27  
Psychological Status of the Participants              (n=125) 
 Mean (SD) Range Lmt Frequency Percent 
Yes 63 50.4 Restriction in enjoyment of life 4.08 (1.18) 1-5 No 62 49.6 
Yes 105 84.0 Not satisfaction with spending the 
rest of life with HF 2.74 (1.50) 1-5 No 20 16.0 
Yes 63 50.4 Felt discouraged or down in the 
dumps  4.05 (1.11) 1-5 No 62 49.6 
Social Functioning 
Social functioning was measured with the KCCQ social limitation subscale, 
which asked the participants to evaluate their limitations in carrying out four social 
activities over the previous two weeks (see Table 28). The possible range for each item 
was from 1 (severely limited) to 5 (not limited). Sixty-four percent of the participants had 
slight to extreme restrictions in taking part in hobbies and recreational activities, 
particularly in taking overnight trips. Approximately 83.2% had mild to great difficulties 
in working or doing household chores. More than half of the group had problems visiting 
family or friends. Among them, 17 (13.6%) of the participants stated that they had 
stopped visiting friends after being diagnosed with HF, and 27 (21.6%) needed the 
assistance of family members when they had to do so. Likewise, 25.6% of the 
participants perceived they had limitations to their ability to maintain intimate 
relationships with loved ones. However, it is worth noting that participants interpreted the 
term “intimate relationship” differently. Several participants explained this term as “doing 
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sexual activities with their spouses.” In contrast, most participants recognized it as 
“maintaining relationship with their families,” particularly for those people who had no 
spouses or stated that they did not have sexual activities with their spouses for a long 
time.  
 
Table 28  
Social Functioning of the Participants                  (n=125) 
Activity Mean (SD) Possible Range Lmt Frequency Percent
Yes 80 64.0 Doing hobbies, recreational 
activities 3.58 (1.46) 1-5 No 45 36.0 
Yes 104 83.2 Working or doing household 
chores 3.12 (1.43) 1-5 No 21 16.8 
Yes 63 50.4 Visiting family or friends 3.77 (1.49) 1-5 No 62 49.6 
Yes 32 25.6 Having intimate relationship with 
loved ones 4.61 (.90) 1-5 No 93 74.4 
Self-Efficacy 
Self-efficacy was measured using the two-item KCCQ self-efficacy subscale. As 
shown in Table 29, the mean score for the 125 subjects was 77.70 (SD = 27.71). For the 
item “how sure are you that you know what to do, or whom to call, if your heart failure 
gets worse,” 100 (80%) of the participants answered that they completely understood 
what they should do; for example, they knew to take certain medication, return to their 
physicians’ clinics, or call 911. Overall, the participants had certain levels of confidence 
in dealing with their HF when symptoms recurred or got worse. Regarding their 
knowledge in preventing HF symptoms from getting worse, 44.8% of the participants 
reported that they completely understood what to do, whereas 21.6% stated that they did 
not quite understand or they did not understand at all. 
 
Table 29  
Self-Efficacy of the Participants                   (n=125) 
 Mean SD Range 
Sure what to do or whom to call, if HF gets worse 4.34 1.40 1-5 
Understand what things can do to keep HF 
symptoms from getting worse 3.87 1.31 1-5 
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Question 3. What are the relationships among HRQOL, sleep disorders, HF 
characteristics, and individual characteristics, including demographics and 
health-related characteristics? 
Relationships Among Sleep Variables 
As shown in Table 30, the Pearson correlation coefficients for the relationships 
between global PSQI and its components ranged from .33 (daytime dysfunction) to .84 
(sleep efficiency). Except for daytime dysfunction, the remaining domains showed 
significant correlations, although the relationships were low to moderate (r = .18 to .69). 
Subjective sleep quality was significantly correlated with all other PSQI domains ranging 
from .18 (p<.05, daytime dysfunction) to .64 (p<.001, sleep efficiency). Among the 
relationships between sleep latency and other PSQI domains, sleep efficiency had the 
highest association (r = .62, p<.001) and daytime dysfunction was the lowest (r = .07, 
p>.05). The associations between sleep duration and other PSQI domains ranged from .69 
(p<.001, sleep efficiency) to .13 (p>.05, daytime dysfunction). Sleep efficiency was 
highly correlated with sleep quality (r = .64, p<.001), sleep latency (r = .62, p<.001), and 
sleep duration (r = .69, p<.001), moderately associated with sleep disturbances (r = .35, 
p<.01) and the use of sleeping medication (r = .26, p<.01), as well as lowly correlated 
with daytime dysfunction (r = .13, p>.05). Sleep disturbance had moderate to low 
correlations with other domains (r = .40 to .15). Daytime dysfunction, however, had a 
significant but small correlation only with subjective sleep quality (r = .21, p<.05). 
Additionally, the use of sleeping medication was lowly associated with other domains (r 
= .33 to r = .23). 
In regard to the relationship between nocturnal sleep quality and daytime 
sleepiness, the ESS score was positively related to daytime dysfunction (.32, p<.001), 
indicating that the greater the daytime dysfunction, the more the HF participants 
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experienced daytime sleepiness. The prevalence, frequency, and duration of daytime 
napping, however, correlated neither with PSQI scores nor with ESS scores. 
 
Table 30  
The Relationships Among Sleep Variables              (n=125) 
Variables 1 2 3 4 5 6 7 8 9 10 11
1. Global PSQI            
2. Sleep quality .78***           
3. Sleep latency .74*** .54***          
4. Sleep duration .73*** .46*** .37***        
5. Sleep 
efficiency .84*** .64*** .62*** .69***        
6. Sleep 
disturbances .61*** .45*** .45*** .35** .47***       
7. Daytime 
dysfunction .33*** .18* .07 .13 .05 .13      
8. Sleeping 
medication .52*** .33*** .25** .26** .28** .21*-.03     
9. CESS .10 .09 -.07 .14 .03 .11 .32*** -.09    
10.Nap- 
prevalence -.02 .02 -.10 .00 .03 .13 -.09 -.01 .02   
11.Nap- 
frequency .05 .12 -.07 .02 .07 .11 -.06 .07 .03 .86***  
12.Nap- duration -.03 -.02 -.02 -.16 -.09 .03 .05 .10 -.001 .00 .02
*p< 0.05 level, **p<.01 level, ***p< 0.001 level (2-tailed). 
Relationships Among Domains of HRQOL 
Table 31 presents the correlations among KCCQ domains and the overall 
summary score. The results showed that all domains were highly associated with the 
KCCQ overall summary score. In addition, the domains were significantly correlated 
with each other. The Pearson correlation coefficients ranged from .46 to .70, all 
representing significance levels less than .001. Symptom stability was significantly 
associated only with physical symptoms (r = .23, p<.05), meaning that the higher the 
score for symptom stability, the better the physical symptom score reported by the HF 
participants. Self-efficacy was not significantly related to any KCCQ domain in this 





Table 31  
Relationships Among Major Variables               (n=125) 
Variables 1 2 3 4 5 6 
1. KCCQ overall       
2. Physical symptom .85***     
3. Functional status .86*** .70***    
4. Psychological status .78*** .61*** .46***   
5. Social functioning .83*** .54*** .70*** .50***  
6. Symptom stability .15 .23* .06 .14 .09 
7. Self-efficacy .14 .10 .12 .12 .15 .13 
*p< 0.05 level, ***p< 0.001 level (2-tailed). 
Relationships Between Demographic Variables and HRQOL 
Several significant but small correlations appeared between demographic data and 
the overall KCCQ summary score, functional status, and social functioning (see Table 32). 
Level of education, however, was the only demographic variable that had a significant 
association with physical symptom. Additionally, no demographic variable showed a 
correlation with psychological status. 
 
Table 32  








KCCQ overall -.20* .16 -.15 .01 .29** -.03 .18* .19* 
Physical symptom -.06 .16 -.06 -.06 .19* .03 .11 .001 
Functional status -.32*** .10 -.23* .06 .31** -.12 .22* .27** 
Psychological status .01 .16 -.03 -.02 .17 .12 .05 .10 
Social functioning -.29** .10 -.18* .05 .32*** -.11 .23* .23* 
*p< 0.05 level, **p<.01 level, ***p< 0.001 level (2-tailed). 
Analyses for the relationships between each demographic variable and the KCCQ 
domains are as follows. Age had negative relationships with the KCCQ overall summary 
score (r = -.20, p<.05), functional status (r = -.32, p<.001), and social functioning (r = 
-.29, p<.01). Gender, living arrangement, and employed status showed no substantial 
associations with KCCQ scores. Marital status was correlated with functional status (r = 
-.23, p<.05) and social functioning (r = -.18, p<.05). Education had small but significant 
relationships with all KCCQ domains (r = .19, p<.05 to r = .32, p<.001), except for 
psychological status (r = .17, p>.05). Financial status and type of language were 
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positively correlated with KCCQ overall summary score (r = .18, p<.05 and r = .19, 
p<.05, respectively), functional status (r = .22, p<.05 and r =.27, p<.01, respectively), and 
social functioning (both r = .23, p<.05).  
Relationships Between Health-Related Demographic Characteristics and HRQOL 
As shown in Table 33, BMI was not correlated with any domains of the KCCQ. 
The scores for CCI-number and CCI-severity were significantly related to the KCCQ 
overall score, functional status, and psychological status (r = -.18 to r = -.23). 
Additionally, CCI-number had a low correlation with social functioning (r = -.19, p<.05). 
Except for the relationship with the domain of psychological status, the number of 
non-cardiovascular problems had significant associations with the remaining domains of 
the KCCQ (r = -.19, p<.05 to r = -.25, p<.01). In contrast, the number of cardiovascular 
diseases was not associated with KCCQ scores. After summing all cardiovascular and 
noncardiovascular problems together, concomitant health problems had only one 
relationship, which was a negative association with social functioning (r = -.19, p<.05). 
Furthermore, perceived health as measured by the modified SRHS was correlated with all 
KCCQ domains (r = .20, p<.05 to r =.33, p<.001), except for the domain of social 
functioning (r = .16, p>.05). 
 
Table 33  
Relationships Between Health-Related Demographic Characteristics and HRQOL 
Variables  CCI Concomitant Problems  
 BMI Number Severity Total CVD Non-CVD SRHS 
KCCQ overall -.04 -.23* -.23* -.12 .07 -.20* .26** 
Physical symptom -.14 -.16 -.17 -.09 .12 -.21* .20* 
Functional status -.004 -.22* -.24** -.13 .04 -.19* .21* 
Psychological status -.13 -.19* -.18* .02 .07 -.03 .33***
Social functioning .13 -.19* -.17 -.19* .02 -.25** .16 
*p< 0.05 level, **p<.01 level, ***p< 0.001 level (2-tailed). 
Relationships Between Heart Failure Characteristics and HRQOL 
Among the relationships with HF characteristics (see Table 34), the strongest 
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correlation was between NYHA Classification and HRQOL (r = -.43, p<.001 for 
psychological status to r = -.68, p< .001 for the KCCQ overall summary score). The type 
of HF had a significant association with the domain of social functioning; however, the 
relationship was small (r= .19, p<.05). Additionally, prescribed HF medication and 
duration since HF diagnosis did not relate to the KCCQ overall score or any domain 
score. 
 
Table 34  
Relationships Between HRQOL and Health-Related Demographic Characteristics 







KCCQ overall .12 -.68*** -.01 .02 
Physical symptom .03 -.58*** .06 .06 
Functional status .14 -.63*** -.02 -.06 
Psychological status .02 -.43*** .04 .09 
Social functioning .19* -.60*** -.10 -.02 
*p< 0.05 level, **p<.01 level, ***p< 0.001 level (2-tailed). 
Relationships Between Sleep Variables and HRQOL 
The relationships between sleep variables and HRQOL are shown in Table 35. 
Except for the prevalence of daytime napping and the KCCQ domain of physical 
symptom, all sleep variables showed low to moderate negative relationships with scores 
on the KCCQ overall score and all domain scores. The strongest correlation was between 
the KCCQ overall summary score and the global PSQI score (r=-.45, p<.001), and the 
weakest relationship was between the KCCQ domain of functional status and the PSQI 
component of use of sleeping medication (r = -.14, p>.05). The scores on global PSQI, 
subjective sleep quality, sleep efficiency, and sleep disturbances had significant 
correlations with all scores on the KCCQ (r = -.21, p<.05 to r = -.45, p<.001). Sleep 
duration was negatively correlated with the KCCQ overall summary score (r = -.22, 
p<.05), physical symptom (r = -.25, p<.01), and social functioning (r = -.21, p<.05), but 
not with functional status and psychological status. Sleep latency did not have a 
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relationship with psychological status (only r = -.05), whereas the use of sleeping 
medication was barely associated with psychological status (r = -.19, p<.05). The domain 
of daytime dysfunction was significantly related to all KCCQ scores (r= -.20, p<.05 to r = 
-.31, p<.001), except for domain of social functioning (r = -.15, p>.05). 
Regarding daytime sleep, the ESS score had the same trend with daytime 
dysfunction. Pearson correlation coefficients for the relationships between ESS and 
HRQOL were from -.14 (p>.05) for social functioning to -.24 (p<.01) for both the KCCQ 
overall summary score and the domain of psychological status. The frequency of daytime 
napping was the only variable that correlated with social functioning (r = -.19, p<.05), 
indicating that the higher the score for frequency of daytime napping, the poorer the score 
for social functioning reported by Taiwanese persons with HF. 
 
Table 35  















Global PSQI -.45*** -.41*** -.36*** -.28** -.44*** -.21* .03 
Sleep quality -.42*** -.38*** -.32*** -.29** -.40*** -.15 .03 
Sleep duration -.22* -.25** -.13 -.15 -.21* -.13 -.06 
Sleep latency -.27** -.22* -.28** -.05 -.34** -.22* .06 
Sleep efficiency -.41*** -.33*** -.40*** -.21* -.43*** -.14 -.06 
Sleep disturbances -.35*** -.40*** -.27** -.22* -.29** -.08 .07 
Daytime dysfunction -.27** -.31*** -.23** -.20* -.15 -1.70 -.01 
Sleeping medication -.14 -.08 -.02 -.19* -.17 -.06 .11 
CESS -.24** -.23* -.19* -.24** -.14 -.12 -.23** 
Prevalence -.06 .01 -.07 -.01 -.11 .10 -.10 
Frequency -.15 -.07 -.13 -.08 -.19* .16 .03 
Daytime 
napping 
Duration -.13 -.16 -.10 -.10 -.08 1.12 -.01 
* p< 0.05 level, ** p< 0.01 level, *** p< 0.001 level (2-tailed). 
In summary, sixteen variables were correlated with the main variable HRQOL, as 
measured by the KCCQ overall summary score. They were age, education, financial 
status, type of language, NYHA classification, CCI-number, CCI-severity, chart-review 
concomitant noncardiovascular health problems, perceived health, subjective sleep quality, 
sleep duration, sleep latency, sleep efficiency, sleep disturbances, daytime dysfunction, and 
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daytime sleepiness. Pearson correlation coefficients ranged from .18 (financial status) 
to .68 (NYHA Classification). A summary of the correlates of HRQOL is shown in Table 
36. According to the results from the analyses of HRQOL and demographic data, 
participants who were younger, had higher educational levels and better financial status, 
and those who could speak both Taiwanese and Mandarin reported better HRQOL. From 
the analyses of HRQOL and HF characteristics, the results showed that participants with 
lower levels of NYHA Classes perceived a better HRQOL. In regard to the relationships 
between HRQOL and health-related characteristics, participants who were living with 
smaller numbers of comorbid conditions and with less severe comorbidity as measured by 
CCI and participants with a smaller number of concomitant noncardiovascular problems 
and better health perceptions experienced better HRQOL. According to the findings from 
the analyses of HRQOL and sleep variables, Taiwanese persons who had higher subjective 
sleep quality, longer sleep durations, less sleep latency, better sleep efficiency, fewer sleep 
disturbances, and lower levels of daytime sleepiness reported better HRQOL. 
 
Table 36  
Correlates of HRQOL  (n=125) 
Variable HRQOL 
NYHA Class -.68*** 
Subjective sleep quality -.42*** 
Sleep efficiency -.41*** 
Sleep disturbances -.35*** 
Education .30** 
Sleep latency -.27** 





Sleep duration -.22* 
Age -.20* 
Concomitant Problems- non-CVD -.20* 
Language .19* 
Financial status1 .18* 
*p< 0.05 level, **p<.01 level, ***p< 0.001 level (2-tailed). 
1Eliminated from the multiple regression analysis.  
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Question 4. What are the predictors of HRQOL among Taiwanese people with HF? 
As described in Question 3, 16 predictor variables showed correlations with 
HRQOL as measured by the KCCQ overall summary score. Before initiating the multiple 
regression analysis to identify the predictors of HRQOL in Taiwanese persons with HF, 
certain assumptions of a multiple regression analysis were examined for the data to 
ensure that the findings from the analyses could be generalized to the general population. 
The assumption of normality was supported by an analysis of a stem-and-leaf chart and 
histogram of the Studentized residual (Norusis, 2004). The Kolmogorov-Smirnov statistic 
for the residual model was .07 (p>.05) (Munro, 2001). Likewise, a Q-Q plot showed that 
the Studentized residuals fell close to a straight line, indicating that the sample was drawn 
from a normal distribution (Norusis, 2004). The assumption of independence was met 
according to a Durbin-Watson statistic of 2.28 (within a range of 1.5 to 2.5) (Norusis, 
2004). The linearity assumption was supported by a linear relationship between the 
Studentized residuals and the KCCQ overall summary score. Furthermore, the plots of the 
Studentized residuals and predicted values showed that the residuals were randomly 
scattered along a horizontal line through zero, indicating that the homoscedasticity 
assumption was met (Norusis, 2004). 
Multicollinearity, however, should be considered a problem because two pairs of 
variables each showed high and moderate correlations: CCI-number vs. CCI-severity (r 
= .95, p<.001) and education vs. type of language (r = .58, p<.001). An initial regression 
analysis with all variables was therefore performed to obtain collinearity diagnostics 
(Hutcheson & Sofroniou, 1999). The results showed that CCI-number and CCI-severity 
had similar data for tolerance (.08 for each) and VIF (12.51 for CCI-number vs. 13.03 for 
CCI-severity). CCI-number, however, had a higher unstandardized coefficient (B = -4.70) 
and standardized coefficient (Beta = -.30) than CCI-severity (B =2.03, Beta = .19). It was 
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decided to exclude CCI-severity and to retain CCI-number. Similarly, education was 
moderately correlated with type of language (r = .68, p<.001). The tolerance and VIF for 
education were .45 and 2.12, respectively, and for type of language they were .43 and 
2.30, respectively. Education had a higher unstandardized coefficient (B = 1.16) and a 
standardized coefficient (Beta = .10) than type of language (B = -0.75, Beta = -.04). 
Therefore, the variable of type of language was eliminated from the regression model. As 
a result, fourteen variables were included in the regression model, and the Pearson 
correlation coefficients among the final predictor variables ranged from -.01 to .69, 
tolerance was from .47 to .88, and VIF was from 1.14 to 3.82. 
Hierarchical Multiple Regression Analysis 
Variables entered into the regression model were based on the conceptual model 
of this study. The fourteen variables were available to enter in three steps using a 
hierarchical multiple regression analysis with forward method. A total of six models were 
generated in the three steps. The R2 for the final model was .585 (p<.001), with an 
adjusted R2 of .564.  
Age, education, and financial status were available to enter in the first step as 
covariates. Education was the only significant predictor among these three predictor 
variables of HRQOL, accounting for 9.0% of the variance (p<.01). Those who had higher 
education levels had better HRQOL. 
CCI-number, noncardiovascular concomitant problem, perceived health, and 
NHYA Class were available to enter in the second step as covariates. Two significant 
predictors were identified from these four variables. When NYHA Class was added to the 
second model, the R-square (R2) increased by .398 (p<.001), from .09 to .488. When 
CCI-number was added to the third model, it accounted for an additional 2.6% of the 
variance (p<.05) and 51.4% of the variance associated with education and NYHA Class. 
 137
NYHA Class and CCI-number collectively accounted for 42.4% of the variance in 
HRQOL. Participants with HF who had lower NYHA Classes and a small number of 
comorbid conditions reported higher HRQOL. 
In the third step, six components of nocturnal sleep quality (subjective sleep 
quality, sleep duration, sleep latency, sleep efficiency, sleep disturbances, and sleep 
dysfunction) and daytime sleepiness were available to enter. The results showed that after 
controlling for education, comorbidity, and NYHA Class, subjective sleep quality, sleep 
disturbances, and sleep latency were identified as significant predictors and accounted for 
7.0% of the variance in HRQOL. Subjective sleep quality, when entered into Model 4, 
accounted for 3.7% of the variance in HRQOL (p<.001), resulting an increased R2, 
from .514 to .551. When sleep disturbances was added to Model 4 to obtain Model 5, the 
percentage of the variance increased by 1.5% (p<.05), from 55.1% to 56.7%. The 
addition of sleep latency to Model 5 to obtain Model 6 explained an additional 1.8% of 
the variance (p<.05). The findings indicated that those who had fewer sleep disturbances, 
better subjective sleep quality, and shorter sleep latency experienced better HRQOL. In 
contrast, sleep efficiency, sleep duration, daytime dysfunction, and daytime sleepiness 
did not show significant contributions to HRQOL. The summary for the hierarchical 
multiple regression of predictor variables on HRQOL is shown in Table 37. 
 
Table 37  
Hierarchical Multiple Regression of Predictor Variables on HRQOL    (n=125)  
Model Predictors B B SE Beta df F R2 Adjusted R2 R2 Change
Step 1          
1 (Constant) 60.33 3.37   1, 123 12.11** .090 .082  
  Education 3.46 1.00 .30**     .090** 
Step 2          
2 (Constant) 119.00 6.53   2, 122 58.14*** .488 .480  
  Education 2.10 .76 .18**      
  NYHA Classes -24.32 2.50 -.64***     .398***
          
3 (Constant) 121.84 6.49   3, 121 42.70*** .514 .502  
  Education 2.18 .75 .19**      
  NYHA Classes -23.57 2.46 -.62***      
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Table 37 (Continued) 
Model Predictors B B SE Beta df F R2 Adjusted R2 R2 Change
  CCI-number 2.56 1.00 -.16***     .026* 
Step 3          
4 (Constant) 124.66 6.32   4, 120 36.88*** .551 .537  
  Education 1.85 .73 .16*      
  NYHA Classes -21.80 2.44 -.58***      
  CCI-number -1.97 .98 -.13*      
  Sleep quality -4.43 1.41 -.21**     .037** 
          
5 (Constant) 128.67 6.54  5, 119 31.12*** .567 .548  
  Education 1.80 .72 .16*      
  NYHA Classes -21.38 2.42 -.57***      
  CCI-number -1.98 .97 -.13*      
  Sleep quality -3.17 1.52 -.15*      
  Sleep disturbance -4.62 2.26 -.14*     .015* 
          
6 (Constant) 130.05 6.46  6, 118 27.69*** .585 .564  
  Education 1.87 .71 .16**      
  NYHA Classes -22.50 2.42 -.59***      
  CCI-number -2.03 .95 -.13*      
  Sleep quality  -4.57 1.62 -.21**      
  Sleep disturbance -5.96 2.30 -.18*      
  Sleep latency 2.99 1.32 .17*     .018* 
Note. Analyzed by the forward method.  
F for final equation = 27.69 with 6/118 degree freedom (df), p<.001. 
*p< 0.05 level, **p<.01 level, ***p< 0.001 level (2-tailed). 
Additional Analyses 
Predictors of Nocturnal Sleep Quality 
The study found that ten variables were correlated with the global PSQI score, as 
shown in Table 38. The participants who experienced poor sleep quality were female; had 
lower educational levels and higher NYHA Classes; higher numbers for comorbidity and 
perceived poor health; and reported poor physical symptom, symptom stability, 
functional status, psychological status, and social functioning. 
 
Table 38  
Correlates of Global PSQI Score         (n=125) 
Variables Global PSQI 
Social functioning -.44*** 
Physical symptom -.41*** 
Functional status -.36*** 
NYHA Class .35*** 
Psychological status -.28** 
Perceived health -.27*** 
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Symptom stability -.21** 
CCI-number .20* 
Education  -.19* 
Gender -.18* 
*p< 0.05 level, **p<.01 level, ***p< 0.001 level (2-tailed). 
A three-step hierarchical multiple regression analysis with forward method was 
then employed to identify predictors of nocturnal sleep quality, as measured by the global 
PSQI. Before the analysis proceeded, assumptions of the multiple regression analysis 
were examined, and the data met the criteria. Variables entered into the regression model 
were based on the conceptual model of this study. The ten variables were available to 
enter on three steps. Gender and education were available to enter in the first step as 
covariates. Education, which was the only significant predictor in this step, accounted for 
3.4% of the variance (p<.05). Those who had higher educational levels reported better 
nocturnal sleep quality. The NYHA Class, CCI-number, and perceived health were 
available to enter in the second step. Two significant predictors were identified from these 
three variables. When NYHA Class was added to the Model 2, it accounted for an 
additional 10% of the variance in nocturnal sleep quality (p<.001). When perceived 
health was added into the third model, R2 was increased by .037 (p<.05), from .134 
to .171. When five KCCQ domains were available to enter into the third step, only social 
functioning and physical symptom were significant predictors of nocturnal sleep quality 
among the six predictor variables. Social functioning, when added to generate Model 4, 
accounted for an additional 6.9% of the variance (p<.01), and physical symptom was 
added for a Model 5, which increased the variance by 2.9%, from 24.0% to 26.9%. The 
summary for the hierarchical multiple regression of predictor variables on nocturnal sleep 
quality is shown in Table 39. 
Overall, the total variance explained by the final model was 26.9%. After 
controlling for education, NYHA Class, and perceived health, the analysis showed that 
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two variables—social functioning, and physical symptom—accounted for 9.8% of the 
variance in nocturnal sleep quality. Participants who experienced better social functioning 
and fewer physical symptoms reported better nocturnal sleep quality. In contrast, the 
overall HRQOL, functional status, and psychological status were not predictors of 
nocturnal sleep quality.  
Table 39  
Hierarchical Multiple Regression of Predictor Variables on Nocturnal Sleep Quality  (n=125) 
Model Predictors B B SE Beta df F R2 Adjusted R2 R2 Change
Step 1          
1 (Constant) 10.54 .82  1, 123 4.34* .034 .026  
  Education -.51 .24 -.19*     .034* 
Step 2          
2 (Constant) 3.58 2.01  2, 122 9.47*** .134 .120  
  Education -.34 .23 -.13      
  NYHA Classes 2.89 .77 .32***     .10*** 
          
3 (Constant) 6.89 2.43  3, 121 8.34*** .171 .151  
  Education -.27 .23 -.10      
  NYHA Classes 2.56 .77 .29**      
  Perceived health -.86 .37 -.20*     .037* 
Step 3          
4 (Constant) 14.43 3.28  4, 120 9.47*** .240 .215  
  Education -.07 .23 -.03      
  NYHA Classes .88 .90 .10      
  Perceived health -.85 .36 -.20*      
  Social functioning -.06 .02 -.34**     .069** 
          
5 (Constant) 18.65 3.77  5, 119 8.74*** .269 .238  
  Education -.06 .23 -.02      
  NYHA Classes .10 .96 .01      
  Perceived health -.78 .35 -.18*      
  Social functioning -.05 .02 -.28*      
  Physical symptom -.05 .02 -.22*     .029* 
 Analyzed by the forward method 
F for final equation = 8.74 with 5/119 degree freedom (df), p<.001. 
*p< 0.05 level, **p<.01 level, ***p< 0.001 level (2-tailed). 
Predictors of Daytime Sleepiness 
Seven variables showed small but significant correlations with daytime sleepiness 
as measured by ESS. Those who had higher level of daytime dysfunction, greater BMI, 
and poor perceptions of health, psychological status, self-efficacy, physical symptom, and 
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functional status experienced higher daytime sleepiness. The summary of correlates of 
daytime sleepiness is given in Table 40. 
 
Table 40  
Correlates of Daytime Sleepiness    (n=125) 
 Daytime sleepiness 
PSQI Daytime dysfunction .32** 
Psychological status -.24** 
Self-efficacy -.23** 
Physical symptom -.23* 
BMI .20* 
Perceived health -.19* 
Functional status -.19* 
*p< 0.05 level, **p<.01 level (2-tailed). 
A multiple regression analysis with forward method was run with the seven 
variables. Three variables were identified as significant predictors among these seven 
variables, and together they accounted for 18.7% of the variance in daytime sleepiness. 
The PSQI daytime dysfunction was first generated for the model, and it explained 10% of 
the variance in daytime sleepiness (p<.001). When self-efficacy was added to the second 
model, R2 increased by .054 (p<.01), from .10 to .154. When BMI was entered the third 
model, R2 increased by .031, from .154 to .187. The results indicated that the Taiwanese 
participants with HF who reported lower level of daytime dysfunction, better 
self-efficacy, and lower BMI levels had lower tendencies to fall asleep or doze off in the 
daytime. The summary for predictors of daytime sleepiness is given in Table 41. 
 
Table 41  
Multiple Regression of Predictor Variables on Daytime Sleepiness  (n=125) 
Model Predictors B B SE Beta df F R2 Adjusted R2 R2 Change
1 (Constant) 5.89 .53  1, 123 13.69*** .100 .093  
  Daytime dysfunction 1.55 .42 .32***     .100***
          
2 (Constant) 9.20 1.29  2, 122 11.10*** .154 .140  
  Daytime dysfunction 1.54 .41 .32***      
  Self-efficacy -.04 .02 -.23**     .054** 
          
3 (Constant) 3.86 2.73  3, 121 9.26*** .187 .167  
  Daytime dysfunction 1.47 .40 .30***      
  Self-efficacy -.04 .02 -.23**     .033* 
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  BMI .21 .10 .18*      
 Analyzed by the forward method 
F for final equation = 9.26 with 3/121 degree freedom (df), p<.001. 
*p< 0.05 level, **p<.01 level, ***p< 0.001 level (2-tailed). 
Summary 
This chapter has described the findings from the data analysis. A total of 125 
participants were enrolled in this study. The mean age of the participants was 67.79 (SD = 
12.19). The majority of the participants were male (55.2%), married (70.4%), living with 
families (88%), literate (69.6%), unemployed or retired (68%), Taiwanese-speaking 
(52.0%), and reported adequate financial status (79.2%). Forty percent of the participants 
had systolic HF, and another 40.8% had diastolic dysfunction. The majority (72.0%) was 
in NYHA Class II. The mean number of prescribed HF medications used was 3.58 (SD = 
1.51), a mean duration since their HF diagnoses of 35.66 months (SD = 43.81), and a 
mean BMI of 25.55 kg/m2 (SD = 4.37). The average Charlson comorbidity severity score 
was 2.39 (SD = 1.88), and the mean comorbidity number was 1.86 (SD = 1.25). The mean 
chart-review concomitant health problem was 4.88 (SD = 1.83), which included both 
cardiovascular problems (mean = 3.05, SD = 1.16) and noncardiovascular problems 
(mean = 1.83, SD = 1.46). The top three cardiovascular concomitant problems were 
hypertension (65.6%), valvular heart disease (56.0%), and coronary artery disease (44%). 
Likewise, the mean SHRS score was 3.26 (SD = 1.07). 
The global PSQI scores of the 125 participants ranged from 0 to 20, with a mean 
of 9.06, and 93 (74.4%) of the participants were identified as poor sleepers (PSQI>5). 
The ESS scores ranged from 0 to 22, with a mean score of 6.99 (SD = 5.07). Thirty (24%) 
of the participants reported excessive daytime sleepiness (ESS> 10). Likewise, 102 
(81.6%) participants reported that they engaged in habitual daytime napping after lunch, 
with 62.4% taking daytime naps everyday. The mean duration of daytime napping for the 
102 participants was 82.3 (SD = 50.42) minutes.  
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The mean KCCQ overall summary score for the 125 participants was 70.50 (SD = 
19.63), with a range from 11.98 to 95.83. The physical symptom domain had the highest 
score (mean = 73.98, SD = 21.31), and psychological status was the lowest (mean = 65.60, 
SD = 24.72). Pearson correlation analyses showed that the correlates of HRQOL included 
age, education, financial status, language, NYHA Class, comorbidity, health perception, 
subjective sleep quality, sleep duration, sleep latency, sleep efficiency, sleep disturbances, 
and daytime sleepiness. 
A three-step hierarchical multiple regression analysis was used to analyze 
significant predictors of HRQOL as measured by the KCCQ overall summary score. Six 
predictors were identified from 14 predictor variables, and those six accounted for 58.5% 
(p<.001) of the variance in HRQOL. After controlling for education, comorbidity, and 
NYHA Class, the analyses showed that three sleep variables (subjective sleep quality, 
sleep disturbances, and sleep latency) accounted for 7% of the variance in HRQOL. The 
study found that the Taiwanese persons with HF who experienced better HRQOL were 
those who had higher levels of education, lower NYHA Classes, and smaller numbers of 
comorbid conditions, and reported better subjective sleep quality, fewer sleep 
disturbances, and shorter sleep latency.  
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Chapter 5: Summary, Implications, and Recommendations
In this chapter, a summary of the study is presented as well as a discussion of
issues related to the sample, the findings, and the methodology. In addition, the chapter
includes the implications of the findings and provides recommendations for future
research. A few closing remarks are provided at the end of the chapter.
Summary of the Study
The goals of this cross-sectional, descriptive, correlational  study were to describe
the characteristics of sleep disorders and HRQOL; to explore the relationships between
individual characteristics, HF characteristics, sleep disorders , and HRQOL; and to
identify predictors of HRQOL. A conceptual model that incorporated HRQOL and sleep
disorders provided a guide for the study. A nonprobability sample of 125 participants with
HF was recruited from the outpatient department s of a large medical center and an
affiliated hospital located in southern Taiwan. Inclusion criteria for participants were as
follows: (1) diagnosed with HF of any NYHA Functional Class (Classes I, II, III, or IV)
(The Criteria Committee of the AHA, 1994)  by physicians, (2) aged 18 years or older, (3)
community-dwelling, (4) able to communicate either by speaking Mandarin or Taiwanese
or by writing Mandarin (the official Chinese language), and ( 5) willing to participate in
this study. All participants were individually interviewed by the principal investigator in
either a private area within a clinic or in their homes, except for two participants who
completed the questionnaires by themselves at locations of their choice. The period for
data collection was approximately four months , from October 2006 to January 2007.
Seven instruments were used for the research study. They included (1) a
demographic questionnaire eliciting individual characteristics and HF characteristics; (2)
the Charlson Comorbidity Index and a chart-review list of ten major concomitant health
problems for measuring comorbidities; (3) the modified Self-Rated Health Subscale for
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measuring perceived health; (4) the Kansas City Cardiomyopathy Questionnaire (KCCQ) 
for measuring HRQOL; and (5) two questionnaires about sleep disturbances, namely, the 
Pittsburgh Sleep Quality Index and the Epworth Sleepiness Scale. The completion time 
for the instruments was 20 to 60 minutes. The data, which included concomitant health 
problems and HF characteristics, were collected from the hospital medical records after 
receiving the participants’ permission. Each participant’s NYHA Class was assessed by a 
senior cardiologist who was blind to the KCCQ scores reported by the participants. Data 
were analyzed by using the SPSS Version 14.0 for Windows. The individual and HF 
characteristics and the major variables were analyzed with descriptive statistical 
techniques. Pearson correlations were used to determine correlates of HRQOL, and 
predictors of HRQOL were identified by using a hierarchical multiple regression analysis. 
Before the data analysis, checks were made for normality and normal distribution of the 
major variables and assumptions of the multiple regression analysis for predictor 
variables of HRQOL. Two variables, language and CCI severity, were eliminated from 
the regression analysis because of multicollinearity considerations. 
Overall, the study findings indicated that insomnia (difficulty initiating sleep, 
maintaining sleep, or both) may be common among the participants. Approximately 
72.8% of the participants reported poor nocturnal sleep quality. The mean sleep duration 
was 5.6 hours with a mean sleep latency of 46.3 minutes, and the mean habitual sleep 
efficiency was 73%. The domain of sleep efficiency presented the strongest relationship 
with nocturnal sleep quality (r = .84, p<.001), whereas daytime dysfunction was the 
weakest (r = .33, p<.001). The three most frequent events regarding sleep disturbances 
were “to have to get up to use the bathroom” at least one to three or more times a week 
(83.2%), “cannot get to sleep within 30 minutes” (62.4%), and “wake up at midnight or 
early morning” (56.0%). 
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In contrast, daytime sleepiness did not physically influence the participants with 
HF. Only 30 (24%) of them reported excessive daytime sleepiness. The top three 
situations causing daytime sleepiness within this sample were “lying down to rest in the 
afternoon,” “watching TV,” and “sitting quietly after a lunch without alcohol.” 
Additionally, the majority (81.6%) of the participants reported they were prone to 
habitual daytime napping after lunch. Except for the significant relationship between 
daytime sleepiness and the component of daytime dysfunction (r= .33, p<.001), daytime 
sleepiness and daytime napping were not significantly correlated with the global and 
componential variables of nocturnal sleep quality. 
The mean KCCQ overall summary score for HRQOL in this sample was 70.50 
(SD = 19.63). HRQOL physical symptom had the highest score, and the psychological 
status domain was the lowest. Of the participants, 24.8% reported swelling feet, ankles, or 
legs; 69.6% reported fatigue; 68% reported SOB, and 24% reported sitting in a chair or 
using more pillows for sleep. The most difficult daily activities performed by the 
participants were “hurrying or jogging” (92.8%), “doing yard work or housework and 
carrying groceries” (66.4%), and “climbing a flight of stairs without stopping” (60.0%). 
Over 84% of the participants reported slight to complete dissatisfaction with living with 
HF. They reported feelings of discouragement (50.4%) and slight to extreme restrictions 
on enjoying their life, taking part in hobbies and recreational activities (64%), working or 
doing household chores (83.2%), and visiting family or friends (50.4%). 
Sixteen predictor variables showed correlations with HRQOL. Pearson’s 
correlation coefficients ranged from .18 (financial status) to .68 (NYHA class). According 
to the results from the analyses of HRQOL and demographic data, age, education, 
financial status, and type of language were significantly associated with HRQOL, but not 
gender, marital status, and living arrangement. From the analyses of HRQOL and HF 
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characteristics, the results showed that NYHA class was highly correlated with HRQOL; 
however, type of HF, prescribed HF medication, and duration since the HF diagnosis were 
not correlates of HRQOL. In regard to the relationships between HRQOL and 
health-related characteristics, CCI-number, CCI-severity, concomitant noncardiovascular 
problems, and perceived health had significant relationships with HRQOL, whereas BMI 
did not. According to the findings from the analyses of HRQOL and sleep variables, except 
for the use of sleeping medication and daytime napping, all components of nocturnal sleep 
quality and daytime sleepiness were significantly related to HRQOL in a negative direction. 
Six predictors of HRQOL were identified from its 14 correlates by using a 
three-step hierarchical multiple regression analysis. Individual characteristics (age, 
education, and financial status) were first available to enter into the model, then NYHA 
Classification, CCI-number, chart-review non-cardiovascular concomitant problems, and 
modified SRHS, and finally sleep variables (daytime sleepiness and all components of 
nocturnal sleep quality except for the use of sleeping medication). Those predictors were 
education (9%), NYHA class (39.8%), CCI-number (2.6%), subjective sleep quality 
(3.7%), sleep disturbances (1.5%), and sleep latency (1.8%), and together they accounted 
for a total of 58.5% of the variance in HRQOL. Overall, Taiwanese persons with HF who 
experienced better HRQOL were those who had higher levels of education, lower NYHA 
Classes, and smaller numbers of comorbidity conditions and who reported better 
subjective sleep quality, fewer sleep disturbances, and shorter sleep latency. Correlates of 
HRQOL that did not act as predictors of HRQOL included age, financial status, 
concomitant noncardiovascular problems, perceived health, sleep efficiency, sleep 
duration, daytime dysfunction, and daytime sleepiness. 
Discussion of Findings 
Issues Related to Demographics 
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The participants lived primarily in four large cities and counties—Tainan City, 
Tainan County, Kaohsiung County, and Chiyi City—distributed over approximately 30 
townships in southern Taiwan. Consequently, a large proportion of the participants lived 
in rural areas. Tsai, Chi, Lee, and Chou (2004) found that elderly people living in rural 
communities had poorer HRQOL, as measured by the SF-36, when compared to 
Taiwanese older adults living in urban and remote island communities. Therefore, 
geographic areas should be taken into account when one interprets the findings of this 
study. In addition, this study found that several participants who lived in rural areas had 
to spend one hour or more traveling to their hospitals. Some of those participants had to 
rely on their families to drive them to the hospital because public transportation was 
inconvenient and they could not ride a motorcycle or drive a car for the visits. 
Participants who did not have families usually made round trips to and from the hospitals 
in cabs (in which cases the drivers waited while the participants were seen by doctors), 
and the fares for the cabs were usually equal to or higher than their medical fees. As a 
result, a small number of participants visited their physicians only intermittently and 
therefore did not take medications regularly, particularly if they thought their symptoms 
were under control. Such participants usually revisited the clinics only when their 
symptoms recurred. 
Over 63.2% of the participants in this study were older than 65 years. As shown in 
Table 9, the trend in the distribution of HF for different ages supports the view that the 
prevalence of HF increases with age (Hunt et al., 2005). Overall, the study sample was 
older (67.79 ± 12.19 years old, n = 125) than those in the Wang (2005) study (65.75 ± 
14.19 years old, n = 80) and the Cheng (2004) study (60.70 ± 10.61 years old, n = 100), 
younger than that in the Yu et al. (2004) study (77.1 ± 7.9 years, n = 227), but similar to 
those in the Shan (2002) study (66.10 ± 13.78 for the interventional group [n = 10] and 
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67.45 ± 10.13 years old for the control group [n = 10]). Furthermore, participants of older 
ages tended to be Taiwanese speaking (r = -.46, p<.001) and were characterized by lower 
levels of education (r = -.27, p<.01), unemployment or retirement (r = .33, p<.001), and 
lower BMIs (r = -.30, p<.01). 
In terms of gender, educational level, employment status, marital status, and 
living arrangement, the participants had demographic characteristics similar to those in 
previous studies addressing Taiwanese HF participants living in northern Taiwan (Chen, 
2004; Cheng, 2004; Wang, 2005). Additionally, it is important to note that several 
participants appeared to be of a low social class (low income, low literacy, and 
unemployment). Of the sample, 30.4% were illiterate, 44% were unemployed, and 21% 
reported poor economic status. As noted previously, the majority of the participants were 
living in rural areas, and 52% could speak Taiwanese only. 
Issues Related to Heart Failure Characteristics 
The prevalence of diastolic and systolic HF in this sample was approximately 
40% for each. A third type, valvular dysfunction, was also identified as HF because it was 
difficult to differentiate that type from either diastolic or systolic HF (Patel & Konstam, 
2001). When the criterion of LVEF greater than 50% was used to include the number 
with valvular dysfunction (19.2%) into the count of those with diastolic HF, however, the 
incidence of diastolic HF increased to 60%. Overall, the prevalence of HF was similar to 
that found in the literature (Banerjee, Banerjee, Khand, Clark, & Cleland, 2002; Bursi et 
al., 2006; Wu & Yu, 2005). 
An issue of concern in this study was that the use of the criterion setting the LVEF 
at less than or greater than 50% (Hunt et al., 2005) to classify HF into systolic or diastolic 
HF may be problematic. The current study found that several participants whose cardiac 
echo tests showed normal LVEF had contractile abnormalities. That finding echoes a 
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recent argument that the categorization of HF into two distinct types based simply on 
LVEF is arbitrary and causes selection bias in HF studies (De Keulenaer & Brutsaert, 
2007; Fukuta & Little, 2007; Shammas, Khan, Nekkanti, & Movahed, 2007). A study of 
556 community residents found that LVEF and diastolic dysfunction were two 
independent factors having associations with higher levels of B-type natriuretic peptide 
(Bursi et al., 2006). Diastolic dysfunction is not unique to HF with preserved ejection 
fraction, whereas systolic dysfunction is not specific for HF with reduced LVEF (De 
Keulenaer & Brutsaert, 2007). Further research is needed into the use of preserved, 
normal, or reduced LVEF as a distinguishing factor. 
Another important issue is that several participants in this study did not present 
with typical features (both symptoms and results from cardiac echo tests) specific to 
either systolic or diastolic dysfunction. Some participants with diastolic HF of NYHA 
Class III presented with more severe HF symptoms, such as shortness of breath and 
activity intolerance, and reduced functioning than those with systolic dysfunction, 
whereas those with systolic HF represented a larger number of NYHA Classes III and IV 
(see Table 42). This might result in non-significant findings about differences in the 
HRQOL domains among the types of HF (see Table 43). Those findings, however, are 
different from those in previous studies showing that HRQOL varied for different 
diastolic and systolic groups (Jaarsma et al., 1999; Kitzman et al., 2002; Wu & Yu, 2005). 
 
Table 42  
Association Between Type of HF and NYHA Classification 
NYHA Classification Total
 I II III IV   
Systolic 2 26 20 2 50 
Diastolic 0 44 7 0 51 
Valvular 1 20 3 0 24 
Total 3 90 30 2 125 
 Pearson Chi-Square = 18.62, df = 6, p<.01 
In conclusion, because different types of HF may have different underlying 
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conditions and precipitating factors, more precise definitions of the types of HF are 
imperative. Such definitions would help healthcare providers select more accurate 
treatments for HF, that is, treatments that specifically target underlying conditions and 
precipitating factors (Nieminen et al., 2006). 
 
Table 43  
Differences in HRQOL Among Types of Heart Failure 
 Systolic HF Diastolic HF Valvular HF F 
Overall HRQOL 69.18 (23.44) 68.95 (15.78) 76.52 (17.88) 1.41 
Physical symptom 75.04 (24.83) 70.67 (19.31) 78.82 (16.52) 1.30 
Symptom frequency 68.58 (27.84) 61.77 (24.53) 73.26 (19.86) 1.94 
Symptom Burden 81.50 (26.10) 79.58 (18.95) 84.38 (18.28) .39 
Symptom stability 52.50 (22.16) 51.47 (16.89) 52.08 (20.74) .03 
Functional status 70.32 (28.13) 72.75 (19.41) 79.86 (21.41) 1.33 
Psychological status 67.33 (26.77) 61.44 (23.09) 70.83 (23.31) 1.39 
Social functioning 64.04 (28.17) 70.96 (22.35) 76.56 (22.21) 2.26 
Self-Efficacy 79.00 (26.30) 72.55 (31.13) 85.94 (20.63) 2.03 
Approximately 72% of the participants had NYHA Class II HF, which was lower 
than those of samples in previous studies, which had higher percentages of NYHA Class 
III (Cheng, 2004; Ho et al., 2004; Wang, 2005; Wang, 2003). There were two reasons for 
the lack of sufficient participants with HF of Class I, III, and IV in this study. (1) The 
clinics did not have many participants with Class I HF during the data-collection phase. 
Indeed, it was not easy to diagnose Class I HF because patients in that group usually do 
not have marked symptoms (Hunt et al., 2005). Such persons seek medical help only 
when they have HF of NYHA Class II or higher. (2) Several participants with Class III 
and IV HF were unable to make clinic visits because of the severity of their symptoms. 
They usually visited emergency rooms or were hospitalized when symptoms occurred. 
Several of those patients who could not make the clinical visits asked their families to 
help them refill their prescribed medications during their monthly or regular clinic visits.  
The mean number of HF medications used was 3.58 (SD 1.51), which was similar 
to that in the Cheng (2004) study (3.91±1.61). However, the participants in the current 
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study received a greater number of beta blockers (28.0% vs. 17%) and calcium channel 
blockers (39.2% vs. 30%) but fewer angiotensin-receptor blockers (43.2% vs. 56%) and 
digitalis (26.4% vs. 78%) than those in the Cheng (2004) study. The use of vasodilators 
(62.4%) was higher than that reported in the Riedinger et al. (2000) study with American 
patients (52.82%). The use of HF medication might vary among the different hospitals 
and cardiologists (Luthi et al., 2006). 
Regarding the time since the patient was diagnosed with HF, approximately 28% 
of the participants received the diagnosis within the previous 1 to 6 months. The actual 
duration for this sample could be even longer. Several participants could not remember 
the date that they received their HF diagnosis. Some stated that they were informed they 
had declined in heart function but not HF, thus, they had difficulty answering this 
question. Those participants generally asked the principal investigator to find the answer 
from their medical records, however, a small number of the participants had been treated 
in other hospitals for several years before visiting the cardiologists in the two hospitals of 
this study. The precise duration for their HF diagnosis, therefore, might be not reliable. 
Overall, the mean time since HF diagnosis (2.97±3.65 years) in this study was less than 
that in the Cheng (2004) study (3.59±2.3 years), but it was similar to that in the Yu et al. 
(2004) study (3.0±2.64 years). 
Issues Related to Health-Related Characteristics 
Obesity was prevalent among the participants. Approximately 21% of the 
participants were overweight, and 38.4% had mild to severe obesity. The BMI decreased 
with age (r = -.30, p<.01), which was similar to the findings of Huang, Pan, Lee, and 
Chang (2006). BMI had a positive direction with dyslipidemia; that is, participants with 
greater BMI were more likely to be those who had dyslipidemia (r = .18, p<.05). 
Several issues are related to comorbidity. Overall, the use of both self-reported 
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and chart-review methods combined with the use of structured check-list forms provided 
more detailed and valuable information about comorbidity. The CCI-number and 
CCI-severity were correlated with chart-review total concomitant health problems and 
noncardiovascular problems (r = .38 to r = .40, all p<.001). However, to prevent 
pre-existing multicollinearity between CCI and HRQOL, the principal investigator 
excluded the comorbid condition HF from the scoring of the self-reported CCI. National 
guidelines in the U.S. promoted by ACC/AHA recommend these same standard data set 
variables be collected in HF research studies for comparisons across studies (Radford et 
al., 2005). 
The findings about comorbidity indicated that the participants experienced a high 
burden of illness. The study showed a higher score for CCI-severity (2.39±1.88) than that 
in the Riedinger et al. (2000) study (0.98±.70), but lower than those in the De Jong et al. 
(2005) and Clark et al. studies (3.63 and 3.7, respectively). The mean number of 
comorbid conditions (1.86) measured by CCI was similar to those in the Cheng (2004), 
Yu et al. (2004), and Friedman (2003) studies; however, the study showed higher 
concomitant health problems (4.88) measured with the chart-review approach than did 
the previous studies. 
Hypertension was the most frequent underlying disease in the sample (65.6%), 
which was similar to the findings of several studies conducted in the U.S., Europe, 
Taiwan, and Hong Kung (De Jong et al., 2005; Nieminen et al., 2006; Subramanian et al., 
2005; Wang, 2005; Yu et al., 2004). In contrast, a history of coronary artery disease or 
previous myocardial infarction was most commonly found in the Wang (2003), Riedinger 
et al. (2000), and Heo et al. (2005) studies (57.1% [n = 60/105], 61.22% [n = 423/691], 
and 53% [n = 155/293], respectively) and was also highly prevalent in the De Jong et al. 
(2005) and Subramanian et al. (2005) samples (70% [n = 61/87] and 82.1% [n = 135/165], 
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respectively). Generally, the proportion of coronary artery disease in those studies tended 
to be higher than those addressing samples from the Taiwanese population. Additionally, 
over 56% of the participants had valvular disorders, particularly mitral regurgitation, 
followed by tricuspid regurgitation. Of those participants with valve problems, 54.3% 
reported arrhythmia, and several expressed worries about the negative effects of the 
valvular disorders on heart function. The findings suggested that the valve dysfunction 
may diminish the therapeutic effects for HF and cause more physical and psychological 
discomfort for the participants (Nieminen et al., 2006). 
Participants who were older, had lower financial status, and had HF of higher 
NYHA Functional Classifications reported greater numbers of concomitant 
noncardiovascular problems (r = .21, -.22, .18, respectively, all p<.05). Notably, 
musculoskeletal problems were the most frequent concomitant health problem among the 
participants (36.8%). The reason for that high frequency might be that the majority of the 
participants were elderly, farmers, and blue-collar workers. Such individuals are more 
likely to experience diminutions of musculoskeletal function, such as osteoporosis, 
spondylosis, and osteoarthritis. Musculoskeletal problems, however, did not significantly 
correlate with any demographics and major variables of this current study. 
Diabetes affected one-third of the participants in this study, similar to that found 
in previous HF studies conducted in different cultures (Cheng, 2004; Heo et al., 2005; 
Nieminen et al., 2006; Wang, 2003). In contrast, Subramanian et al. (2005) found a 
higher proportion of diabetes (75%) in their study. In the current study, however, diabetes 
did not show relationships with any demographics and major variables. 
The finding that chronic renal insufficiency affected 17 participants was found 
with the chart-review approach. Participants with chronic renal insufficiency were more 
likely to be those having HF of higher NYHA classifications (r = .26, p<.01). Research 
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has found that patients with decompensated HF usually are resistant to diuretics and have 
to be treated with higher doses to reduce salt and water (Francis, 2006). In the long-term, 
however, treatment with diuretics may decrease renal function. Moreover, research has 
found that worsening renal function is correlated with higher levels of preventable 
hospitalization and in-hospital mortality in patients with HF (Braunstein et al., 2003; 
Chen et al., 2003). Likewise, in the current study, chronic renal insufficiency was 
correlated with worsening HRQOL, including functional status (r = -. 19, p<.05), social 
functioning (r = -.22, p<.05), and the KCCQ overall summary score (r = -.19, p<.05). 
Overall, chronic renal insufficiency may have significant adverse effects on both HRQOL 
and HF mortality. Those effects can increase the difficulty in treating HF and result in 
poor HRQOL for people with HF. 
In regard to perceived health, the study found that participants answered the four 
items of the SRHS in different ways, resulting in low inter-correlations among the items. 
As shown in Table 44, of the participants who rated their health as poor, 15 perceived 
their health problems did not affect their ability to do the things they wanted to do, and 2 
viewed their health as better than that of others their age. For the three participants who 
ranked their health as good, two reported that their health predominantly hindered them 
from doing the things they wanted. Similarly, the only participant who rated his health as 
excellent and who reported his health as better than that of others his age answered that 
he perceived great limitations in doing the things he wanted to do. That 79-year-old 
participant stated that, after several cardiac episodes, he rarely went outside his house and 
spent his days worshipping Buddha and reading Buddhist Sutras. 
Several other participants in the study reported similar situations when answering 
the items of SRHS. They noted that they engaged in basic daily activities only to prevent 
exacerbation of their HF condition. Family members of a number of participants 
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requested that the participants stay home from work or refrain from performing 
household chores to prevent recurrence of symptoms. Some reported that they had severe 
limitations because of their previous experiences, whereas others said they had no 
problem doing things because all they had to do were the basic activities of daily living. 
Participants who were used to traveling outside the country, however, perceived great 
limitations on their ability to engage in their hobbies. One participant remarked that since 
his HF diagnosis, he lacked the energy for singing, his favorite hobby, and no longer 
participated in that pastime with friends. He expressed concerns about that change in his 
life. 
In the data analysis, scores for the item “health problem limited ability to do 
things I want” correlated with all domains of HRQOL. The psychological status domain 
had the highest correlation coefficient (r = -.53, p<.001), whereas, the functional status 
domain was the lowest (r = -.29, p<.05). Thus, a perceived limitation in doing the things 
the participants wanted was strongly related to adverse psychological effects.  
 
Table 44  
Associations Between Perceived Overall Health and the Remaining Items of SRHS 












Health problems limited ability to do the thing they wanted1 
 A great deal 16 13 2 1 32 
 A little 12 34 0 0 46 
 Not at all 15 31 1 0 47 
Compared health to 1 year ago2 
 Not as good 37 33 1 0 71 
 Same 4 31 2 0 37 
 Better 2 14 0 1 17 
Compared with most people’s health in the same age3 
 Not as good 24 21 1 0 46 
 Same 17 41 1 0 59 
 Better 2 16 1 1 20 
1Pearson Chi-square =12.78, df = 6, p<.05 
2Pearson Chi-square =30.12, df = 6, p<.001 
3Pearson Chi-square =17.70, df = 6, p<.01 
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Approximately 78 (62.4%) of the participants rated their overall health as fair. 
That finding was higher than the 48.0% in the Hu, Adler, Goldman, Weinstein, & 
Seeman (2005) study of 991 adults aged 60 years and older. Among those 78 participants, 
16 rated their health as better than that of most people the same age; however, 21 reported 
they had poorer health than that of their peers. Bivariate correlation analyses showed that 
participants who perceived their overall health as better than that of their peers 
experienced better HRQOL, including physical symptom (r = .26, p<.01), psychological 
status (r = -.34, p<.001), and overall HRQOL (r = -.28, p<.01); however, the perception 
that one’s health was better than that of peers correlated only with psychological status (r 
= .23, p<.05). 
Two items with lower corrected item-total correlations less than .3 were excluded 
from the SRHS (Ferketich, 1991), and the remaining two items (perceived overall health 
and health compared to that one year ago) were summed to yield a total score for the 
modified SRHS. The total score of SRHS for perceived health had a negative correlation 
with NYHA classification and CCI-severity (both with r = -.21, p<.05); that is, the 
participants who perceived themselves as having better health were those whose HF was 
of lower NYHA classifications and who had lower severity of comorbidity. That finding 
supports the view that diseases, disability, and functional limitations have detrimental 
effects on perceived health (Johnson & Wolinsky, 1993).  
Findings of Nocturnal Sleep Quality 
Approximately 74.4% of the participants scored higher than 5 on the self-reported 
global PSQI, indicating that they had severe sleep difficulties in at least two components 
or that they had moderate sleep difficulties in more than three components of sleep 
quality (Buysse et al., 1989). Likewise, 16 (12.8%) of the participants reported a global 
PSQI of 15 or greater; that is, they had severe sleep difficulties in at least five areas or 
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moderate sleep difficulties in all domains of nocturnal sleep quality over the past month. 
In particular, 8 (6.4%) of the participants had been diagnosed with insomnia with or 
without regular medical treatments. Although the PSQI is primarily intended to measure 
sleep quality and identify good or poor sleepers rather than to provide a clinical diagnosis, 
the findings suggest a higher 1-month prevalence of insomnia among the HF participants 
in the current study than that in a previous study of 2045 urban community elderly (6% 
for total, 8% for women, and 4.5% for men) (Su, Huang, & Chou, 2004). In regard to 
participants with greater scores on the PSQI, however, the findings can serve as 
references for confirming sleep disorders and determining potential causes when using 
objective measurements such as diagnostic criteria and polysomnography.  
Overall, the mean global PSQI score (9.06±4.64) was lower than scores for 47 
patients with chronic cancer pain (12.38±4.59) (Wang, Wang, Chang, & Lin, 2007), for 
47 patients with chronic daily headaches (11.64±4.35) (Wang et al., 2007), for 205 
institutionalized elderly (9.35±4.89) (Lin, 2000), and for 82 first-time mothers with 
depression during the early postpartum period (10.99±2.65) (Huang et al., 2004). The 
mean global PSQI score was higher, however, than scores for 197 menopausal women 
(5.5±3.47) (Lu et al., 2005), for 81 first-time mothers without depression (8.17±2.75) 
(Huang et al., 2004), and for 61 American persons with stable systolic HF (7.21±3.39) 
(Redeker & Hilkert, 2005). The findings support the view that sleep can be affected by 
several factors, including age, psychological problems such as depression and anxiety, 
and particularly by medical conditions characterized by pain or other physical 
discomforts, such as Parkinson’s disease, arthritis, and shortness of breath, which are 
often associated with frequent awakenings that disrupt sleep continuity (Lin, 2000; Roth, 
2004).  
The sleep duration (5.62±1.72 hours) for the participants in this study was shorter 
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than that reported in the Redeker and Hilkert (2005) study of HF patients (6.54±1.51 
hours). Sleep duration was correlated with physical symptom, social functioning, and 
overall HRQOL, but not with functional status and psychological status. Those findings 
were similar to those of the Redeker and Hilkert (2005) study of 61 people with HF, 
which showed that sleep duration measured by Actiwatch Actigraph did not relate to any 
components of the HRQOL, six-minute walk test, and daytime activity. However, in the 
same study, time in bed (8.20±1.59 hours, ranging from 4.73 to 11.55 hours) showed a 
negative correlation with physical functioning (r = -.31, p<.05) and daytime activity (r = 
-.31, p<.05). In the current study, the mean self-reported time in bed was 7.87±1.60 hours, 
with a range of 4.5 hours to 13.0 hours. Time in bed was correlated with functional status 
(r = -.43, p<.001), social functioning (r = -.34, p<.001), and overall HRQOL (r = -.29, 
p<.01). The findings suggest that sleep duration is not necessarily as important for 
HRQOL as sleep quality for people who perceive that their sleep was refreshing upon 
awakening.  
On the other hand, habitual sleep efficiency was important to subjective sleep 
quality in that the better the habitual sleep efficiency, the higher the subjective sleep 
quality reported by the participants with HF (r =.64, p<.001). The participants, however, 
reported a large proportion (47.2%) of sleep inefficiency. Overall, the participants in this 
study had lower habitual sleep efficiency (1.42±1.29) than did 59 American patients with 
HF (0.67±1.01) (Redeker & Stein, 2006), 51 Taiwanese insomniacs (0.82±1.05), 171 
from the general population (0.42±0.81) (Tsai et al., 2005), and 205 institutionalized 
elderly people (1.04±1.01) (Lin, 2000). The participants in this study had greater habitual 
sleep efficiency than did those in the Wang et al. (2007) study of patients with chronic 
cancer pain (2.13±1.17) and with chronic headache (1.62±1.23). The bivariate correlation 
analyses suggested that the poor sleep efficiency could result from several conditions, 
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including long sleep latency, difficulties initiating and maintaining sleep (also long sleep 
latency), frequent sleep disturbances (such as nocturia, frequent awakenings at midnight, 
and early awakening), and the nonuse of sleeping medications for sleep problems. 
Likewise, sleep efficiency could be poor for participants experiencing several conditions 
at the same time. 
Nocturia was the most frequent sleep disturbance, affecting 104 (83.2%) of the 
participants in the sample. The prevalence of nocturia was higher than it was in the Lin 
(2000) study of 205 institutionalized elderly (39.5%) and in the Yu et al. (2006) study of 
community-dwelling adults aged 40 years old or more (39%). The score for nocturia 
(2.51±1.29) was similar to that for 43 Western patients with lung cancer (2.67), but 
slightly higher than that for 36 healthy Western adults (2.06). Nocturia in HF is a 
consequence of an increase in the atrial natriuretic peptide hormone (Asplund, 2004). The 
effects of nocturnal polyuria, which include dry eyes and dry month, might partly explain 
the finding that 11.2% of the participants complained of dry mouth during sleep and had 
to get up to drink. Likewise, nocturia has been viewed as an independent concept 
correlated with impairments in HRQOL, including less sleep, less vitality, a decrease in 
emotional health (Yu, Chen et al., 2006), poorer sleep quality, and higher mortality 
(Asplund, 2005). In the current study, nocturia was associated with poorer global sleep 
quality (r = .29, p<.01), more frequent sleep disturbances (r = .37, p<.001), longer sleep 
latency (r = .25, p<.01), and poor subjective sleep quality (r = .27, p<.01). Likewise, it 
was negatively correlated with HRQOL functional status (r = -.19, p<.05), which meant 
that participants who reported higher frequencies of nocturia also had poorer functional 
status than their counterparts. However, the lack of adequate information about nocturia 
and sleep suggests that nocturia is an area that has been ignored in HF clinical practice. 
The use of sleeping medications had positive effects on all domains of global 
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nocturnal sleep quality except for daytime dysfunction. The participants, however, 
appeared to avoid using sleeping medication despite its benefits. Of the participants, 
42.4% reported poor subjective sleep quality, but only 16.8% used sleeping medication 
for their sleep problems once or more per week over the month prior to the interview for 
this study. The use of sleeping medication was lower than that in the Erickson et al. (2003) 
study of HF patients (32%) and the Lin (2000) study of institutionalized elderly people 
(38.5%). During the interviews for this study, several participants explained that they did 
not take sleeping medication frequently because of their concerns about sleeping 
medication-dependence and about interactions between sleeping medication and HF 
medication. In addition, a small number of the participants explained that many of their 
friends and physicians attributed their sleep problems to mental problems, and as a result 
the participants felt too embarrassed to continue seeking medical help. That finding 
suggests that healthcare providers should refrain from attributing sleep disorders to 
psychogenic illnesses when they discuss the causes of sleep disorders with Taiwanese 
people (Lee, 1995). By avoiding the use of psychological terms and phrases such as 
neurosis, anxiety, and “you worry too much,” healthcare providers might be more 
effective in helping patients increase their adherence to sleep treatments and decrease the 
secondary psychological hurt associated with their sleep problems. The underlying causes 
of the sleep disorders, including both physical and psychological mechanisms, should be 
identified to help obtain accurate diagnoses and plan effective interventions. 
Several factors were correlated with global sleep quality. Gender was weakly 
correlated with global nocturnal sleep quality, with females reporting poorer global sleep 
quality (10.0±4.93 vs. 8.30±4.28 for men, t = 2.06, p<.05) and sleep efficiency 
(1.70±1.36 vs. 1.20±1.20 for men, t = 2.13, p<.05). Gender, however, was not a predictor 
of global nocturnal sleep quality. According to the interviews for this study, women who 
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were responsible for household chores, such as preparing breakfasts for families and 
taking care of kids and grandkids, complained more often of sleep difficulties. Because 
they were physically tired, they had no problem falling asleep within a short time, but 
maintaining their sleep was difficult because of the stress from knowing that they had to 
get up on time or check on their sleeping children. 
Similarly, two studies conducted in Taiwan found significant relationships 
between gender and sleep. Su et al. (2004) found that the prevalence of insomnia in 
community-dwelling women was higher than that for men, although the female gender 
was not an independent risk factor of insomnia. The study of a Taiwanese 2001 “social 
trend survey” of 39,588 citizens aged 15 years or older found that men had better sleep 
quality than women did, even after controlling for marital status, employment status, and 
number of children in the household (Chen, Kawachi et al., 2005). Gender, however, did 
not correlate with sleep quality in a study of American people with HF (Erickson et al., 
2003) and a study of institutionalized Taiwanese elderly (Lin, 2000). Further research is 
necessary to clarify whether several factors, particularly socioeconomic status, mediate 
the effects of gender on sleep disorders in Taiwanese people with HF (Lauderdale et al., 
2006).  
Indeed, in the Office of National Statistics Omnibus Survey in the United 
Kingdom, Adams (2006) found that women with lower levels of education reported a 
greater quantity of sleep (> 8.5 hours/night) compared to those with higher levels of 
education. In men, however, total sleep quantity did not correlate with education. In the 
current study, participants with higher educational levels reported greater sleep efficiency 
(r = -.22, p<.05) and better overall sleep quality (r = -.19, p<.05). This finding regarding 
sleep efficiency and education was consistent with the Coronary Artery Risk 
Development in Young Adults (CARDIA) study, which showed that more education 
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correlated with greater sleep efficiency (Lauderdale et al., 2006). Additionally, education 
was associated with gender (chi-square = 33.58, df = 7, p<.001), where the women group 
tended to be lower educated. Approximately 53.6% of the women participants were 
illiterate, whereas 76.8% of the men reported an educational level of elementary school or 
more.  
Research has found that self-reported sleep complaints are associated with NYHA 
classifications or are more likely to occur as NYHA classifications become worse 
(Principe-Rodriguez et al., 2005; Redeker & Hilkert, 2005). In the current study, a simple 
regression analysis indicated that NYHA classification was a predictor of global sleep 
quality. Participants who had higher NYHA classifications experienced poor global sleep 
quality (r = .35, p<.001) and all domains of nocturnal sleep quality (r = .33, p<.001 [sleep 
latency] to r = .19, p<.05 [daytime dysfunction]), with the exception of the use of 
sleeping medication (r = .06, p>.05). Higher NYHA classifications were also 
significantly correlated with several sleep disturbances, including inability to fall asleep 
within 30 minutes (r = .28, p<.01), difficulty breathing during sleep (r = .23, p<.05), and 
feeling too cold (r = .25, p<.01). Similarly, Erickson et al. (2003) found that NYHA 
classification was associated with breathing cessation during sleep, restless legs, and 
waking before necessary, although NYHA classification was not a predictor of significant 
sleep disturbances in their study. 
In the present study, NYHA classification was not a predictor of global sleep 
quality when HRQOL physical symptom was added to the regression model, which 
indicated that physical symptoms diminished the effects of NYHA classification on sleep. 
Higher NYHA classifications were associated with greater physical symptom, including 
both symptom frequency and symptom burden. Participants who suffered from the 
symptoms of swelling (r = -.22, p<.001), fatigue (r = -.42, p<.001), and shortness of 
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breath (r = -.30, p<.01) reported poorer global sleep quality. Physical symptom in this 
study, however, was a predictor of global nocturnal sleep quality, which was inconsistent 
with the finding of the Erickson et al. (2003) study, which showed that HF symptoms did 
not predict significant sleep disorders. Results from the current study, however, might 
support the view that participants with more severe HF conditions and greater HF 
symptoms are more likely to experience sleep disorders. Further clarification is needed of 
whether impaired sleep quality is caused by HF itself or by sleep-related breathing 
disorders such as obstructive sleep apnea and central sleep apnea. 
Perceived health was correlated with global sleep quality, subjective sleep quality, 
sleep disturbances, sleep efficiency, sleep latency, and daytime dysfunction. Information 
about sleep disorders and perceived health is sparse; however, Kate and McHorney (2002) 
found that general health perception measured by the SF-36 was correlated with insomnia 
in people with chronic illness. Insomnia was associated with health dissatisfaction in 
three Asian countries: Japan, South Korea, and Taiwan (Nomura et al., 2005). In the 
current study, perceived health of HF participants had a strong association with 
psychological status (r = .59, p<.001). Psychological status had the poorest score among 
the HRQOL domains. Redeker and Hilkert (2005) argued that the perception of sleep 
may be most relevant to mental health. Thus, improvements in perceived health may lead 
to improvements in psychological health and sleep disorders, and vice versa. 
HRQOL social functioning explained 6.9% of the variance in global nocturnal 
sleep quality. Participants who had greater limitations in pursuing hobbies, recreational 
activities, household chores, working, visiting families or friends, and maintaining 
intimate relationship with loved ones, experienced higher sleep disorders. Skobel and 
associates (2005) found that social functioning was moderately correlated with 
apnea/hypopnea index in patients with HF and sleep-related breathing disorders (r = -.60, 
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p=.001). Dissatisfaction with social life (friendships, spouse, children, and frequency of 
social meetings) was a predictor of insomnia in samples aged 15 years and older taken 
from three general populations, namely, the United Kingdom, Germany, and Italy 
(Ohayon, Zulley, Guilleminault, Smirne, & Priest, 2001). Satisfaction with social life was 
also a protective factor against insomnia for persons of any age. Life events such as 
retirement, death of a spouse, and physical and mental illnesses could have a great 
influence on the sleep-wake pattern. For example, some participants in the current study 
stated that they were not bothered by sleep disorders because they had few or no life 
constraints that required them to keep a fixed wake-up time. Encouraging patients to 
continue to engage themselves in social activities is thus one of the important 
interventions for helping them preserve better sleep quality. Several participants, however, 
stated that the reason they did not engage in hobbies or recreational activities was that 
they were exercise intolerant. Therefore, interventions to enhance cardiopulmonary 
fitness have to be considered when patients are being encouraged to engage in social 
activities. Increases in daytime activity levels have been found to be correlated with 
shorter times in bed and wake times in patients with HF, though they did not correlate 
with global sleep quality (Redeker & Hilkert, 2005). Further research is needed on the 
effects of daytime activities on sleep quality. 
Findings of Daytime Sleepiness 
The prevalence of daytime sleepiness (24%) was similar to that in the study of HF 
patients (21%) (Brostrom et al., 2004), but higher than that in the study of samples aged 
15 years or older taken from general populations (Ohayon et al., 1997). Daytime 
sleepiness did not show correlations with global nocturnal sleep quality, which partially 
supports the view that excessive daytime sleepiness may follow insomnia (Brostrom et al., 
2004; Whitney et al., 1998). The possible reasons for the nonsignificant relationship 
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between daytime sleepiness and nocturnal sleep quality might be that the participants in 
the current study were not physically influenced by daytime sleepiness because over 64% 
of the participants took daytime naps everyday. Likewise, a large proportion of the 
participants did not suffer from HF symptoms. Research has shown that symptoms and 
emotional distress may bring about daytime sleepiness (Edelll-Gustaffson, 2002; Vena et 
al., 2006; Whitney et al., 1998; Yu, Tang, Kuo, & Yu, 2006), which might have been true 
for the HF participants in the current study. This study found that participants who had 
greater frequency and burden of fatigue and shortness of breath had more propensity to 
fall asleep during daytime (for both factors, r = -.26, p<.01). Likewise, the better the 
psychological status, the lower was the daytime sleepiness reported by the participants 
with HF (r = -.24, p<.01). Further research, however, is needed on patients with more 
severe HF conditions and symptoms to clarify the relationship between daytime 
sleepiness and nocturnal sleep quality. 
Daytime dysfunction was the strongest predictor of daytime sleepiness in the 
current study. Participants who had more difficulties staying awake and keeping up 
enough enthusiasm to perform daily activities were more likely to fall asleep in daytime. 
That observation was consistent with the finding of a study of advanced lung cancer 
patients (Vena et al., 2006). Daytime dysfunction may be caused by HF symptoms and 
impairment of functional status. The current study found that fatigue was correlated with 
difficulty in staying awake while engaging in social activity (r = -.30, p<.01), whereas 
fatigue (r = -.39, p<.001), swelling (r = -.25, p<.01), and shortness of breath (r = -.31, 
p<.001) were associated with the problem of keeping up enough enthusiasm to get things 
done. Patients with greater functional impairments experienced more daytime 
dysfunction (r = -.26, p<.01) because they lacked the energy to engage in daily and social 
activities, and as a result they had difficulties in maintaining normal circadian 
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activity–rest patterns and overcoming poor sleep quality (Vena et al., 2006). Daytime 
dysfunction, however, was associated with poor subjective sleep quality in the current 
study. 
Notably, HRQOL self-efficacy was a predictor of daytime sleepiness, which 
accounted for 5.4% of the variance. Participants who had lower confidence in their ability 
to deal with HF conditions reported a higher likelihood of daytime sleepiness. It was not 
clear whether the perception of poor self-efficacy in dealing with HF conditions resulted 
in greater reluctance to face obstacles. The decision in doing nothing about HF may result 
in a sedentary lifestyle, thus increasing the opportunities for falling asleep in daytime 
(Lauderdale et al., 2006). Likewise, self-efficacy decreased with age (r = -.19, p<.05). In 
a study conducted with six focus groups (Leung, Wu, Lue, & Tang, 2004), 44 Taiwanese 
elderly defined perceived self-efficacy as “the perception of control related to the feeling 
of good health,” and they went on to say that “dependency is a state of loss of control.” 
Additionally, they identified participation in social activities and service to others as 
sources of self-efficacy. In the current study, several elderly were illiterate and required 
their families’ assistance to receive medical services, and they therefore were more likely 
to perceive themselves as useless and lacking in self-efficacy. In a study of patients with 
multiple sclerosis, Wassem and Dudley (2003) found that, as self-efficacy in symptom 
management increased, sleep and fatigue levels significantly improved. At any rate, 
further research is needed that examines the relationship between daytime sleepiness and 
HRQOL self-efficacy. 
The role of BMI as a predictor of daytime sleepiness was consistent with that in a 
previous study (Bixler et al., 2005). However, BMI is most often related to obstructive 
sleep apnea (Jahaveri et al., 1995; Principe-Rodriguez et al., 2005; Rostagno et al., 2003; 
Sin et al., 1999). The current study did not directly analyze sleep apnea, thus, it is not 
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possible to determine whether higher BMI was related to sleep apnea among the 
participants. The BMI of this HF group was higher than normal, particularly for the 
younger people, indicating that some intervention was needed to help participants lose 
weight or prevent weight gain. 
Findings of Daytime Napping 
Daytime napping was prevalent in 81.6% of the participants. The prevalence of 
daytime napping was similar to that in the Lin (2000) study of 205 institutionalized 
elderly (83.9%), but lower than in the Hong (Hong, 2005) study of 80 (90%) 
institutionalized elderly. The duration of daytime napping (82.3±50.42 minutes) was 
similar to that in Hong (2005) study (82.03±45.47 minutes). In this present study, 
younger people had lower frequencies of daytime napping, however, older adults usually 
took shorter naps in the daytime. Those findings were consistent with the age-related 
increase in daytime napping found by Asplund (1996), but they were inconsistent with 
research that showed no differences in napping patterns by age, gender, and ethnicity 
among Taiwanese community-dwelling older adults (Lai, 2005) Additionally, daytime 
napping was correlated with global nocturnal sleep quality. The current study did find 
that daytime napping was more prevalent among HF participants who had lower levels of 
education and who were Taiwanese speaking. This finding supports the common 
perception in Taiwan society that people who are older and who are of a lower 
socioeconomic status are more likely to take naps during daytime (Lai, 2005).  
Overall, the study findings in regard to sleep variables did not support the view 
that excessive daytime sleepiness is associated with poor mental health. The study did 
find an association, however, between poor nocturnal sleep and poor functional status 
(Edelll-Gustaffson, 2002; Vena et al., 2006), which supports the position that the aging 
process itself is not alone responsible for the increase of insomnia often reported by older 
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people (Ohayon et al., 2001). The three major sleep variables were not correlated with 
each other; however, daytime napping may be helpful for restoring energy in Taiwanese 
people with HF and for reducing the number and severity of their symptoms. 
Findings of Health-Related Quality of Life 
HRQOL and its domains. Overall, the participants appeared to have a higher mean 
overall summary score (70.50±19.63) on the KCCQ than those reported in several other 
studies (55.9 to 66.9) (Clark et al., 2003; Green et al., 2000; Masoudi et al., 2004; Shin et 
al., 2001). Although the current study showed an overall summary score similar to that 
found by Myers et al. (2006) (mean = 74.2±19), the two studies yielded different scores 
for the domains. For example, the score for physical symptom was the lowest (54.5±18) 
in the Myers et al. (2006) study, but it was the highest in the current study (74.98±21.31). 
The participants in both studies, however, scored symptom burden higher than symptom 
frequency, indicating that both sets of participants may have had HF symptoms but were 
less likely to perceive the burden of those symptoms than they were the frequency of the 
symptoms. Physical symptoms was the highest score (76.6) among the domains of the 
KCCQ not only in the current study but also in the Green et al. (2000) study of stable HF 
participants. 
An explanation for the high score on symptom burden (indicating low burden of 
symptoms) may reflect less HF severity within the sample. Indeed, the participants with 
advanced HF (NYHA Classes III and III) reported lower scores on physical symptom 
than did the participants with NYHA Classes I and II HF (54.98±22.79 vs. 80.52±18.38, t 
= 5.84, p<.001). Some participants, however, may have accepted the symptom as part of 
their life situation. For example, a number of participants, particularly those with valvular 
heart diseases as precipitating factors of HF and those who had suffered HF for longer 
periods, reported that they had become used to living with the symptoms; as a result, they 
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no longer perceived that any symptoms still existed. Among those participants, however, 
some had observable shortness of breath during the interviews for this study. Participants 
who did not work or carry out household chores indicated that they perceived little 
burden from their HF symptoms because they engaged only in daily activities that 
demanded little energy. 
Among the four domains, participants gave the lowest score to psychological 
status (65.60±24.72), which is consistent with the score (64.50) reported by Green (2000) 
and the same as Myers et al. (2006) study (65.2±26.0). Researchers have suggested that 
patients with HF experience more significant psychological problems, such as depression 
and anxiety, than do other cardiac patients and the normal population (Carels, 2004; 
Havranek et al., 2004; Hawthorne & Hixon, 1994; Riedinger et al., 2002). Yu and 
colleagues (2004) found that Chinese HF patients have high levels of psychological 
distress because of their cardiac dysfunctions and decline in functional ability. The 
current study found that several participants viewed HF as a terminal disease and 
therefore felt that they were useless and waiting to die. Researchers have suggested that 
both Taiwanese and Chinese patients report more negative effects of illness in the 
psychological domain than in the physical domain (Leung et al., 2004; Yu et al., 2004). 
Further qualitative research is needed to acquire more comprehensive information 
regarding the effect of HF on psychological status. 
On the other hand, researchers have suggested that psychological problems, 
particularly depression, are natural characteristics of HF, and those characteristics may 
adversely affect the prognosis of HF. For example, recent HF studies indicate that 
psychological problems may be the adverse effects of the activation of 
renin-angiotensin-aldosterone system and the sympathetic nervous system (Dantzer & 
Kelley, 2007; Parissis et al., 2004; Parissis, Fountoulaki, Paraskevaidis, & Kremastinos, 
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2005). Those systems activate physiological adaptations, including inflammatory 
reactions, apoptosis processes, and neuroendocrine changes in the central nervous system, 
that promote survival in HF patients. In particular, cytokine overexpression has been 
found to play an important role in the development and worsening of depressive 
symptoms in people with HF.  
Whatever the pathophysiological mechanism linking HF to depression, early 
recognition and treatment of psychological disturbances should be an important 
component of HF care. Researchers have found that major depression was independently 
related to a poor prognosis of HF, including mortality and frequent hospitalizations (Jiang 
et al., 2001; Rutledge, Reis, Linke, Greenberg, & Mills, 2006). Antidepressant 
medications should be prescribed to patients with HF to treat their depression (Parissis et 
al., 2005), however, due to the study findings showing that antidepressants were 
correlated with increased likelihood of death or cardiovascular hospitalization, continuing 
to closely monitor patients who are treated with antidepressants is necessary (Sherwood 
et al., 2007). 
In the current study, the score for functional status (73.14±23.70) was similar to 
that (74.5±21.0) reported by Myers et al. (2006) but higher than the score (64.4) reported 
by Green (2000). Researchers have shown that, across different cultures, the domain of 
physical functioning has the lowest level of agreement of all the domains of HRQOL 
(Fox-Rushby & Parker, 1995). Functional status in the current study was highly 
correlated with physical symptoms (r = .70, p<.001). Because the HF participants 
reported fewer physical symptoms, it was reasonable to expect higher scores on 
functional status. However, the participants may have had a high willingness to perform 
basic daily living activities but were nevertheless reluctant to engage in physical and 
social activities because of their lack of energy. That argument was supported by the 
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study finding that a number of the participants in the current study appeared to be 
physically inactive. Likewise, lower functional capacity was significantly associated with 
lower social functioning (r = .70, p<.001). 
When answering the items relative to HRQOL social functioning, several 
participants stated that they had formerly traveled with groups of friends or groups 
arranged by travel agencies; however, they had stopped traveling because they were 
worried that their slow pace would cause inconvenience for others. In addition, some 
participants with more severe symptoms expressed concerned that their visits would 
cause their friends discomfort and anxiety, becau se their HF symptoms could suddenly 
worsen anywhere and anytime. Some elderly participants said that they did not know who 
they could visit because most of their friends were deceased. 
Overall, the study findings regarding domains of HRQOL supported the view that 
HRQOL is a multidimensional concept. The moderate to strong intercorrelations among 
the domains indicate that they strongly interact with each other. Improving one domain 
may also improve the remaining domains. 
Demographics and HRQOL. There was no significant relationship between 
gender and overall HRQOL. That finding is consistent with previous findings (Westlake 
et al., 2002), but it contrasts with findings from the majority of the literature that 
addresses other HF populations. Previous studies indicated that women have a lower 
HRQOL than men (Friedman, 2003; Hou et al., 2004; Luttik, Jaarsma, Veeger, & van 
Veldhuisen, 2006; Smith et al., 2005). The women and men in the current study had 
similar individual and HF characteristics, except for education and type of language. 
In the current study, younger participants reported higher HRQOL, which is 
inconsistent with the majority of previous studies in which elderly patients reported better 
HRQOL than younger people (Clark et al., 2003; Hou et al., 2004; Masoudi et al., 2004; 
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Riedinger et al., 2000). However, the current finding is similar to that of previous studies 
that measured HRQOL with different instruments (Gott et al., 2006; Luttik et al., 2006). 
In the current study, older participants were more likely to be illiterate or poorly educated, 
unemployed, low income, and living in rural areas. Researchers found that low social 
status (low income, low educational level, and unemployment) could hinder rural elderly 
from taking part in health-promoting behaviors, such as self-care activities and 
acquisition of medical information, and they therefore reported lower HRQOL (Hu et al., 
2005; Li, Chen, & Kuo, 2005; Wang, 2001). The situation was particularly prevalent in 
the elderly HF participants who had poor functional status and lacked assistance in 
obtaining medical services (Luttik et al., 2006). 
Education played an important role in HRQOL in this sample, accounting for 9% 
of the variance in overall HRQOL. This finding was similar to those reported in previous 
studies conducted in Taiwan and Hong Kong (Lai et al., 2005; Lam & Lauder, 2000; Tsai 
et al., 2004; Yu et al., 2004). That agreement among the studies may support the argument 
that Taiwanese people with higher education have less difficulty in receiving medical 
information printed in the Chinese-Mandarin language. Accordingly, they have better 
resources and greater ability to adjust to their illnesses and changes in life expectations, 
and they can employ better critical thinking in making decision about their treatments. 
Rockwell & Riegel (2001) found that HF patients with higher education performed better 
self-care. Additionally, people who were better at reading and writing Chinese engaged in 
more positive health-promoting behaviors (Lee & Wang, 2005). In the current study, 
participants who could speak Mandarin showed better functional status (79.10 vs. 67.64, 
p<.01), social functioning (74.51 vs. 64.42, p<.05), and overall HRQOL (74.09 vs. 67. 18, 




Table 45  
Differences in HRQOL Between Types of Language 
  Mandarin Taiwanese t 
Functional status 79.10 (18.42) 67.64 (26.67) 2.81** 
Symptom stability 50.42 (23.24) 53.46 (15.86) -.86 
Symptom frequency 66.77 (25.22) 66.64 (25.64) .03 
Symptom burden 81.53 (21.38) 81.03 (22.51) .13 
Physical symptom  74.15 (21.14) 73.83 (21.62) .08 
Self-efficacy 80.83 (25.16) 74.81 (29.77) 1.23 
Psychological status 68.61 (24.81) 62.82 (24.57) 1.31 
Social functioning 74.51 (23.63) 64.42 (25.58) 2.29* 
Overall HRQOL 74.09 (17.73) 67.18 (20.82) 1.99* 
*p< 0.05 level, **p<.01 level, ***p< 0.001 level (2-tailed). 
HF characteristics and HRQOL. The length of time since diagnosis of HF was 
not correlated with overall HRQOL. That finding was similar to those of previous studies 
(Juenger et al., 2002; Wang, 2005). Of the participants in the current study who had been 
newly diagnosed with HF, several were in NYHA Class III. In contrast, several other 
participants who had had HF for a longer time did not perceive HF symptoms. In this 
sample, perceived severity of HF may be the more important factor in determining 
perception of HRQOL than the length of time since HF diagnosis. That conclusion may 
be supported by the weak relationship between systolic HF and poor social functioning (r 
= .19, p<.05) and the strong relationships among NYHA functional classification and 
overall HRQOL and the domains of HRQOL. 
Worse NYHA functional classification was consistently predicted by all domains 
of HRQOL. This finding is congruent with previous research that found that NYHA 
classification was a correlate of HRQOL (Clark et al., 2003; Cline et al., 1999; De Jong et 
al., 2005; Juenger et al., 2002; Wang, 2005; Westlake et al., 2002; Yu et al., 2004). In the 
current study, the NYHA functional classification was the strongest predictor of HRQOL, 
accounting for 39.8% of the variance. The greater the HF severity, the more likely were 
the participants to experience lower levels of HRQOL. Approximately 74.4% of the 
participants, however, had stable HF conditions. 
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The number of medications did not relate to the HRQOL domains. The use of 
AECI was positively correlated with symptom stability and symptom frequency (both 
with r = .18, p<.05), supporting the contention that the use of HF medications can have 
positive effects on HRQOL by improving symptoms (Riedinger et al., 2000). The use of a 
calcium channel blocker was correlated with lower levels of symptom frequency (r = -.20, 
p<.05) and less physical symptoms (r = -.19, p<.05). Those findings supported earlier 
indications that HF medication may increase treatment-related effects, resulting in poor 
HRQOL for people with HF (Hunt et al., 2005; Riedinger et al., 2000). In addition, 
treatment of systolic HF entailed a greater amount of HF medication than did treatment of 
either diastolic or valvular HF (F = 12.27, p<.001). Likewise, the number of HF 
medications used increased with NYHA classification (r = .22, p<.05). Several 
participants in the current study complained of side effects from HF medications, such as 
dry mouth and swelling in the lower legs. Findings from the current study suggest that, to 
ensure a better HRQOL, it is important that healthcare providers take into account the HF 
patients’ perceptions and concerns about medications. Some relationships showed 
statistical significance but were of unlikely clinical importance (e.g. the use of a 
lipid-lowering agent was associated with self-efficacy in a positive direction [r = .19, 
p<.01]; the use of a vasodilator had a negative relationship with social functioning [r = 
-.23, p<.01]). 
Health-related characteristics and HRQOL. Comorbidity was a predictor of 
overall HRQOL in the current study. Participants with a greater number of comorbid 
conditions, as measured by both the Charlson Comorbidity Index and chart-review 
method, reported lower HRQOL than their counterparts. That finding is consistent with 
some previous studies (Chin et al., 2003; Clark et al., 2003; Feldman et al., 2004; Yu et 
al., 2004), but different from others (De Jong et al., 2005; Heo et al., 2005; Redeker & 
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Hilkert, 2005). Some studies, however, used a simple checklist to measure comorbid 
conditions, and did not separate cardiovascular health problems from noncardiovascular 
concomitant problems. As a result, the findings regarding comorbidity and HRQOL could 
vary. In the current study, the number of noncardiovascular diseases was correlated with 
HRQOL and not with the number of cardiovascular health problems. Braunstein and 
associates (2003) stated that noncardiac comorbidities are highly prevalent in older 
patients with HF and strongly associated with adverse clinical outcomes, such as 
hospitalization and mortality. Those findings, however, supported the view that the HF 
care has shifted from the paradigm in which HF is considered a dominant condition to a 
new paradigm in which HF is considered one of several comorbid conditions (Havranek 
et al., 2003). 
Perceived health was a correlate of overall HRQOL, a finding that is similar with 
those of previous studies (Heo et al., 2005; Yu et al., 2004). Clark et al.(2003) and De 
Jong et al (2004), however, found that perceived health was not associated with HRQOL. 
In the current study, perceived health was influenced by NYHA classification and 
severity of comorbidity measured by the CCI, supporting the view that disease, disability, 
and functional limitation have detrimental effects on perceived health (Johnson & 
Wolinsky, 1993). Research studies found that perceived health was strongly correlated 
with mortality and worsening cardiac events (Chin et al., 2003; Havranek et al., 2001). 
The current study, however, did not find any correlation between perceived health and 
HRQOL social functioning. That lack of correlation can be explained by the fact that 
energetic activity may not be the norm for Chinese patients, particularly for elderly 
patients (Leung et al., 2004). Patients are allowed to be physical inactive and absent from 
social activity, regardless of the severity or lack of severity of their illnesses. 
Sleep variables and HRQOL. In the current study of Taiwanese people with HF, as 
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sleep disorders increased, HRQOL decreased. This finding accords with the majority of 
previous studies involving participants with HF (Brostrom et al., 2004; Redeker & 
Hilkert, 2005; Skobel et al., 2005; Villa et al., 2003). Among the four domains of 
HRQOL, social functioning had the strongest correlation with global sleep quality (r = 
-.44, p<.001), whereas psychological status had the weakest correlation (r = -.28, p<.01). 
Table 46 shows the results of further analysis of the differences in HRQOL for good 
sleepers (PSQI≤5) and poor sleepers (PSQI>5). The mean differences in the four HRQOL 
domains between these two groups ranged from 10.53 (psychological status) to 22.14 
(social functioning), indicating the large effects of sleep disorders on HRQOL. The 
significant influence of sleep disorders on social functioning was also found in the 
Brostrom et al. (2004) study with 223 HF patients in Sweden. 
 
Table 46  
Differences in HRQOL Between Good Sleepers and Poor Sleepers      (n=125) 
  PSQI≤5 (n=32) PSQI>5 (n=93) Mean Differences t 
Overall HRQOL 83.26 (11.93) 66.11 (19.88) -17.15 (2.95) -5.82***
Physical symptom 86.88 (14.05) 69.55 (21.63) -17.34 (3.34) -5.18***
Symptom frequency 80.79 (24.02) 61.85 (24.03) -18.94 (4.92) -3.85***
Symptom burden 92.97 (9.49) 77.24 (23.48) -15.73 (2.96) -5.32***
Functional status 86.98 (11.14) 68.38 (25.01) -18.60 (3.26) -5.71***
Psychological status 73.44 (19.68) 62.90 (25.82) -10.53 (4.39) -2.40* 
Social functioning 85.74 (14.22) 63.60 (25.55) -22.14 (3.65) -6.06***
Symptom stability 58.59 (18.63) 49.73 (19.68) -8.86 (3.98) -2.23* 
Self-efficacy 82.03 (28.80) 76.21 (29.66) -5.82 (4.79) -1.21 
*p< 0.05 level, ***p< 0.001 level (2-tailed). 
The findings above, however, were somewhat different from two other studies 
showing that nocturnal sleep disorders were most associated with psychological health 
rather than functional performance among Western people with chronic illnesses 
(Manocchia et al., 2001) and among Western people with HF (Redeker & Hilkert, 2005). 
The findings in the current study, however, were supported by Lee (1995) who showed 
that Taiwanese people usually attribute sleep problems to physical illness. In the 
traditional Chinese health belief of Yin and Yang, when night is coming (Yin), people 
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have to sleep to restore the Yin–Yang balance that reflects good health. Similarly, Hwu, 
Coates, and Boore (2001) found that Taiwanese patients with chronic illnesses viewed 
sleep as a physical health behavior necessary to restore and prepare energy for activities 
during the next day. When sleep disorders occur, patients may begin to be more aware of 
their physical functioning in carrying out daily activities and the various roles that are 
most affected. Likewise, poor sleep quality may affect progression of HF; thus, patients 
may experience more symptoms, encounter greater symptom burden, and experience less 
stability in their HF symptoms. A drop in HRQOL, however, could also contribute to 
sleep disorders because of the bidirectional relationships between sleep disorders and 
HRQOL. 
Three predictors of overall HRQOL were subjective sleep quality, sleep 
disturbances, and sleep efficiency, all of which accounted for a total of 7% of the variance. 
Indeed, the effects of sleep disorders may be larger than the multiple regression analysis 
found. In this study, components of global sleep quality and HRQOL created a vicious 
cycle in sleep quality as indicated by their correlations in Table 30 and 35. When sleep 
disturbances were initiated by HF symptoms, such as nocturia and shortness of breath, 
sleep continuity was disrupted, resulting in a longer sleep duration and a feeling of poor 
sleep quality. The perception of poor sleep quality became stronger if the participants 
could not fall asleep within a short time (normally 15 minutes) because of sleep 
disruptions. Perceived sleep inefficiency was further pronounced because the time in bed 
was much longer than actual sleep duration. Participants noted that their sleep no longer 
refreshed them and restored the energy for performing their daily functions. Poor 
functional status could result in more sedentary lifestyles, which in turn could reduce 
their cardiopulmonary tolerance. Perceived lifestyle changes and frequent sleep 
disturbances could cause mood swings, which could also affect perceptions of sleep 
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quality. Likewise, engaging in few social activities could result in more opportunities for 
daytime napping, which again could worsen nocturnal sleep quality. Daytime dysfunction, 
however, resulted in the greater likelihood of falling asleep or dozing off during daytime. 
Longer sleep latency was correlated with poorer HRQOL functional status. That 
finding was supported by the Redeker and Hilkert (2005) study. Sleep latency, however, 
was not associated with HRQOL psychological status (r = -.05, p>.05). Helping patients 
identify the potential causes including both physical and psychological mechanisms may 
be indicated. 
The use of sleeping medication was negatively correlated with HRQOL 
psychological status only (r = .19, p<.05), showing that participants who took sleeping 
medication also reported better psychological status. The findings, however, suggest that 
the participants were receiving insufficient treatment for their sleep problems and needed 
more encouragement to seek treatment for their sleep disorders. The use of sleeping 
medication may be necessary for certain patients with HF; however, alternative 
treatments, such as music (Lai & Good, 2006) and acupoint massage (Tsay et al., 2003), 
are particularly important for people who are concerned about the side effects of 
medications. 
Daytime sleepiness was correlated with overall HRQOL and all domains of 
HRQOL except social functioning. When participants were categorized into two groups, 
however, namely, those with excessive daytime sleepiness (ESS>10) and those without 
excessive daytime sleepiness (ESS≤10), the two groups showed significant differences in 
all four domains of HRQOL, indicating the important effects of daytime sleepiness on 
HRQOL (see Table 47). That finding is similar to the findings of previous studies 
showing that excessive daytime sleepiness was associated with reduced HRQOL in 223 
patients with HF (Brostrom et al., 2004), in 43 patients with lung cancer (Vena et al., 
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2006), in 5816 persons from general population (Baldwin et al., 2001), and in 94 
Taiwanese adult patients with sleep-related breathing disorders (Wang et al., 2006). The 
regression model of the current study indicated that daytime sleepiness was not a 
predictor of HRQOL. Daytime sleepiness, however, may be independent to global 
nocturnal sleep quality in its effect on HRQOL in patients with HF, in that daytime 
sleepiness was associated with only one domain of global nocturnal sleep quality, 
daytime dysfunction. Further research with patients with more severe NYHA 
classifications may be useful to help understand the relationship between daytime 
sleepiness and HRQOL. 
 
Table 47  
Differences in HRQOL between Excessive Daytime Sleepiness and Without Excessive Daytime 
Sleepiness                             
 ESS≤10 (n=95) ESS>10 (n=30) Mean Difference t 
Physical symptom 76.24 (21.17) 66.84 (20.49) 9.40 2.17* 
Symptom frequency 70.29 (24.73) 55.35 (24.23) 14.94 2.90** 
Symptom burden 82.19 (21.66) 78.33 (22.70) 3.86 .84 
Functional status 76.02 (22.49) 64.03 (25.46) 11.99  2.47*  
Psychological status 68.95 (22.72) 55.00 (28.16) 13.95 2.47* 
Social functioning 71.93 (23.57) 60.83 (28.14) 11.10 2.14* 
Overall HRQOL 73.28 (18.11) 61.68 (21.87) 11.61 2.91** 
Symptom stability 52.90 (19.59) 49.17 (20.22) 3.73 .90 
Self-efficacy 80.26 (26.71) 69.58 (29.67) 10.68 1.86 
*p< 0.05 level, **p<.01 level (2-tailed). 
Ohayon et al. (2001) found that social interactions had no influence on napping. 
In keeping with the findings regarding daytime sleepiness, however, the current study 
showed that poor HRQOL social functioning was correlated with greater frequency of 
daytime napping. Likewise, participants with poor levels of perceived health and greater 
numbers of concomitant health problems reported higher frequencies and longer 
durations of daytime napping. This finding may suggest that the use of naps to restore 
energy among Taiwanese people with HF is common. Likewise, the current study found 
that longer daytime napping was correlated with lower symptom frequency, suggesting 
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that daytime napping may slow the occurrence of HF symptoms. Further research is 
needed, however, to clarify the effects of daytime napping on HF. 
Issues Related to Conceptual Model 
Because there was no existing theoretical framework for HRQOL and sleep 
disorders, a conceptual model was developed to guide the current study. The study 
findings supported some aspects of the model. For example, the data showed that 
demographic characteristics, including age, education, financial status, and type of 
language, were correlates of HRQOL. On the other hand, the data did not support 
relationships between gender, marital status, living arrangement, and HRQOL, and 
further research is required to clarify those associations. Among the HF characteristics, 
NYHA functional classification presented the strongest association with HRQOL among 
the variables. NYHA classification also had significant effects on global nocturnal sleep 
quality. Future research, however, is necessary to clarify relationships between LVEF, 
type of HF, length of time since HF diagnosis, and HRQOL. The study findings 
supported relationships between health-related characteristics, including comorbidity and 
perceived heath, and sleep variables, including global nocturnal sleep quality and daytime 
sleepiness. Likewise, a weak relationship was found between daytime napping and social 
functioning. The study findings, however, did not support any causal relationships among 
the major variables in the conceptual model because of the limitations of the study design. 
Further longitudinal research is suggested to explore the long-term effects of correlates 
and causal relationships among the variables in the population with HF. 
Implications and Recommendations 
The findings of the study have several implications for nursing practice, nursing 




1. NYHA functional classifications played an important role in both HRQOL and sleep 
disorders. Assessing patients’ perceptions of their HF severity and impact on HRQOL 
is important as a part of HF care and teaching. HF is a long-term illness, often 
associated with certain functional difficulties and characterized by life-threatening 
exacerbations that result in multiple problems for patients and their families.  
2. Sixteen factors were found to be associated with HRQOL in Taiwanese people with 
HF suggesting that HRQOL is an extremely complex concept. Nurses should use a 
holistic perspective to help patients understand and manage the impact of HF on their 
daily lives. Effective interventions for improving HRQOL should be designed based 
on patients’ needs. 
3. Healthcare providers should carefully assess patients’ perceptions of HF symptoms as 
well as use clinical observation skills to evaluate for the presence of symptoms. , 
Participants were less likely to perceive the burden of their symptoms than they were 
the frequency of the symptoms. This may have resulted from participants’ adaptation 
to their symptoms and the adoption of more sedentary daily activities. Patients, 
however, may overlook the severity of their symptoms and postpone treatment when 
symptoms are gradually getting worse. 
4. Since psychological status had the lowest score among HRQOL domains, routinely 
assessing HF patients’ emotional status is recommended. Depression is a common 
finding in people with HF. Interventions, such as encouraging patients to express their 
concerns, providing opportunities to talk, and appropriately referring patients for 
counseling should be considered.  
5. Nurses and other healthcare providers should to pay particular attention to the needs 
of illiterate or nearly illiterate patients. The study findings supported the position that 
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healthcare providers needed to direct more educational efforts toward health 
promotion and maintenance within the illiterate or poorly educated population. 
Providers should also be aware of patients’ literacy levels before they distribute 
written teaching materials. Spoken explanations are particularly needed for Taiwanese 
people. In addition, efforts should be made to evaluate patients’ understanding of the 
teaching, encourage them to ask questions, and to clarify points of misunderstanding. 
Furthermore, the families should become involved in the patient teaching or 
educational programs to increase the educational effects of the programs. 
6. Many of the participants in this study were obese and lacked physical activity in their 
lives. Sometimes the inactivity was in response to family member requests to restrict 
activities to prevent the recurrence of symptoms. Nurses are ideal teachers for helping 
patients safely design exercise plans. We should communicate with family members 
about the importance of physical activity to promote patients’ cardiopulmonary 
fitness and how to engage in safely physical activity.  
7. The importance of ongoing screening for sleep disorders in people with HF is 
highlighted based on the study findings about the prevalence of low global nocturnal 
sleep quality and daytime sleepiness among the participants in this study. Nurses 
should encourage patients to describe their sleep symptoms in detail and any related 
HRQOL impairments. Early detection of sleep disorders may help healthcare 
providers minimize potential poor outcomes and improve health-related quality of life 
in people with HF. 
8. Effective interventions for sleep disorders in patients with HF should be designed in 
accordance with each patient’s life style. Many participants in the study who 
experienced nocturia habitually drank tea in the afternoon. Attempts to manage 
nocturia in that group would include teaching the participants to avoid excessive fluid 
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intake late in the day and consulting with physicians about the timing of prescription 
diuretic medications (Asplund, 2005). Interventions for sleep disorders should focus 
on both pharmacologic (e.g. sleeping medication) and nonpharmacological treatments 
(e.g. relaxation strategies). Nurses should consider significant impact of sleep 
disorders on HRQOL and avoid viewing patients’ sleep problems only from the 
psychological perspective. Instead, we should investigate sleep disorders from 
multiple perspectives. 
Nursing Education 
1. Sleep disorders are common in people living with HF and content about the topic 
needs to be incorporated into nursing curricula. Specifically, knowledge about sleep 
disorders and HRQOL among people with HF should be taught to nursing students 
around the world. To foster students’ knowledge in this area, nursing faculty should 
include HRQOL, sleep hygiene, sleep assessment, and sleep-related pathophysiology. 
As a result, students will be better able to help patients evaluate and manage sleep 
disorders.  
2. HRQOL is an important concept that should be included in basic and advanced 
nursing education to prepare future nurses to address health needs of people with 
chronic conditions, such as HF. Participants in the current study expressed the 
importance of seeing HRQOL from a multidimensional perspective. 
3. HF is a lethal condition affecting millions of people around the world. 
Evidence-based treatment of HF should be incorporated into the nursing curricula to 
help nursing students better care for this population. As a result, they may be better 
able to teach patients about their HF treatment and to judge whether the treatments 
have caused any unexpected side effects. Some prescribed HF medications were 
found to be associated with HRQOL in the current study. 
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Nursing Research 
1. Findings from this cross-sectional correlational study could serve as a baseline for 
further longitudinal studies of HRQOL and sleep conditions in Taiwanese people with 
HF. The use of a longitudinal study design would be helpful in identifying predictors 
of HRQOL over time and ascertaining causal relationships between sleep variables 
and HRQOL. HF is a chronic disease that requires long-term treatment and can result 
in changes in HRQOL over time.  
2. The study examined the relationships between nocturnal sleep quality, daytime 
sleepiness, daytime napping, and HRQOL in people with HF. Replication studies are 
needed to support the findings of this current study. Future research also can compare 
the study findings with other research studies and population. 
3. The combination of two HRQOL instruments may provide richer information and 
reveal diverse perspectives regarding the impact of HF on HRQOL. Different 
instruments for self-reporting HRQOL may measure HRQOL from varied 
perspectives. Because HRQOL is a multidimensional concept, the use of only one 
instrument may overlook other dimensions of this complex concept.  
4. The low level of Cronbach’s alpha of the SRHS may suggest that this subscale was 
not appropriate to be used to measure perceived health in the participants with HF. 
Modifing the scale options may be helpful to make the SRHS more plausible and 
applicable since the participants tended to answer the questions with a neutral 
manner. 
5. The study supported that belief that psychological problems are common in people 
with HF across different cultures. Future research could focus on neuroendocrine 
changes related to depression and levels of cytokines to help build an understanding 
of the pathophysiological mechanisms in Taiwanese people with HF. Such research 
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would help healthcare providers to not only accurately diagnose psychological 
problems in people with HF, but also to plan and administer effective interventions. 
6. Future qualitative research studies are needed to explore patients’ subjective 
perception about effects of HF on HRQOL, particularly the domain of psychological 
status. Adding an instrument to measure depression or mood state may be helpful to 
provide more comprehensive information about this area.  
7. Multiple methods for documenting sleep problems for people with HF are 
recommended in future studies. Two valuable methods for obtaining objective data on 
sleep disorders are polysomnography and Actiwatch Actigraphy. Nocturnal 
polysomnography, the gold standard confirmatory laboratory technique in the 
diagnosis of sleep disturbances, has provided researchers extensive data on sleep 
disturbances, especially sleep-related breathing disorders (Bootzin et al., 1994). 
Research has also supported the ability of Actiwatch Actigraphy to accurately identify 
sleep arousals in a simple and time-saving manner (Pillar et al., 2003). Moreover, the 
technique can be used in the home environment. Overall, both subjective and 
objective measures are necessary to better understand sleep problems in patients with 
HF. In addition, an activity diary that records daytime sleepiness and daytime napping 
may be useful for capturing a participant’s propensity to fall asleep or dose off. 
8. The relationship between physical activity and sleep quality in this population should 
be further clarified. Furthermore, the use of objective measures would help to explore 
the extent to which HF patients engage in physical activity. 
9. Studies that test the effects of specific interventions for sleep disorders and HRQOL 
are highly recommended. Some patients can improve their HF conditions if they can 
improve their sleep quality (Leung & Bradley, 2001; Trupp, 2004). Several 
participants in the current study, however, were concerned about the interaction 
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effects between sleeping medications and HF medications. More research, therefore, 
is needed that addresses the design of effective nonpharmacological interventions for 
sleep disturbances for this population. 
Summary 
This chapter has presented a summary and discussion of the study findings. In 
addition, the chapter included the implications and recommendations in three areas: 
nursing practice, nursing education, and nursing research. Overall, the study has added to 
our knowledge of HRQOL and sleep disorders in Taiwanese people with HF. In 
particular, the study findings supported the existence of relationships between HRQOL 
and sleep disorders in Taiwanese people with HF. From those findings, interventions 
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Title: Health-Related Quality of Life and Sleep Disorders in People Living with Heart Failure. 
 
Conducted by: Hsing-Mei Chen                       IRB PROTOCOL # 2006-09-0058 
The University of Texas at Austin: School of Nursing      Telephone: 0987038359 
Email address: hsingmei@mail.utexas.edu 
 
Sponsor: Angela Clark, PhD, RN, CNS, FAAN, FAHA, Associate Professor,  
Telephone: 512-471-9078 . Email address: apclark@mail.utexas.edu 
 
You are being asked to participate in a research study. This form provides you with information about 
the study. Please read the information below and ask questions about anything you don’t understand 
before deciding whether or not to take part. Your participation is entirely voluntary and you can refuse 
to participate without penalty or loss of benefits to which you are otherwise entitled. You can stop 
your participation at any time by simply telling the researcher. 
 
The purpose of this study is to understand how the quality of life and sleep are affected when one has 
heart failure. This study will enroll 125 Taiwanese participants. 
 
If you decide to participate, I will invite you to fill out a set of questionnaires, which include personal 
information, such as, age, education, and married status, questions about your sleep conditions and 
health-related quality of life. After obtaining your permission, I will collect information about your heart 
failure condition from your medical record. At your convenience, you can fill-out the questionnaires in 
the clinic or at your home. If you choose to do it at home, a stamped pre-addressed envelope will be 
given to you to mail it back. 
 
Total estimated time to take part in the study will be about 30-60 minutes.  
 
Risks: The risk associated with this study is no greater than everyday life. No discomfort, physical or 
emotional harm is anticipated as a result of being in this study. You can stop or postpone the 
participation if you feel discomfort, such as dyspnea and fatigue. You can also withdraw voluntarily 
from the study at any time without adversely affecting your health care. 
 
Benefits: Although there is no direct benefit to you, you may benefit from knowing that you are 
helping researchers learn more about heart failure in Taiwanese people. 
 
Privacy and Confidentiality: All of the questionnaires and codebook will be stored in a locked 
cabinet in the principal investigator’s home. Only the principal investigator can access the codebook ad 
questionnaires. Any information that is obtained in connection with this study and that can be identified 
with you will remain confidential. Authorized persons from The University of Texas at Austin, and 
members of the Institutional Review Board have the legal right to review your research records and will 
protect the confidentiality of those records to the extent permitted by law. Any publications or 
presentations will exclude any information that will make it possible to identify you as a subject. Any 
identifying information, codebook, and questionnaires will be destroyed after the study is published.  
 
Contacts and Questions: 
If you have any questions, please ask me. If you have questions later or want additional information, 
you may call me. You may also contact my supervisor: Angela P. Clark, PhD, RN. Our phone numbers 
and e-mail addresses are at the top of this page. If you have questions about your rights as a research 
participant, please contact Lisa Leiden, PhD, Chair, The University of Texas at Austin Institutional 
Review Board for the Protection of Human Subjects, +1-512-232-4383. 




主要研究者：陳幸眉                    人權審核委員會號碼: #2006-09-0058 
美國德州大學奧斯汀校區護理系       電話：0987038359 
Email address: hsingmei@mail.utexas.edu 
 
研究者的指導教授：安琪拉克拉克 (Angela Clark)教授    Telephone: 



















































Appendix B  
Questionnaires--English  
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                            Demographic Data                 ID: 
 
Birth Date:                             Gender: Female   Male 
Body Height:              cm           Body Weight:           Kilogram 
How long since the diagnosis of heart failure?   Year      Month       
Married Status: Married    Separated   Divorced   Widow/Widower    
 Single     Other (please write down)                     
Education: Illiterate, No Schooling  Literate, but no formal schooling  
Elementary School   Junior high school   High school   Junior 
College   College   Graduate School   Other    
Living Arrangement: Alone   Living with Families    Living with Friends   
Nursing Home    Other                   
Employed Status: Yes    No    Unemployed due to disability Retired    
Other          
Financial Status: Poor, not enough for daily expenses  some, merely enough for 
daily expenses  Adequate, very sufficient for daily expenses    
Other                
Language: Taiwanese   Mandarin   Both above  Other              
 
 193
Data from practice medical record: 
New York Heart Association Functional Classification:              
Ejection Fraction:           Heart Failure: systolic    diastolic 
Medications: ACEI_________________   Beta-Blocker________________   
ARB________________    Diuretic____________________       
Digitalis______________   Aldosterone Inhibitor____________ 
Vasodilator___________    alpha adrenergic antagonist________ 
Blood thinner____________ ASA_______________     
Anti-lipid_______________    
 
Concomitant Health Problems  
 Other CVD= hypertension, atrial arrhythmia, ventricular arrhythmias, ICD, 
Pacemaker, valvular heart disease, EP ablation, peripheral artery disease, 
CABG, angina, MI, CAD, cardiac PCI (angioplasty, stent), dyslipidemia, 
or________________________________ 
 Diabetes= type 1, type 2 
 Thyroid= hypothyroidism, hyperthyroidism, goiter  
 Pulmonary= asthma, emphysema, chronic bronchitis, COPD, or_______________ 
 Renal= chronic renal insufficiency, hemodialysis, peritoneal dialysis, or___________ 
 GI= chronic hepatitis, cirrhosis, ulcers, or______________________ 
 Neuro= CVA, TIA, carotid artery surgery/angioplasty, dementia, Alzheimer, or 
______________ 
 Cancer=_____________________________________________ 
 Musculoskeletal= RA, osteoarthritis, or__________________________________ 
 Psych/MH= depression, alcohol abuse, chronic pain, dementia, or _______________ 
 Other:_____________________________________________________________ 
Resource: 
Radford, M. J., Arnold, J. M. O., Bennett, S. J., Cinquegrani, M. P., Cleland, J. G. F., Havranek, E. P., et al. 
(2005). ACC/AHA key data elements and definitions for measuring the clinical management and 
outcomes of patients with chronic heart failure. Circulation, 112, 1888-1916. 
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Comorbidity Questionnaire 
Please check which of the following medical conditions you have. If you do not have a 
condition, please check “no.” 
Myocardial infarction: 
1. Have you ever had a heart attack?  ____(1) Yes   ____(0)No 
 
Congestive heart failure: 
2. Have you ever been treated for heart failure? (You may have been short of breath and 
the doctor may have told you that you had fluid in your lungs or that your heart was 
not pumping well.)            ____(1) Yes   ____(0)No 
 
Peripheral vascular disease: 
3. Have you had an operation to unclog or bypass the arteries in your legs?  
___(1) Yes   ___(0)No 
 
Cerebrovascular accident: 
4. Have you had a stroke, cerebrovascular accident, blood clot or bleeding in the brain, or 
transient ischemic attack (TIA)?   ____(1) Yes   ____(0)No 
 
Hemiplegia: 
4a. Do you have difficulty moving an arm or leg as a result of the stroke or 
cerebrovascular accident?  ____(1) Yes   ____(0)No 
 
Chronic obstructive pulmonary disease: 
5. Do you have asthma?         ____(1) Yes   ____(0)No 
If yes, do you take medicines for your asthma? ____(1) Yes   ____(0)No 
If yes, only with flare-ups of my asthma? ____(1) Yes   ____(0)No 
I take medicines regularly, even when I'm not having a flare-up. ___(1) Yes ___(0)No 
6. Do you have emphysema, chronic bronchitis, or chronic obstructive lung disease? 
____(1) Yes   ____(0)No 
If yes, do you take medicines for your lung disease? ____(1) Yes   ____(0)No 
If yes, only with flare-ups?  ____(1) Yes   ____(0)No 
I take medicines regularly, even when I'm not having a flare-up. ___(1) Yes ___(0)No 
 
Ulcer disease: 
7. Do you have stomach ulcers, or peptic ulcer disease? ____(1) Yes   ____(0)No 
If yes, has this condition been diagnosed by endoscopy (where a doctor looks into your 
stomach through a scope) or an upper GI or barium swallow study (where you 
swallow chalky dye and then x-rays are taken)?   ____(1) Yes   ____(0)No 
 
Diabetes: 
8. Do you have diabetes (high blood sugar)?      ____(1) Yes   ____(0)No 
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8a. If yes, treated by modifying my diet?         ____(1) Yes   ____(0)No 
8b. If yes, treated by medications taken by mouth?  ____(1) Yes  ____(0)No 
8c. Treated by insulin injections?               ____(1) Yes   ____(0)No 
8d. Has the diabetes caused problems with your kidneys? ____(1) Yes   ____(0)No 
8e. Has the diabetes caused problems with your eyes, treated by an ophthalmologist? 
____(1) Yes   ____(0)No 
 
Renal: 
9. Have you ever had poor kidney function (blood tests show high creatinine)?    
____(1) Yes   ____(0)No 
9a. Have you used hemodialysis or peritoneal dialysis? ____(1) Yes   ____(0)No 
9b. Have you received kidney transplantation? ____(1) Yes   ____(0)No 
 
Connective tissue disease: 
10. Do you have rheumatoid arthritis? ____(1) Yes   ____(0)No 
10a. If yes, do you take medications for it regularly?  ____(1) Yes   ____(0)No 
10b. Do you have Lupus (systemic lupus erythematosus)? ____(1) Yes   ____(0)No 
10c. Do you have Polymalgia rheumatica? ____(1) Yes   ____(0)No 
 
Dementia, liver disease, leukemia, lymphoma, tumor, metastases, AIDS: 
11. Do you have any of the following conditions? 
11a. Alzheimer's Disease, or another form of dementia? ____(1) Yes   ____(0)No 
11b. Cirrhosis, or serious liver damage? ____(1) Yes   ____(0)No 
11c. Leukemia or polycythemia vera?____(1) Yes   ____(0)No 
11d. Lymphoma?   ____(1) Yes   ____(0)No 
11e. Cancer, other than skin cancer, leukemia or lymphoma? ____(1) Yes   ____(0)No 
11f. If yes, has the cancer spread, or metastasized to other parts of your body? 
 ____(1) Yes   ____(0)No 
11g. AIDS?   ____(1) Yes   ____(0)No 
Resource:  
Katz, J. N., Chang, L. C., Sangha, O., Fossel, A. H., & Bates, D. W. (1996). Can 
comorbidity be measured by questionnaire rather than medical record review? 
Medical Care, 34, 73-84. 
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Self-Rated Health Subscale 
Please answer the following four questions by CIRCLING the answer which you think 
best describes your own health. 
1.How would you rate your overall health at the present time? 
  excellent   good   fair   poor  
2.Is your health now better, about the same, or not as good as it was one year ago? 
  better   same   not as good  
3.Do your health problems stand in the way of your doing the things you want? 
  not at all   a little   a great deal  
4.Would you say that your health is better, about the same, or not as good as most people 
your age? 




Lawton, M. P., Moss, M., Fulcomer, M., & Kleban, M. H. (1982). A research and service 
oriented multilevel assessment instrument. Journal of Gerontology, 37, 91-99. 
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The Kansas City Cardiomyopathy Questionnaire 
The following questions refer to your heart failure and how it may affect your life. Please read and 
complete the following questions. There are no right or wrong answers. Please mark the answer that best 
applies to you.  
 
1. Heart failure affects different people in different ways. Some feel shortness of breath while others feel 
fatigue. Please indicate how much you are limited by heart failure (shortness of breath or fatigue) in 
your ability to do the following activities over the past 2 weeks.  
 











Not at all  
Limited 
Limited for other 
reasons or did not 
do the activity 
Dressing yourself       
Showering/ Bathing       
Walking 1 block on 
level ground       
Doing yardwork, 
housework or carrying 
groceries 
      
Climbing a flight of 
stairs without 
stopping  
      
Hurrying or jogging 
(as if to catch a bus)        
 
2. Compared with 2 weeks ago, have your symptoms of heart failure (shortness of breath, fatigue or ankle 
swelling) changed?  











I've had no symptoms over the 
last 2 weeks 
      
 
3. Over the past 2 weeks, how many times did you have swelling in your feet, ankles or legs when you 
woke up in the morning? 
Every 
morning 
3 or more times a week, but 
not every day 
1-2 times a 
week 
Less than once 
a week 
Never over the past 
2 weeks 
     
 
4. Over the past 2 weeks, how much has swelling in your feet, ankles or legs bothered you?  
It has been … 
Extremely 
bothersome 






Not at all 
bothersome 
I've had no 
swelling 
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once a day 
3 or more times per 








the past 2 
weeks 
       
6. Over the past 2 weeks, how much has your fatigue bothered you?  
It has been. ..  
Extremely 
bothersome 






Not at all 
bothersome 
I've had no 
fatigue 
      
 
7. Over the past 2 weeks, on average, how many times has shortness of breath limited your ability to do 







once a day 
3 or more times per 








the past 2 
weeks 
       
8. Over the past 2 weeks, how much has your shortness of breath bothered you?  
It has been. ..  
Extremely 
bothersome 






Not at all 
bothersome 
I've had no 
shortness of 
breath 
      
9. Over the past 2 weeks, on average, how many times have you been forced to sleep sitting up in a chair or 
with at least 3 pillows to prop you up because of shortness of breath? 
Every night 3 or more times a week, but 
not every day 
1-2 times a 
week 
Less than once a 
week 
Never over the past 
2 weeks 
     
10. Heart failure symptoms can worsen for a number of reasons. How sure are you that you know what to 
do, or whom to call, if your heart failure gets worse?  






     
 
11. How well do you understand what things you are able to do to keep your heart failure symptoms from 
getting worse? (for example, weighing yourself, eating a low salt diet, etc.)  
Do not understand at 
all 














12. Over the past 2 weeks, how much has your heart failure limited your enjoyment of life?  
It has extremely 
limited my 
enjoyment of life 
It has limited my 
enjoyment of life 
quite a bit 
It has moderately 
limited my 
enjoyment of life 
It has slightly 
limited my 
enjoyment of life 
It has not 
limited my 
enjoyment of 
life at all 
     
 
13. If you had to spend the rest of your life with your heart failure the way it is right now, how would you 
feel about this?  










     
 
14. Over the past 2 weeks, how often have you felt discouraged or down in the dumps because of your heart 
failure?  
I felt that way all 
of the time 
I felt that way most 
of the time 
I occasionally felt 
that way 
I rarely felt that 
way 
I never felt that 
way 
     
 
15. How much does your heart failure affect your lifestyle? Please indicate how your heart failure may have 
limited your participation in the following activities over the past 2 weeks.  











Does not apply 




activities       
Working or doing 
household chores       
Visiting family or 
friends out of your 
home 
      
Intimate relationships 
with loved ones       
 
Resource: 
Green, C. P., Porter, C. B., Bresnahan, D. R., & Spertus, J. A. (2000). Development and evaluation of the 
Kansas City Cardiomyopathy Questionnaire: A new health status measure for heart failure. 
Journal of the American College of Cardiology, 35, 1245-1255. 
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Pittsburgh Sleep Quality Index (PSQI) 
 
INSTRUCTIONS: 
The following questions relate to your usual sleep habits during the past month only.  Your answers 
should indicate the most accurate reply for the majority of days and nights in the past month.  Please 
answer all questions. 
 
1. During the past month, what time have you usually gone to bed at night?   
 
BED TIME ___________ 
 
2. During the past month, how long (in minutes) has it usually taken you to fall asleep each night? 
NUMBER OF MINUTES ________ 
 
3. During the past month, what time have you usually gotten up in the morning?    
  
GETTING UP TIME ________ 
 
4. During the past month, how many hours of actual sleep did you get at night? (This may be different 
than the number of hours you spent in bed.)   
 
HOURS OF SLEEP PER NIGHT ___________ 
 
For each of the remaining questions, check the one best response.  Please answer all questions. 
 
5. During the past month, how often have you had trouble sleeping because you . . . 
 
a) Cannot get to sleep within 30 minutes 
 
Not during the Less than Once or twice Three or more 
past month_____ once a week_____ a week_____ times a week _____ 
 
b) Wake up in the middle of the night or early morning 
 
Not during the Less than Once or twice Three or more 
past month_____ once a week_____ a week_____ times a week_____ 
 
c) Have to get up to use the bathroom 
 
Not during the Less than Once or twice Three or more 
past month_____ once a week_____ a week_____ times a week_____ 
 
d) Cannot breathe comfortably 
 
Not during the Less than Once or twice Three or more 





e) Cough or snore loudly 
 
Not during the Less than Once or twice Three or more 
past month_____ once a week_____ a week_____ times a week_____ 
 
f) Feel too cold 
 
Not during the Less than Once or twice Three or more 
past month_____ once a week_____ a week_____ times a week_____ 
 
g) Feel too hot 
 
Not during the Less than Once or twice Three or more 
past month_____ once a week_____ a week_____ times a week_____ 
 
h) Had bad dreams 
 
Not during the Less than Once or twice Three or more 
past month_____ once a week_____ a week_____ times a week_____ 
 
i) Have pain 
 
Not during the Less than                Once or twice Three or more 
past month_____ once a week_____ a week_____ times a week_____ 
 
j) Other reason(s), please describe_________________________________________ 
How often during the past month have you had trouble sleeping because of this? 
 
Not during the Less than Once or twice Three or more 
past month_____ once a week_____ a week_____ times a week_____ 
 
6. During the past month, how would you rate your sleep quality overall? 
    
Very good _____   Fairly good _____  Fairly bad _____ Very bad _______ 
 
7. During the past month, how often have you taken medicine to help you sleep (prescribed or "over the 
counter")? 
 
Not during the Less than Once or twice Three or more 
past month_____ once a week_____     a week_____ times a week_____ 
 
8. During the past month, how often have you had trouble staying awake while driving, eating meals, or 
engaging in social activity? 
 
Not during the Less than Once or twice   Three or more 
past month_____ once a week_____ a week_____   times a week_____ 
 
9. During the past month, how much of a problem has it been for you to keep up enough enthusiasm to get 
things done? 
 
No problem at all _______        Only a very slight problem_______ 
Somewhat of a problem_________  A very big problem__________ 
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10. Do you have a bed partner or room mate? 
   
No bed partner or room mate ______  Partner/room mate in other room________ 
Partner in same room, but not same bed _______ Partner in same bed ________ 
 
11.If you have a room mate or bed partner, ask him/her how often in the past month you have had . . . 
 
a) Loud snoring 
 
Not during the Less than Once or twice Three or more 
past month_____ once a week_____ a week_____ times a week_____ 
 
b) Long pauses between breaths while asleep 
 
Not during the Less than Once or twice Three or more 
past month_____ once a week_____ a week_____ times a week_____ 
 
c) Legs twitching or jerking while you sleep 
 
Not during the Less than Once or twice Three or more 
past month_____ once a week_____ a week_____ times a week_____ 
 
d) Episodes of disorientation or confusion during sleep 
Not during the Less than Once or twice Three or more 
past month_____ once a week_____ a week_____ times a week_____ 
 
e) Other restlessness while you sleep; please describe ________________________ 
 
Not during the Less than Once or twice Three or more 
past month_____ once a week_____ a week_____ times a week_____ 
 
Resource 
Buysse, D. J., Reynolds, . C. F., Monk, T. H., Berman, S. R., & Kupfer, D. J. (1989). The Pittsburgh Ⅲ




The Epworth Sleepiness Scale 
 
How likely are you to dose off or fall asleep in the following situations, in contrast to 
feeling just tired? This refers to your usual way of life in recent times. Even if you have 
not done some of these things recently try to work out how they would have affected you. 
Use the following scale to choose the most appropriate number for each situation: 
0— would never doze; 1—light chance of dozing; 2—moderate chance of dozing; 
3—high chance of dozing. 
 
1. Sitting and reading 0 1 2 3 
2. Watching TV 0 1 2 3 
3. Sitting, inactive in a public place (e.g. a theater or a 
meeting) 
0 1 2 3 
4. As a passenger in a car for an hour without a break 0 1 2 3 
5. Lying down to rest in the afternoon when circumstances 
permit 
0 1 2 3 
6. Sitting and taking to someone 0 1 2 3 
7. Sitting quietly after a lunch without alcohol 0 1 2 3 
8. In a car, while stopped for a few minutes in the traffic 0 1 2 3 
Resource: 
Johns, M. W. (1991). A new method for measuring daytime sleepiness: The Epworth 
Sleepiness Scale. Sleep, 14, 540-545. 
 
Do you take a nap in daytime?  No    Yes    
If yes, please indicate how many times per week:______________ or check from the 
below answers. 
everyday  5-6 times per week   3-4 times per week  1-2 times per week 
How long for the napping each time _____hours ______minutes 
 
Thanks so much for completing the questionnaires!
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Demographic Questionnaire (Chinese Version) 
個人基本資料                ID: 
出生年月日：                             性別： 女  男 
 
身高：              公分        體重：              公斤 
 
患心臟衰竭已    年    月    
 
婚姻狀況： 已婚   分居  離婚  喪偶  未婚   其它                      
 
教育程度： 不識字  識字，未曾上學或小學肄業  小學畢業  國中畢業 
高中畢業  專科   
大學  研究所或以上   其它          
 
居住狀況： 獨居   與家人同住   與朋友同住   安養院與其它機構   
其它                  
 
職業： 有    無    因疾病失去工作    退休    其它          
 
經濟狀況： 差，不夠日常生活開銷   正好足夠日常生活開銷         
          很好，非常足夠日常生活開銷   其它                         
 
語言: 國語  台語  以上二種 
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病歷資料收集 (Data from practice medical record) 
 
紐約心臟功能分類：                心射出率：       
 
心衰竭： 收縮性    舒張性 
 
Medications: ACEI_________________    Beta-Blocker__________________ 
           ARB__________________    Diuretic_______________________ 
           Digitalis________________   Aldosterone Inhibitor____________ 
Vasodilator______________   alpha adrenergic antagonist_______ 
Blood thinner____________    ASA_______________     
Lipid-Lower _____________   Calcium Blocker ______________ 






 糖尿病= 第一型、第二型 
 甲狀腺= 功能低下、功能亢進、甲狀腺腫 
 肺部疾病= 氣喘、肺氣腫、慢性支氣管炎、或慢性阻塞性肺疾病、或______ 
 腎臟疾病= 慢性腎功能缺失、血液透析、腹膜透析， 或___________________ 
 腸胃疾病= 慢性肝炎、肝硬化、潰瘍、或________________________ 
 神經系統= 中風、短暫性缺血發作、頸動脈手術/血管成型術、失智、阿茲海莫
症、或___________________ 
 癌症= __________________________________________ 
 肌肉骨骼疾病= 風濕性關節炎、骨性關節炎、或________________________ 
 心理方面= 憂鬱、酒精濫用、慢性疼痛、或________________________ 
 其它= _____________________________________________________________ 
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Self-Reported Charlson Comorbidity Index (Chinese Version) 
疾病史 
請勾選您罹患的疾病，如果您並沒有該項疾病或情況，請選 “無”。 
  有 無 
心肌梗塞 
1. 您曾心臟病發作過?   
心臟衰竭 
2. 您曾接受心臟衰竭治療?   
週邊血管疾病 
3. 您的小腿動脈曾開刀清除血栓或進行繞道手術?   
中風 
4. 您曾有中風、腦部血栓或出血、或短暫缺血性發作?   
半身癱瘓 
5. 您因為中風而有困難移動手或腳?   
慢性阻塞性肺疾病 
6. 您有氣喘嗎?   
6a. 若有，有服用藥物嗎?   
6b. 您只有在發作時服用?   
6c. 您規則服藥，甚至沒有發作也是?   
6d. 您有肺氣腫、慢性支氣管炎、或慢性阻塞性肺疾病嗎?   
6e. 若有，有服用藥物嗎?   
6f. 您只有在發作時服用?   
6g. 您規則服藥，甚至沒有發作也是?   
胃潰瘍 
7. 您有胃潰瘍或消化性潰瘍?   
 若有，是經由吞胃鏡、上消化道檢查或吞鋇劑檢查(吞一種白
色液體之後照 X 光)所做出的診斷? 
  
糖尿病 
8. 您有糖尿病(高血糖)?   
8a. 若有，目前以飲食控制?   
8b. 若有，現在以口服血糖藥物控制?   
8c. 以注射胰島素控制?   
9a. 您的糖尿病已有造成腎功能問題?   
9b. 您的糖尿病已有造成眼睛問題，須接受眼科醫師治療?   
腎臟疾病 
10. 您曾有腎功能變差(抽血檢查顯示血清肌酸酐升高)?   
10a. 您曾接受洗腎或腹膜透析?   
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10b. 您曾接受腎臟移植?   
結締組織疾病 
11. 您有風濕性關節炎?   
11a. 若有，您有規則服用藥物?   
11b. 您有狼瘡(全身性紅斑性狼瘡)?   
11c. 您有風濕性 多發性肌痛症   
失智症、肝疾病、白血病、淋巴瘤、腫瘤、癌症轉移、愛滋病 
您有下列任何一個疾病? 
12. 阿茲海莫疾病，或其他種類的失智症?   
13. 肝硬化，或其他肝損傷?   
14. 這肝臟損傷是中度或重度?   
15. 白血病、或真性紅細胞增多症?   
16. 淋巴瘤?   
17. 癌症，除皮膚癌、白血病、淋巴瘤外?   
18. 若有癌症，癌症已擴散或轉移到其他器官?   
19. 愛滋病?   
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Self-Rated Health Subscale (Chinese Version) 
自評健康狀況 
請回答以下四個問題，並勾選一個最適合描述您的健康狀況的答案。 
5. 您認為您現在的整體健康狀況如何？  
非常好  好   還可以   差 
6. 跟一年前比，您現在的健康狀況？   
比較好   相同   比較差 
7. 您目前的健康問題會妨礙您做您想要做的事嗎？     
一點也不妨礙     有些妨礙     妨礙很多 
8. 跟大多數同年齡的人比較起來，您認為您現在的健康狀況？    








1. 心臟衰竭對不同的人有不同的影響，有些人感到呼吸急促 (喘)，而有些人感到疲憊 (累)。請指
出在過去的二個禮拜內，心臟衰竭（呼吸急促 [喘] 或疲憊 [累]）對您從事下列活動的能力有多
少限制。 















自己穿衣服       
淋浴/盆浴       
在平地上走一個路段 (在平
地上走一百公尺)       
做庭院工作，家事，或拿食
品雜貨(買的東西)       
爬一段的階梯 (大約半層樓) 
不需要停       
趕時間或小跑步（如就像去
趕搭公車） 
      
 
2.跟二個禮拜前相比，您的心臟衰竭症狀 (呼吸急促[喘]、疲憊[累]或腳踝腫脹[水腫])有改變嗎？   
我的心臟衰竭症狀變的… 
變的更差 稍微變差 沒有改變 稍微變好 好很多 我在過去二個禮拜沒有症
狀 

















嚴重的困擾 相當的困擾 中度困擾 稍微困擾 一點也沒有困
擾 
我並沒有腫脹 





































































一點也不確定 不是很確定 一半確定 大部分確定 完全確定 
     
 
11.您有多了解您可以做哪些事來避免您的心臟衰竭症狀變嚴重？(例如:秤體重、吃低鹽飲食…等等) 
一點也不了解 不是很了解 一半了解 大部分了解 完全了解 
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12. 在過去的二個禮拜，您的心臟衰竭有多限制您享受您的生活？ 
    我的生活享受已經被…. 
嚴重受到限制 相當受到限制 中度受到限制 稍微受到限制 並沒有受到限制 
     
 
13.假如您的後半輩子都必須與您目前有的心臟衰竭狀況相處，您對這樣的狀況滿意嗎？ 
一點也不滿意 大部分不滿意 一半滿意 大部分滿意 完全滿意 





























興趣、休閒活動       
工作或做家務       
外出拜訪家人或朋友       
與親愛的人有親密關係       
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1.過去一個月來，您晚上通常幾點睡覺？            點            分 
2.過去一個月來，您在上床後，通常躺多久才能入睡？            分 
3.過去一個月來，您早上通常幾點起床？            點            分 
4.過去一個月來，您每天晚上真正睡著的時間約多少？ (這可能和您躺在床上所花














a.無法在 30 分鐘內入睡 
    
b.半夜或清晨醒來     
c.需要起床上廁所     
d.呼吸不順暢     
e.咳嗽或大聲打鼾     
f.感覺很冷     
g.感覺很熱     
h.作惡夢     
i.疼痛     
j.其他情況請說明:______________。     
6.過去一個月來，您有多少次需要藉助藥
物(醫師處方或成藥)來幫助睡眠？ 
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 非常好 好 不好 非常不好
9.過去一個月來，您對您自己的睡眠品質
整體評價如何？ 
    
 
您有無室友或睡眠伴侶? 
沒有室友或睡眠伴侶                     室友或睡眠伴侶睡在其他房間 




 從未發生 每週少於一次 每週 1-2 次 每週 3 次以上
大聲打鼾     
呼吸暫停     
腿部抽動     








    
 
Resource: 
Tsai, P.-S., Wang, S.-Y., Wang, M.-Y., Su, C.-T., Yang, T.-T., Huang, C.-J., et al. (2005). 
Psychometric evaluation of the Chinese version of the Pittsburgh Sleep Quality 
Index (CPSQI) in primary insomnia and control subjects. Quality of Life Research, 
14, 1943-1952. 
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0:從未 1:很少 2:一半以上 3:幾乎都會 
 0 1 2 3 
1.坐著閱讀時 0 1 2 3 
2.看電視時 0 1 2 3 
3.在公眾場合安靜坐著 (如在戲院或會議中) 0 1 2 3 
4.坐車連續超過一小時 (不包含自己開車) 0 1 2 3 
5.在下午躺下休息時 0 1 2 3 
6.坐著與人交談時 0 1 2 3 
7.沒有喝酒的情況下, 在午餐後安靜坐著時 0 1 2 3 
8.開車或坐車中遇到交通問題而停下數分鐘時 0 1 2 3 
ESS v.2 Authority from Dr. Chen, Ning-Hung 
Published in Quality of Life Research. 2002;11:817-21 
 
 
您是否有午睡習慣   無  有，若有，一周約幾次:                       
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